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ABSTRACT 
 
 
Recovery after prolonged or high-intensity exercise is characterised by a substantial 
increase in adipose tissue lipolysis, resulting in elevated rates of plasma-derived fat 
oxidation. Despite the large increase in circulating fatty acids (FAs) after exercise, 
only a small fraction of this is taken up by exercised muscle in the lower extremities. 
Indeed, the predominant fate of non-oxidised FAs derived from post-exercise 
lipolysis is reesterification in the liver. During recovery from endurance exercise, a 
number of changes also occur in skeletal muscle that allow for a high metabolic 
priority towards glycogen resynthesis. Reducing muscle glycogen during exercise 
potentiates these effects, however the cellular and molecular mechanisms regulating 
substrate oxidation following exercise remain poorly defined. The broad aim of this 
thesis was to examine the regulation of fat metabolism during recovery from 
glycogen-lowering exercise in the presence of altered fat and glucose availability. In 
study I, eight endurance-trained males completed a bout of exhaustive exercise 
followed by ingestion of carbohydrate (CHO)-rich meals (64-70% of energy from 
CHO) at 1, 4, and 7 h of recovery. Duplicate muscle biopsies were obtained at 
exhaustion and 3, 6 and 18 h of recovery. Despite the large intake of CHO during 
recovery (491 ± 28 g or 6.8 ± 0.3 g · kg-1), respiratory exchange ratio values of 0.77 
to 0.84 indicated a greater reliance on fat as an oxidative fuel. Intramuscular 
triacylglycerol (IMTG) content remained unchanged in the presence of elevated 
glucose and insulin levels during recovery, suggesting IMTG has a negligible role in 
contributing to the enhanced fat oxidation after exhaustive exercise. It appears that 
the partitioning of exogenous glucose towards glycogen resynthesis is of high 
metabolic priority during immediate post-exercise recovery, supported by the trend 
towards reduced pyruvate dehydrogenase (PDH) activity and increased fat oxidation. 
The effect of altering plasma FA availability during post-exercise recovery was 
examined in study II. Eight endurance-trained males performed three trials consisting 
of glycogen-lowering exercise, followed by infusion of either saline (CON), saline + 
nicotinic acid (NA) (LFA) or Intralipid and heparin (HFA). Muscle biopsies were 
obtained at the end of exercise (0 h) and at 3 and 6 h in recovery. Altering the 
availability of plasma FAs during recovery induced changes in whole-body fat 
oxidation that were unrelated to differences in skeletal muscle malonyl-CoA. 
Furthermore, fat oxidation and acetyl-CoA carboxylase (ACC) phosphorylation 
 vi 
appear to be dissociated after exercise, suggesting mechanisms other than 
phosphorylation-mediated changes in ACC activity have an important role in 
regulating malonyl-CoA and fat metabolism in human skeletal muscle after exercise. 
Alternative mechanisms include citrate and long-chain fatty acyl-CoA mediated 
changes in ACC activity, or differences in malonyl-CoA decarboxylase (MCD) 
activity. Reducing plasma FA concentrations with NA attenuated the post-exercise 
increase in MCD and pyruvate dehydrogenase kinase 4 (PDK4) gene expression, 
suggesting that FAs and/or other factors induced by NA are involved in the 
regulation of these genes. Despite marked changes in plasma FA availability, no 
significant changes in IMTG concentration were detected, providing further evidence 
that plasma-derived FAs are the preferential fuel source contributing to the enhanced 
fat oxidation post-exercise during recovery. To further examine the effect of 
substrate availability after exercise, Study III investigated the regulation of fat 
metabolism during a 6 h recovery period with or without glucose infusion. Enhanced 
glucose availability significantly increased CHO oxidation compared with the fasted 
state, although no differences in whole-body fat oxidation were apparent. Consistent 
with the similar rates of fat metabolism, no difference in AMPK or ACCβ 
phosphorylation were observed between trials. In addition, no significant treatment 
or time effects for IMTG concentration were detected during recovery. The large 
exercise-induced PDK4 gene expression was attenuated when plasma FAs were 
reduced during glucose infusion, supporting the hypothesis that PDK4 is responsive 
to sustained changes in lipid availability and/or changes in plasma insulin. 
Furthermore, the possibility exists that the suppression of PDK4 mRNA also reduced 
PDK activity and thus maintained PDH activity to account for the higher rates of 
CHO oxidation observed during glucose infusion compared with the control trial. 
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CHAPTER ONE 
LITERATURE REVIEW 
 
 
1.1.  INTRODUCTION 
The production of ATP (oxidative phosphorylation) for resting and contracting 
skeletal muscle is derived mainly from stores of fat and carbohydrate in well-fed 
humans. Skeletal muscle is the primary site for glucose and fatty acid (FA) disposal 
and therefore has a significant role in maintaining whole body metabolic 
homeostasis. Fat is available to skeletal muscle in the form of FAs, derived primarily 
from lipolysis within peripheral adipose tissue stores and possibly from adipocytes 
located between skeletal muscle fibers. FAs are also obtained in small amounts from 
circulating chylomicrons and very low-density lipoproteins (VLDL) as well as 
intramuscular triacylglycerols (IMTG). Carbohydrates however, are stored primarily 
as glycogen within muscle fibers. The liver also stores limited amounts of glycogen, 
which serves to maintain plasma glucose levels during rest and muscle contraction. 
An overview of fat and carbohydrate (CHO) energy stores is provided in Table 1.1. 
 
As an energy source, fat has a higher energy yield per unit mass than CHO (37.5 vs 
16.9 kJ/g) and is stored in relatively large quantities in the body (Table 1.1). 
Therefore, fat can provide a substantial amount of substrate for oxidative 
phosphorylation at rest and during submaximal endurance exercise. Although fat is 
an important metabolic fuel, the capacity to oxidise FAs from extra- and 
intramuscular fat stores is often limited and in many cases CHOs are the major 
substrate. The underlying mechanisms for this limitation are not completely 
understood and the interpretation of studies examining the regulation of fat 
metabolism remain equivocal. FAs are also known to function as precursors for lipid-
signaling molecules and ligands for transcription factors that control gene expression. 
Thus, there is an increasing need to understand the role of FAs at the molecular level 
and how they regulate cellular metabolism. 
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Table 1.1.  Energy stores of an 80 kg man 
Substrate Weight (g) Energy (kJ) 
Fat                       Plasma fatty acids 0.4 15 
                             Plasma triacylglycerols 4.0 150 
                             Intramuscular triacylglycerols 300 11 250 
                             Adipose tissue 12 000 450 000 
                             Total (approximately) 12 304 461 400  
Carbohydrate     Plasma glucose 20 338 
                             Liver glycogen 100 1790 
                             Muscle glycogen 350 6265 
                             Total (approximately) 470 7943 
Based on estimates for a “normal”, non-obese male with a body mass of 80 kg.  
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1.2.  OVERVIEW OF SKELETAL MUSCLE FAT METABOLISM 
Skeletal muscle is the predominant tissue regulating whole body fat oxidation, 
accounting for up to 90% of energy requirements at rest (Dagenais et al., 1976; van 
Loon et al., 2001). In the post-absorptive state, plasma FAs derived from peripheral 
adipose tissue triacylglycerols (TG) contribute almost exclusively to oxidative 
energy production (van Loon et al., 2001), most likely from a FA mediated reduction 
in glucose metabolism (Spriet et al., 2004). The role of fat as an energy substrate 
during short and long-term exercise has been well reviewed in recent publications 
(Holloszy et al., 1998; Jeukendrup et al., 1998b, a; Wolfe, 1998b; Jeukendrup, 2002; 
Spriet, 2002), however much less is known about the mechanisms regulating FA 
metabolism during post-exercise recovery. 
 
 1.2.1. Fat as a Fuel During Exercise   
In the transition from rest to low intensity exercise (25% of 2OV& max), FAs released 
from adipose tissue continue to provide a majority of the oxidative fuel for working 
muscle (Romijn et al., 1993a). During the first 2 h of moderate intensity exercise 
(55–65% of 2OV& max), the relative contribution of plasma FA and TG sources (sum of 
IMTG and lipoprotein derived triglycerides) to total fat oxidation is approximately 
equal in endurance-trained individuals (Romijn et al., 1993a; van Loon et al., 2001). 
However, when moderate intensity exercise extends beyond 2 h the progressive 
increase in plasma FFA is associated with a greater reliance on blood-borne fat 
oxidation (Watt et al., 2002a). At high exercise intensities (>80% of 2OV& max) 
circulating FAs are markedly reduced, although this does not entirely account for the 
decline in fat oxidation (Romijn et al., 1993a; Romijn et al., 1995). Evidence 
suggests that FA oxidation during high intensity exercise is also limited by direct 
inhibition of long-chain FAs (LCFAs) entry into the mitochondria (Sidossis et al., 
1997; Kiens et al., 1999; van Loon et al., 2001).  
 
During moderate intensity exercise, fat oxidation from sources other than plasma 
FAs is thought to be derived primarily from IMTG since the contribution from 
circulating lipoproteins (VLDL) under normal dietary conditions is typically less 
than 10% of total fat metabolism (Helge et al., 2001). On the basis of these findings, 
many investigators believe that IMTG is an important energy substrate during long-
term endurance activities (Havel et al., 1967; Essen et al., 1977; Romijn et al., 
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1993a; Klein et al., 1994; Romijn et al., 1995; Watt et al., 2002b). Studies using 
tracer methodology have generally reported IMTG utilisation across a range of 
exercise intensities (30–80% 2OV& max)  in both untrained (Martin et al., 1993; Phillips 
et al., 1996; Sidossis et al., 1997; Friedlander et al., 1999; Schrauwen et al., 2000) 
and trained individuals (Romijn et al., 1993a; Coyle et al., 2001; van Loon et al., 
2001) during cycle exercise lasting 30-120 min. Using the non-invasive technique of 
magnetic resonance spectroscopy (1H-MRS), a majority of studies also demonstrate a 
net utilisation (~20-50%) of IMTG during 90-120 min of exercise (Boesch et al., 
1997; Boesch et al., 1999; Krssak et al., 2000; Rico-Sanz et al., 2000; Brechtel et al., 
2001b; Decombaz et al., 2001; Larson-Meyer et al., 2002), while direct measurement 
of IMTG content from skeletal muscle biopsies have been controversial (for review, 
see (Watt et al., 2002b). The discrepancies reported in these studies may be 
explained by the methodological differences in measuring IMTG, limitations 
associated with the muscle biopsy technique, and the variability in IMTG content 
between trained and untrained individuals (Szczepaniak et al., 1999). A major 
limitation when using the muscle biopsy procedure is the technical difficulty in 
separating intra- from extramuscular triglyceride (EMTG). Indeed, EMTG has been 
found to be highly variable in humans as measured by 1H-MRS (Szczepaniak et al., 
1999). Training status may also be an important consideration for reducing the 
variability associated with IMTG measurement from muscle biopsies (Wendling et 
al., 1996; Watt et al., 2002a), as EMTG storage is lower in endurance trained 
compared to untrained individuals (Hoppeler, 1986; Szczepaniak et al., 1999). 
 
 1.2.2. Fat Metabolism During Post-Exercise Recovery   
In the fasted state, there is substantial FA mobilisation from adipose tissue following 
prolonged exercise (Mulla et al., 2000), resulting in elevated rates of plasma-derived 
fat oxidation (Ahlborg & Felig, 1982; Krzentowski et al., 1982; Bielinski et al., 
1985; Devlin et al., 1989; Wolfe et al., 1990; Tuominen et al., 1996; Schrauwen et 
al., 1997; Tuominen et al., 1997; Kiens & Richter, 1998; Mulla et al., 2000). Despite 
the large increase in circulating FAs after exercise, only a small fraction of this is 
taken up by exercised muscle in the lower extremities (Mulla et al., 2000). Evidence 
suggests the predominant fate of the non-oxidised FAs derived from post-exercise 
lipolysis is reesterification in the liver, accounting for up to 90% of the FAs released 
during recovery (Wolfe et al., 1990). Furthermore, exercise intensity is positively 
related to fat oxidation during recovery (Pritzlaff et al., 2000), whilst FA uptake and 
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oxidation are enhanced during moderate-intensity exercise in a glycogen depleted 
state (Wojtaszewski et al., 2003). These data suggest that the magnitude of muscle 
glycogen depletion during exercise influences the utilisation of LCFAs as an energy 
substrate (Blomstrand & Saltin, 1999).  
 
During recovery from glycogen-depleting exercise in well-trained individuals, it has 
been demonstrated using the muscle biopsy technique that IMTG is also an important 
source of FAs for skeletal muscle oxidation (Kiens & Richter, 1998). Paradoxically, 
the reduction in IMTG concentration occurred during conditions of elevated glucose 
and insulin which are known to reduce hormone-sensitive lipase (HSL) activity 
(Watt et al., 2004) and calculated IMTG oxidation during low intensity exercise 
(Coyle et al., 1997). Studies using 1H-MRS in endurance-trained subjects have failed 
to demonstrate a reduction in muscle triglyceride (TG) when a high-CHO diet is 
consumed during post-exercise recovery, reporting either unchanged (Decombaz et 
al., 2000; Decombaz et al., 2001) or increased (Larson-Meyer et al., 2002) IMTG 
content. It should be noted that there are several differences between the biopsy and 
MRS studies which may result in different findings. First, IMTG is measured in 
soleus or tibialis anterior muscles (primarily Type I fibres) in the MRS studies, as 
opposed to the vastus lateralis (50% Type I / 50% Type II) in the biopsy studies. 
Second, the recruitment pattern is likely to be different in these muscles given the 
different modes of exercise (running, MRS; cycling, biopsy). Third, the timing of 
post-exercise sampling may be an issue, since an initial post-exercise IMTG 
measurement was not determined until 22 h of recovery using MRS (Larson-Meyer 
et al., 2002) as opposed to a more detailed time course in the first 6 h of recovery 
using biopsies (Kiens & Richter, 1998). Therefore, further research is warranted to 
elucidate whether IMTG is a significant source of FAs contributing to post-exercise 
skeletal muscle fat metabolism.   
 
The role of CHO ingestion on muscle TG resynthesis after prolonged exercise has 
also been examined. Following glycogen reducing exercise, IMTG concentration 
failed to return to baseline after 24 h of high CHO feeding (83% of total energy) 
(Starling et al., 1997). Subsequent studies using 1H-MRS in endurance-trained males 
(Van Loon et al., 2003) and females (Larson-Meyer et al., 2002) have also 
demonstrated that IMTG repletion is impaired when a typical CHO-rich athlete’s diet 
consumed for 48 h (Van Loon et al., 2003) and 70 h (Larson-Meyer et al., 2002) 
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after prolonged exercise. These data suggest that a certain quantity of dietary fat is 
required to replenish IMTG after endurance exercise. Indeed, high-fat feeding (68% 
of total energy) was observed to increase IMTG stores and reduce muscle glycogen 
synthesis 24 h after prolonged cycling compared with a high-CHO diet (Starling et 
al., 1997). More recent studies have also demonstrated that IMTG content increases 
in response to high-fat feeding after glycogen-lowering exercise (Decombaz et al., 
2000; Decombaz et al., 2001; Larson-Meyer et al., 2002) and that this effect is 
independent of training status (Decombaz et al., 2001). In the absence of glycogen-
lowering exercise, increases in IMTG stores are also observed during conditions of 
elevated plasma FAs with (Bachmann et al., 2001; Brechtel et al., 2001a) and 
without (Boden et al., 2001) a hyperinsulinemic glucose clamp. Conversely, a 3 
week low-fat diet (2% of total energy) significantly reduces IMTG concentration 
compared with an intake of 22% of energy from fat (Coyle et al., 2001). 
 
1.3.  PATHWAY OF SKELETAL MUSCLE FAT OXIDATION 
Fatty acid oxidation within skeletal muscle involves a complex sequence of events 
that include: 1) mobilisation from peripheral adipose tissue, 2) transport to the 
muscle, 3) uptake of plasma FAs by the muscle cell, 4) mobilisation from IMTG 
pools, 5) transport into the mitochondria, and 6) oxidation within the mitochondria. 
Some of these steps are also potential sites for the regulation of fat metabolism which 
will be discussed in section 1.4. 
 
 1.3.1. Adipose Tissue Lipolysis and FFA Delivery to Muscle   
The mobilisation of FAs from adipose tissue is the first important step in the 
regulation of fat metabolism and overall energy homeostasis during rest and exercise. 
Lipolysis is mediated by the activation of the rate-limiting enzyme HSL in adipose 
tissue (Fredrikson et al., 1981). Control of lipolysis is complex and occurs mainly by 
sympathetic nervous system activity, plasma catecholamine concentrations 
(norepinephrine and epinephrine) and plasma insulin levels. Stimulation of 
adrenergic receptors on the adipocyte membrane activates a cyclic AMP-dependent 
protein kinase A (PKA) and simulataneously phosphorylates HSL and the lipid-
droplet associated protein, perilipin, resulting in increased HSL activity and the 
translocation of the enzyme from the cytosol to the surface of the lipid droplet. 
Recent evidence indicates that β-adrenergic stimulation may also activate HSL via 
extracellular signal-regulated kinases (ERK), one of the mitogen-activated protein 
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kinase (MAPK) pathways that transduce extracellular signals into intracellular 
responses (Greenberg et al., 2001). Increased HSL activity alone catalyses the 
hydrolysis of triglycerides and diglycerides to yield two molecules of nonesterified 
FAs, whereas the participation of monoglyceride lipase (MGL) is required to liberate 
the remaining FA and a glycerol molecule (Figure 1.1). Insulin is the most important 
physiological inhibitor of catecholamine-induced lipolysis, inducing a decrease in 
cAMP levels and concomitant decrease in HSL activity. Indeed, ingestion of 
carbohydrate can be a powerful mediator of adipose tissue lipolysis at rest and during 
exercise. Small elevations in plasma insulin concentration (i.e., 10-30 µU/ml) 
dramatically reduce lipolysis at rest, although lipolytic rate still remains in excess of 
FA oxidation in basal conditions (Campbell et al., 1992).  
 
Studies using microdialysis in abdominal adipose tissue in man have shown 
antilipolytic α2-adrenergic receptors to modulate lipolysis at rest (Arner et al., 1990) 
and during exercise (Wolfe et al., 1990), whereas β1-adrenergic stimulatory effects 
are predominant only during exercise (Arner et al., 1990). Following 1 h of exercise 
at 70% of 2OV& max, in vivo lipolytic sensitivity to epinephrine mediated β-adrenergic 
stimulation does not increase in endurance trained individuals (Klein et al., 1995). 
However, triglyceride-FA cycling in the resting state is markedly increased in highly 
trained endurance athletes, providing FAs in excess of the rate of FA oxidation that 
may enhance the potential for increasing FA oxidation rapidly at the onset of 
exercise (Romijn et al., 1993b).  
 
The delivery of FA to skeletal muscle is a function of adipose tissue blood flow, the 
plasma FA concentration and muscle blood flow. Upon release into the blood stream, 
FA are quickly bound to serum albumin and transported primarily to skeletal muscle 
and liver tissue where they are oxidised or reesterified into a TG molecule 
(extracellular reesterification). At rest, non-oxidative lipolysis can account for ~70% 
of all nonesterified FA released from adipose tissue, resulting primarily from 
extracellular reesterification (Wolfe et al., 1990). Delivery of plasma FA are closely 
matched to uptake at rest and during low intensity exercise, while FA levels increase 
progressively at a moderate exercise intensity (65% of 2OV& max) to maintain high 
plasma FA uptake and oxidation rates (Watt et al., 2002a). During high intensity 
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exercise (85% of 2OV& max), plasma FA concentration is markedly reduced despite the 
maintenance of lipolysis, suggesting that the decline in adipose tissue blood flow 
limits the availability of albumin for FA transport in the blood (Romijn et al., 1993a). 
 
 1.3.2. FA Transport Across the Muscle Cell Membrane 
Until recently, permeation of FAs across the plasma membrane was believed to occur 
via a simple process of passive diffusion down a concentration gradient because of 
the lipophilic nature of the FA molecule (Potter et al., 1989). However, it is now 
recognised that at least part of the uptake of FAs may occur through a protein-
mediated transport system that allows FA entry into the cell and movement within 
the cytosol for mitochondrial oxidation (Bonen et al., 1998; Turcotte, 2000). Three 
proteins with potential roles in fat transport have been identified and cloned in 
skeletal muscle: the FA-binding protein in the plasma membrane (FABPPM) (Calles-
Escandon et al., 1996), the FA translocase (FAT/CD36) and the FA transport protein 
(FATP-1) (Abumrad et al., 1993). Consistent with the putative role of FABPPM and 
FAT/CD36 as FA transporters, palmitate transport rates into giant sarcolemmal 
vesicles appears to be a saturable process (Bonen et al., 1998), and palmitate uptake 
into red and white muscles correlates well with the expression of FABPPM and 
FAT/CD36 (Luiken et al., 1999). The role of FATP in fat transport is uncertain 
however as FATP content is inversely correlated with LCFA uptake (Luiken et al., 
1999). 
 
Endurance training has been demonstrated to increase the content of FABPPM in 
human skeletal muscle (Kiens et al., 1997), although equivocal findings have been 
observed in the rodent model (Turcotte et al., 1999; Dyck et al., 2000a). The 
expression of FAT/CD36 mRNA and protein is also enhanced when the oxidative 
capacity of skeletal muscle is increased by chronic electrical stimulation (Bonen et 
al., 1999). Furthermore, muscle contraction enhances palmitate uptake by giant 
vesicles that occurs in parallel with increases in plasma membrane FAT/CD36 
content (Bonen et al., 2000). More interestingly however, the same study has 
demonstrated that the acute regulation of FA transport during muscle contractions is 
mediated by translocation of the FAT/CD36 protein from an intracellular pool to the 
muscle membrane (Bonen et al., 2000), in a manner analogous to that reported for 
GLUT 4 stimulated glucose uptake. Therefore, exercise appears to be a powerful 
stimulus for promoting the intracellular redistribution of the FAT/CD36 transporter 
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and the rapid uptake of FAs from the plasma. Fat transporter activity and 
translocation is also under hormonal regulation. Insulin has recently been 
demonstrated to induce the translocation of FAT/CD36 to the plasma membrane 
(Luiken et al., 2002), thus enhancing FA uptake into resting skeletal muscle (Dyck et 
al., 2001; Luiken et al., 2002). However, factors that regulate fat transporter 
activation/translocation remain unknown. One possible candidate includes AMP-
activated protein kinase (AMPK) because it is associated with regulation of fat 
oxidation in resting and contracting skeletal muscle and has a role in controlling 
GLUT 4 translocation to the sarcolemma (Winder, 2001).   
 
 1.3.3. Muscle Triacylglycerol Utilisation 
The IMTG content in human skeletal muscle varies greatly (Wendling et al., 1996) 
and is relatively small compared with peripheral stores in adipose tissue. Normally 
skeletal muscle contains around 5–15 mmol⋅kg-1  wet weight of TG or a total store of 
300–400g, located as small fat droplets within the cytoplasm of muscle cells in close 
proximity to the mitochondria (Boesch et al., 1997; Hoppeler et al., 1999). In 
contrast to the uniform distribution of glycogen in muscle fibers, IMTG stores are 
variable within individual muscle fibres, between different fibre types and between 
different muscle groups. Histochemical techniques using oil red O staining has 
revealed that type I fibers contain considerably more TG (2.8-fold) than type II 
fibers, and type IIa fibers contain more TG than type IIb fibers (Essen, 1977). 
Quantifying the volume density of fat droplets using morphometric analysis has also 
shown similar patterns of fat storage in muscle fibers (Howald et al., 1985). 
Triglyceride stored between muscle fibers (EMTG) may also supply FFA for 
oxidation but little is known about the role of extra- versus intramuscular 
triacyglycerol stores. Recent 1H-MRS technology has established that EMTG is a 
relatively stable TG pool in comparison with IMTG during exercise and post-
exercise recovery (Larson-Meyer et al., 2002).  
 
Skeletal muscle contains three different types of triacylglycerol lipases (Oscai et al., 
1990). One is a lysosomal lipase with an in vitro pH optimum of 5. Another is a 
lipoprotein lipase (LPL) that was previously believed to control IMTG degradation 
because of the direct relationship between LPL activity and TG depletion in muscle. 
However, the presence of a neutral TG lipase, or the muscle version of HSL with a 
pH optimum of 7 has been identified in skeletal muscle (Holm et al., 1987) that 
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appears to have an important role in muscle TG hydrolysis (Langfort et al., 1999). 
HSL is covalently activated by kinase phosphorylation as previously described for 
adipose tissue (Figure 1.1). There are at least five known kinases that stimulate or 
inhibit HSL activity. Skeletal muscle HSL expression is correlated to fibre type, 
being higher in oxidative than in glycolytic fibres (Langfort et al., 1999). By using 
neutralising antibodies it was further confirmed that HSL accounts for a significant 
fraction of the TG lipase activity in skeletal muscle fibres (Langfort et al., 1999). 
HSL is also activated in parallel with glycogen phosphorylase in response to 
epinephrine, suggesting simultaneous activation of glycogen and TG breakdown 
(Langfort et al., 1999). The mechanisms involved in the β-adrenergic–induced 
activation of HSL are likely to mimic those in adipose tissue as described above. 
Indeed, increased ERK phosphorylation has been demonstrated to coincide with HSL 
activity in response to epinephrine infusion in resting human skeletal muscle (Watt et 
al., 2003c).  
 
 1.3.4. FA Transport Across the Mitochondrial Membrane 
After being transported across the muscle cell membrane, FAs can either be 
esterified and incorporated into various lipid pools (Dyck & Bonen, 1998) or bound 
to a FA binding protein in the cytosol (FABPc) and shuttled to the mitochondrial 
membrane. Once LCFA have been activated to fatty acyl-CoA by acyl-CoA 
synthase, their transport into the mitochondria for subsequent oxidation is facilitated 
by the carnitine palmitoyltransferase (CPT) complex, consisting of CPT I, 
acylcarnitine translocase and CPT II. Fatty acyl-CoA is free to permeate the outer 
mitochondrial membrane, however a carrier is required for the passage through the 
inner membrane. Translocation of fatty acyl-CoA requires the addition of carnitine, 
achieved by the conversion of the acyl-CoA ester to acyl-carnitine by CPT I, located 
on the outer mitochondrial membrane. Upon translocation into the mitochondrial 
matrix, the enzyme CPT II facilitates the reconversion of acyl-carnitine into fatty 
acyl-CoA, which undergoes enzymatic cleavage in the process of β-oxidation. The 
release of carnitine from CPT II enables the exchange with acyl-carnitine across the 
inner mitochondrial membrane in a 1:1 ratio, a process controlled by the enzyme acyl 
carnitine translocase (Figure 1.2). 
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 1.3.5. Mitochondrial β-Oxidation 
Mitochondrial β-oxidation is initiated when acyl-CoA is oxidised to enoyl-CoA by a 
family of four closely related, chain length specific enzymes known as fatty acyl-
CoA dehydrogenases (ACD). The next step involves hydration of enoyl-CoA to 
hydroxyacyl-CoA via enoyl-CoA hydratase, which is then oxidised to ketoacyl-CoA 
by the rate limiting enzyme beta-hydroxyacyl-CoA dehydrogenase (β-HAD). Studies 
have demonstrated that β-HAD is responsive to endurance training (Spina et al., 
1996) and to increases in FA availability induced by a fat-rich diet (Helge & Kiens, 
1997). The third and final step in the β-oxidation pathway is the cleavage of 
ketoacyl-CoA by acetyl-CoA acyltransferase, yielding an acetyl-CoA and fatty acyl-
CoA molecule. Acetyl-CoA immediately enters the tricarboxylic acid (TCA) cycle to 
ultimately generate ATP (Figure 1.2), whilst the fatty acyl-CoA repeats the β-
oxidative pathway until the entire carbon chain has been cleaved. 
 
1.4.  REGULATION OF SKELETAL MUSCLE FAT AND CARBOHYDRATE 
METABOLISM 
Many theories may account for the interaction between fat and CHO oxidation at rest 
and during exercise (Spriet & Watt, 2003), however substrate availability and the 
activity of key regulatory enzymes are believed to be the primary mechanisms. The 
reciprocal relationship between fat and CHO oxidation was first examined by 
(Randle et al., 1963) using contracting rat heart and resting diaphragm muscles. The 
‘glucose-fatty acid cycle’ was postulated to describe the down regulation of glucose 
oxidation due to the inhibitory effects of FAs on the enzymes phosphofructokinase 
(PFK), pyruvate dehydrogenase (PDH) and hexokinase (HK). The accelerated flux of 
FAs through β-oxidation has been proposed to increase the ratio of acetyl-CoA to 
CoA and inhibit PFK, whereas a TCA cycle mediated increase in citrate inhibits 
PDH. An increase in glucose-6-phosphate resulting from a reduction in PFK and 
PDH activities has been proposed to inhibit hexokinase activity and ultimately 
decrease the uptake of glucose presumably by decreasing the glucose gradient across 
the muscle cell membrane (Randle et al., 1963).  
 
Since the original in vitro glucose-fatty acid cycle was proposed, attempts at 
examining this theory in human skeletal muscle suggest that a reciprocal relationship 
between glucose and FA oxidation is evident but the mechanisms controlling this 
shift are clearly different. Several studies have utilised infusion of a triglyceride 
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emulsion (Intralipid) and heparin to acutely elevate arterial FA levels during exercise 
without additional substrate or hormonal changes that are associated with high-fat 
feeding. However these studies have yielded inconsistent results, demonstrating 
either no change in CHO or fat oxidation during prolonged low-intensity exercise 
(Ravussin et al., 1986), or a significant increase in glycogen sparing and FA 
oxidation during prolonged moderate-intensity exercise (Vukovich et al., 1993). 
Using moderate-intensity one-legged knee extensions, thigh glucose uptake is 
attenuated without a decrease in muscle glycogen utilisation, suggesting that FAs 
may directly inhibit glucose transport rather than the classic glucose-fatty acid cycle 
(Hargreaves et al., 1991). During high-intensity exercise, Intralipid infusion 
increased total fat oxidation with a concomitant reduction in CHO oxidation due 
solely to a decrease in muscle glycogen utilisation (Romijn et al., 1995). 
Furthermore, the significant sparing of muscle glycogen during high-intensity 
cycling with high circulating FAs appears to be regulated at the level of glycogen 
phosphorylase, as opposed to citrate and acetyl-CoA suggested in the original 
glucose-fatty acid cycle (Dyck et al., 1993; Dyck et al., 1996). In contrast, studies 
using glucose ingestion (Coyle et al., 1997), a hyperinsulinemic, hyperglycaemic 
clamp (Sidossis et al., 1996; Sidossis & Wolfe, 1996) and dextrose infusion (Sidossis 
et al., 1999) provide evidence that glucose, rather than FA, controls the relative use 
of fat and CHO as energy substrates during rest and exercise. Indeed, the direct 
inhibition of FA oxidation by accelerated carbohydrate metabolism has led to the 
hypothesis that the glucose-fatty acid cycle is reversed in human skeletal muscle 
(Wolfe, 1998a). The regulation of skeletal muscle fat and CHO metabolism is clearly 
multifactorial, and different mechanisms may dominate during rest compared to 
exercising conditions. Most studies in resting humans support the concept that an 
increased availability of FAs suppresses the oxidation of intracellular or extracellular 
glucose or both (Baron et al., 1989; Walker et al., 1991; Yki-Jarvinen et al., 1991). 
However, the underlying mechanisms are largely unknown and although there are 
indications that the Randle cycle is operative in resting human skeletal muscle, other 
plausible mechanistic links between FA availability and fat and CHO metabolism do 
exist. 
 
The key sites of metabolic regulation for CHO and fat metabolism include the PDH 
complex and the CPT I system, respectively. The PDH reaction catalyses the 
oxidative decarboxylation of pyruvate to acetyl-CoA, thus controlling the rate of 
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entry of pyruvate into the mitochondria (Figure 1.2). CPT I primarily governs fat 
oxidation by committing LCFA to mitochondrial β-oxidation. Competition exists 
between the two major substrates, glucose and FAs, and the choice substrate for 
oxidation is heavily dependent on the balance between the activities of the key 
enzymes PDH and CPT 1. 
 
 1.4.1. Regulation of CPT I by Malonyl-CoA 
The CPT complex plays a pivotal role in the regulation of LCFA entry into the 
mitochondria for subsequent β-oxidation. Skeletal muscle CPT 1 is considered the 
rate limiting step in the oxidation of LCFA and is reversibly inhibited by malonyl-
CoA, which is synthesised by the enzyme acetyl-CoA carboxylase (ACC) in the first 
committed step in FA biosynthesis (McGarry et al., 1983). CPT I activity is very 
sensitive to malonyl-CoA concentration (McGarry et al., 1983), and it is believed 
that malonyl-CoA could be the key regulator of fat oxidation in skeletal muscle 
during muscle contraction (Winder, 1998). Studies in rodent skeletal muscle show 
that malonyl-CoA levels are highest at rest to inhibit CPT I activity and maintain low 
rates of fat transport. During exercise, malonyl-CoA concentration decreases, 
relieving the inhibition of CPT I and allowing for enhanced LCFA oxidation (Winder 
et al., 1989; Winder et al., 1990). However, studies in human skeletal muscle have 
not observed a decrease in malonyl-CoA concentration in response to moderate-
intensity exercise when there are large increases in the rate of fat oxidation (Odland 
et al., 1996; Odland et al., 1998; Dean et al., 2000). Furthermore, a malonyl-CoA 
resistant CPT I subfraction has been detected in rodent skeletal muscle (Kim et al., 
2002), suggesting that malonyl-CoA is not the sole regulator of CPT I activity at rest 
or during exercise. Indeed, CPT I is also inhibited by in vitro decreases in pH that 
may explain the decrease in fat metabolism in the shift from moderate to high 
intensity exercise (Starritt et al., 2000). Taken together, these findings suggest that 
the regulation of CPT I activity is more complex than simple changes in malonyl-
CoA levels and/or that malonyl-CoA inhibition is overridden during exercise 
(Bezaire et al., 2004) 
 
Acutely increasing plasma FFA provision during moderate-intensity exercise does 
reduce malonyl-CoA levels in human skeletal muscle however, and along with the 
decline in PDH activity, may explain the enhanced lipid oxidation in the presence of 
elevated FFA availability (Odland et al., 2000). Significant increases in malonyl-
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CoA concentration have also been observed following a resting euglycemic 
(Bavenholm et al., 2000) and hyperglycaemic (Rasmussen et al., 2002) clamp with 
hyperinsulinemia in human skeletal muscle. These data suggest that in the presence 
of high glucose and insulin, elevated malonyl-CoA appears to decrease muscle FA 
oxidation, inhibit functional CPT I activity and shunt LCFA away from oxidation 
and towards storage (Rasmussen et al., 2002). Furthermore, malonyl-CoA is reduced 
in response to Intralipid infusion at rest (Odland et al., 2000) and remains depressed 
for up to 90 min after a single bout of exercise in rats which has been postulated to 
allow for increased fat utilisation and a partitioning of glucose towards muscle 
glycogen resynthesis (Rasmussen et al., 1998). Therefore, while it appears that 
factors other than changes in malonyl-CoA concentration are involved in regulating 
the shift in fuel utilisation during exercise, evidence suggests that malonyl-CoA has 
an important role in regulating FA oxidation in resting skeletal muscle (Dean et al., 
2000). 
 
 1.4.2. AMP Activated Protein Kinase and Regulation of Malonyl-CoA 
Concentration 
Regulation of malonyl-CoA concentration and potentially skeletal muscle fat 
metabolism is likely to be mediated by the metabolic fuel sensor or “fuel gauge” 
5’AMP-activated protein kinase (AMPK) (Hardie & Hawley, 2001). AMPK is a 
heterotrimeric protein kinase, consisting of one catalytic subunit (α) and two 
regulatory subunits (β and γ) (Hardie et al., 1998; Kemp et al., 1999). Two catalytic 
subunits have been identified (α1 and α2), of which α1 is the most abundant and 
widely distributed, whilst α2 is predominant in skeletal muscle, heart and liver tissue 
(Stapleton et al., 1996). AMPK activity is upregulated in part by increases in the 
allosteric activator AMP and decreases in the allosteric inhibitor phosphocreatine. 
The primary regulator of AMPK is an upstream kinase, AMP-activated protein 
kinase kinase (AMPKK), that phosphorylates a threonine residue (Thr-172) of the α-
subunit resulting in activation (Hardie & Hawley, 2001). An increase in AMP that 
occurs during cellular stress such as exercise also promotes AMPKK 
phosphorylation both by binding to dephospho-AMPK and enhancing it as a 
substrate, and by activating AMPKK itself (Hawley et al., 1995). 
 
An increasing body of evidence suggests that activation of the catalytic subunit (α) 
of AMPK (AMPKα) increases FA oxidation by lowering the concentration of 
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malonyl-CoA (Ruderman et al., 2003). AMPK is postulated to decrease malonyl-
CoA levels through two mechanisms: 1) phosphorylating and therefore inactivating 
ACC on serine residue 221 (ser221) (Park et al., 2002b), 2) phosphorylating and 
activating malonyl-CoA decarboxylase (MCD), an enzyme involved in the 
degradation of malonyl-CoA (Park et al., 2002a). ACC catalyses the carboxylation of 
acetyl-CoA to form malonyl-CoA in the first committed step in FA biosynthesis. 
There are two major isoforms of ACC (ACCα and ACCβ) that are encoded by 
separate genes and expressed in mammalian tissues. ACCα is highly expressed in 
non-oxidative tissues and generates malonyl-CoA primarily for FA synthesis, 
whereas ACCβ is the predominant isoform expressed in the heart, skeletal muscle 
and liver that produces malonyl-CoA primarily for the regulation of CPT I activity 
(McGarry & Brown, 1997). Consistent with its role in the regulation of 
mitochondrial LCFA transport and oxidation, ACCβ is located in close proximity to 
CPT I on the outer mitochondrial membrane in skeletal muscle (Abu-Elheiga et al., 
2000). In contrast, MCD is an enzyme that decreases the concentration of malonyl-
CoA by catalysing the conversion of malonyl-CoA to acetyl-CoA in a wide variety 
of rodent tissues (Voilley et al., 1999). Although the metabolic role of this reaction 
has not been fully defined in mammalian cells, two isoforms of MCD have been 
identified from a single gene in the goose uropygial gland (Courchesne-Smith et al., 
1992). The longer of the two proteins is ubiquitously expressed and targets the 
mitochondrial matrix, whereas the shorter form has a more restricted pattern of 
expression as a cytosolic enzyme. In rat cardiac muscle, a 50-kDa MCD isoform is 
expressed that has a putative role in regulating fatty acid oxidation rates (Dyck et al., 
1998), while increased MCD activity appears to account for the disposal of malonyl-
CoA in oxidative skeletal muscle (Alam & Saggerson, 1998).  
 
The dual control of skeletal muscle malonyl-CoA by MCD and ACC, via AMPK, is 
increasingly being recognised as having a major role in regulating fat metabolism 
(Saha et al., 2000; Park et al., 2002a). AMPK activation by 5’-aminoimidazole-4-
carboxamide ribonucleoside (AICAR) decreases ACC activity (Merrill et al., 1997) 
and activates MCD in skeletal muscle (Saha et al., 2000), suggesting that MCD and 
ACC may be jointly regulated by AMPK (Figure 1.3). Indeed, an increase in MCD 
and decrease in ACC activities are coordinately regulated by AMPK activation in 
response to exercise and AICAR treatment (Park et al., 2002a). Since AICAR 
induced activation of AMPK decreases malonyl-CoA in skeletal muscle (Merrill et 
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al., 1997; Kaushik et al., 2001), such coordinated changes in MCD and ACC 
attributable to AMPK are suggested to lower malonyl-CoA concentration and result 
in an increased oxidation and decreased synthesis of FAs (Park et al., 2002; 
Ruderman et al., 2003). Not all studies demonstrate that MCD is a substrate for 
AMPK however, suggesting instead that the principal mechanism by AMPK 
regulates malonyl-CoA content is through its regulation of ACC (Habinowski et al., 
2001). Furthermore, activation of MCD may also be regulated by increased protein 
content (Dyck et al., 2000b; Sakamoto et al., 2000), or by the existence of a separate 
protein or allosteric regulator (Dyck et al., 2000b; Young et al., 2001), although the 
exact nature of these regulatory mechanisms remain unknown. Gene expression may 
also be an important determinant of MCD activity, since MCD mRNA is most 
abundant in human cardiac and skeletal muscles, tissues in which cytoplasmic 
malonyl-CoA is a potent inhibitor of CPT I and, thus, of mitochondrial LCFA 
oxidation (Sacksteder et al., 1999). 
 
 1.4.3. Activity of the Pyruvate Dehydrogenase (PDH) Complex 
Carbohydrate oxidation is primarily regulated by PDH, a multi-enzyme complex 
which catalyses the irreversible oxidative decarboxylation of pyruvate to acetyl-CoA. 
This reaction controls the flux of pyruvate across the mitochondrial membrane and 
through the tricarboxylic acid (TCA) cycle. The complex consists of three subunits: 
pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and 
dihydrolipoamide dehydrogenase (E3) and is tightly controlled by two specific 
regulatory enzymes, PDH kinase (PDK) and PDH phosphatase (PDP). PDK 
phosphorylates and inactivates the E1α-subunit of the PDH complex, whereas 
dephosphorylation by PDP restores the enzyme activity (Figure 1.2). PDK activity is 
highly regulated by the intramitochondrial effectors ATP, acetyl-CoA and NADH, 
and is inhibited by elevated pyruvate concentrations, whereas PDP activity is Mg2+ 
dependent and is stimulated by Ca2+ and increased pyruvate (Cooper et al., 1975; 
Howlett et al., 1998).  
 
Four PDK isoforms (1-4) have been identified in human tissues that phosphorylate 
and inactivate the PDH complex. Each isoenzyme has unique regulatory properties 
that vary in their level of expression in different cell types. PDK1 is expressed 
predominately in heart tissue whilst PDK2 is ubiquitously expressed and most 
abundant in heart and skeletal muscle (Gudi et al., 1995). In contrast, PDK3 is found 
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almost exclusively in heart and skeletal muscle in low amounts (Gudi et al., 1995). 
PDK4 is primarily expressed in heart and skeletal muscle (Rowles et al., 1996) and is 
fibre type dependent, as a higher content has been observed in oxidative muscle (type 
I and IIa) compared to fast twitch glycolytic muscle (type IIb) (Peters et al., 2001a). 
PDK expression and activity in several oxidative tissues is increased in response to 
nutritional and endocrine manipulations that increase fat availability and oxidation 
(Sugden & Holness, 2003). In particular, PDK4 is modified when there is a sustained 
change in tissue FA delivery and/or handling and is hypothesised to be a “lipid 
status”-responsive PDK isoform (Sugden et al., 2001). During conditions of reduced 
glycolytic flux and increased FA oxidation, PDK activity is elevated in resting 
human skeletal muscle (Peters et al., 1998; Peters et al., 2001b). PDK4 expression is 
induced in skeletal muscle during fasting (Wu et al., 1999; Holness et al., 2002; 
Spriet et al., 2004), high fat feeding (Peters et al., 1998; Holness et al., 2000) and 
streptozotocin-induced diabetes in rats (Wu et al., 1999) and correlates with IMTG 
concentration in obese patients before and after weight loss (Rosa et al., 2003). 
Furthermore, the progressive increase in PDK4 mRNA during prolonged fasting in 
humans has been associated with a decline in PDH activity (PDHa) (Spriet et al., 
2004). Hence, one long-term mechanism of PDK regulation in response to altered fat 
delivery and oxidation involves changes in the relative expression of PDK4 and this 
may relate to changes in PDHa. 
 
 1.4.4. Regulation of IMTG Hydrolysis 
Evidence from the dual-label “pulse-chase” technique in isolated rodent skeletal 
muscle has demonstrated that the IMTG pool is a dynamic substrate, undergoing 
simultaneous esterification and hydrolysis at rest and during tetanic contractions 
(Dyck & Bonen, 1998). In isolated rat skeletal muscle, the activity of the neutral TG 
lipase HSL appears to be under dual control by epinephrine (Langfort et al., 1999) 
and contraction-related mechanisms (Langfort et al., 2000). Epinephrine has also 
been demonstrated to induce IMTG hydrolysis in exercising human skeletal muscle 
(Cleroux et al., 1989; Kjaer et al., 2000). During prolonged exercise to exhaustion, 
nonselective β-adrenergic blockade completely inhibited IMTG degradation 
compared to placebo treatment (Cleroux et al., 1989). In addition, HSL activation 
was undetected in adrenalectomised individuals during moderate and high intensity 
cycling, however when epinephrine was infused to mimic control levels, HSL 
activity increased at both moderate and high power outputs (Kjaer et al., 2000). 
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Furthermore, epinephrine infusion and contraction appear to have an additive effect 
on HSL activation during exercise (Watt et al., 2003c). However, at the onset of 
exercise, HSL activity is independent of epinephrine levels at power outputs 
corresponding to 30, 60 and 90% of 2OV& peak, suggesting that HSL activation is 
regulated by factors related to the onset of exercise such as intracellular Ca2+ levels 
(Watt et al., 2003b) and increased ERK phosphorylation (Watt et al., 2003c).  
Moreover, given the apparent mismatch between activation of HSL early in exercise 
and the negligible IMTG and fat oxidation, it is postulated that HSL activation may 
not be the only rate-limiting factor regulating IMTG hydrolysis and that other 
postactivational factors (i.e. HSL translocation and perilipin phosphorylation) may 
also mediate IMTG degradation in skeletal muscle (Watt et al., 2003b). 
 
HSL activity is also thought to be allosterically inhibited by long chain fatty acyl 
CoA (LCFA CoA) (Jepson & Yeaman, 1992). One inviting hypothesis is that LCFA-
CoA inhibits HSL activity after binding to a specific site on the enzyme, thus 
preventing further mobilisation of FFAs from the IMTG pool. In support of this 
theory, LCFA-CoA accumulation has been observed during 2 h of moderate-intensity 
exercise which may account for the decrease in HSL activity (Watt et al., 2003a) and 
the reduction in IMTG utilisation previously reported late in prolonged exercise 
(Watt et al., 2002a). Clearly, the regulation of skeletal muscle HSL during exercise is 
complex and is thought to involve both β-adrenergic and perhaps more importantly 
AMPK-mediated mechanisms (Watt et al., 2004c). In circumstances where AMPK is 
elevated, net IMTG degradation is measurable despite reduced HSL activity. 
Therefore, the physiological importance of activating HSL for triacylglycerol 
hydrolysis is uncertain (Watt et al., 2004c) and requires further investigation during 
exercise and the immediate recovery period. 
  
1.5.  METABOLIC GENE EXPRESSION IN SKELETAL MUSCLE 
Control of substrate metabolism in response to sustained alterations in substrate 
availability and exercise training is influenced by changes in gene expression that 
encode for key enzymatic, regulatory and myofibrillar proteins. Alterations in gene 
expression are responsible for both morphologic and phenotypic changes and 
importantly are indicative of cellular responses to environmental stimuli and 
perturbations such as stress and growth factors, energy availability and contractile 
activity (Lockhart & Winzeler, 2000).  
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Metabolic protein synthesis is initiated by the transcription of genomic DNA 
resulting in the transient increase of messenger ribonucleic acid (mRNA). Increases 
in muscle mRNA levels reflect the balance between rates of production and the 
decay of mRNA or its chemical half life, and thus are most likely to result from 
transcriptional activation and/or increased mRNA stability (Hargreaves & Cameron-
Smith, 2002). The half-life of many mRNAs can fluctuate in response to 
environmental stimuli such as hormones, temperature shifts and substrate availability 
(Day & Tuite, 1998). Similarly, the rate of translation and the rate of degradation will 
determine the amount of functional protein at any one time, although the half-life of 
a given protein is typically longer than the half-life of its corresponding mRNA. 
Therefore, transcriptional rather than translational control of mRNA may result in 
measurable changes in protein synthesis and content (Williams & Neufer, 1996).  
 
The rate of gene transcription into mRNA is controlled by multiple regulatory 
pathways that precede the initiation of transcription by RNA polymerase. Genes 
consist of coding regions for the synthesis of proteins as well as non-coding or 
promoter regions that contain binding sites for transcription factors which are critical 
to the regulation of gene expression. Transcription factors are proteins which upon 
activation, move from the cytosol to the nucleus and bind to enhancer and repressor 
DNA sites, resulting in increased and decreased transcriptional activity, respectively 
(Baar et al., 1999). Activation of appropriate transcription factors is the culmination 
of a signaling pathway that can be initiated by changes in nutrient availability 
(Young et al., 2001; Muoio et al., 2002b) and exercise (Pilegaard et al., 2003). Once 
transcription factors are bound to form a stable transcriptional complex, RNA 
polymerase initiates the continuous polymerization of ribonucleotide precursors into 
RNA (Jiang et al., 1996). In addition to the regulation of gene transcription rates, 
post-transcriptional control mechanisms also influence the change in protein content. 
These regulatory factors include nuclear export of mRNA, localisation and stability 
within the cytosol and translational regulation and degradation. Post-translational 
modifications or proteolytic clevage may also alter protein function and activity. 
Although these pre-translational, translational and post-translational events are all 
involved in the molecular regulation of skeletal muscle metabolism, activation of 
gene expression is still an integral part of the adaptive process.  
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 1.5.1. Metabolic Gene Expression During Post-Exercise Recovery 
The cellular and molecular mechanisms facilitating the increase in skeletal muscle fat 
oxidation following prolonged exercise remain poorly defined. Increases in 
metabolic gene transcription relevant to carbohydrate and fat oxidation are well 
documented during exercise and appear to increase further during the post-exercise 
recovery period (Kraniou et al., 2000; Pilegaard et al., 2000; Pilegaard et al., 2002). 
For many genes, transcriptional activity peaks during the initial recovery phase after 
endurance exercise and returns to basal levels within a ~24 h period (Pilegaard et al., 
2000). Indeed, transcriptional activation of key regulatory proteins increase by three- 
to sevenfold after 1–2 h of post-exercise recovery, followed by increases in mRNA 
that peak at 2–4 h after exercise (Pilegaard et al., 2000). These findings suggest that 
the cumulative effect of transient increases in the transcriptional activity of metabolic 
genes may be important in the cellular adaptation to repeated bouts of exercise 
(Williams & Neufer, 1996).    
 
The role of gene expression in regulating fat metabolism in the post-exercise 
recovery period has received little attention. Gene expression most integral to FFA 
uptake include FABPPM and FAT/CD36, while those relevant to oxidation are CPT I 
and the key enzyme of β-oxidation, β-hydroxyacyl-CoA dehydrogenase (β-HAD) 
(Tunstall et al., 2002). In response to a single bout of exercise following 9 days of 
aerobic training, the expression of genes involved in FFA uptake and oxidation 
(FABPPM, FAT/CD36, CPT 1, β-HAD) were unchanged at the cessation of exercise 
and at 3h post-exercise (Tunstall et al., 2002). However, the increased capacity for 
lipid oxidation after exercise training was accompanied by an increased mRNA 
abundance of FAT/CD36 and CPT 1 and FAT/CD36 protein expression. Therefore, 
it appears that increases in total lipid oxidation in response to short-term endurance 
training are associated with the genes involved in regulating FFA uptake across the 
plasma (FAT/CD36) and mitochondrial membrane (CPT 1) (Tunstall et al., 2002). 
Similarly, 5 days of knee extensor training also increases CPT I mRNA abundance at 
rest, whilst more dramatic increases in LPL and CPT I gene transcription and 
expression were observed during a 4 h post-exercise recovery period (Pilegaard et 
al., 2000).  
 
During recovery from endurance exercise a number of changes occur in skeletal 
muscle that allow for a high metabolic priority towards glycogen resynthesis (Richter 
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et al., 2001). Insulin stimulated glucose uptake and glycogen synthase activity are 
increased during post-exercise recovery in human skeletal muscle (Mikines et al., 
1988; Wojtaszewski et al., 2000) and this appears to be influenced by the extent of 
muscle glycogen depletion (Nielsen et al., 2001). Furthermore, skeletal muscle 
insulin sensitivity is increased at least 48 h after a bout of exercise (Mikines et al., 
1988), leading to a rapid rate of glycogen resynthesis when high-carbohydrate foods 
are consumed following glycogen-depleting exercise (Kiens & Richter, 1998).  
Consistent with these findings, reduced muscle glycogen is associated with greater 
PDK4 transcription and mRNA levels after prolonged exercise (Pilegaard et al., 
2002). PDK4 is a highly exercise-responsive gene in human skeletal muscle 
(Pilegaard et al., 2000; Pilegaard et al., 2002). Therefore, the possibility exists that 
signaling mechanisms sensitive to muscle glycogen content may be linked to the 
transcriptional control of exercise-responsive genes (Pilegaard et al., 2002). Further 
studies are required to delineate the role of exercise in mediating the expression of 
genes pertinent to the regulation of fat metabolism. 
 
 1.5.2. Effect of Substrate Availability on Metabolic Gene Expression 
Sustained utilisation of FAs as a primary energy substrate for skeletal muscle can be 
induced by lipid infusion, dietary manipulation and fasting. Increasing circulating 
FAs in vivo using Intralipid infusion has frequently been utilised to investigate the 
effect of FAs on hepatic and adipose tissue gene expression, however relatively few 
have examined this effect in skeletal muscle. Intralipid infusion is reported to 
increase the gene expression of FAT/CD36 in rat skeletal muscle (Fabris et al., 2001; 
Vettor et al., 2002) and in human adipose tissue (Nisoli et al., 2000). Furthermore, 
skeletal muscle mRNA abundance of GLUT4 is decreased in the rat, whilst PDK4 
mRNA is markedly increased (~10-fold) following a continuous infusion of 
triglycerides and heparin in human skeletal muscle (Tunstall, 2003, unpublished 
observations).  
 
Increases in the mRNA abundance of selected fat and CHO metabolic genes are also 
observed after consuming high fat in comparison to high CHO diets (Young et al., 
2001; Cameron-Smith et al., 2003). Following 5 days of high-fat feeding (>65% of 
energy as lipids), the gene expression of FAT/CD36, β-HAD and PDK4 and the 
protein concentration of FAT/CD36 were markedly higher in comparison to 5 days 
of a high-CHO intake (70-75% of energy as CHO) in endurance cyclists (Cameron-
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Smith et al., 2003). In response to a similar dietary intervention of shorter duration (2 
days), the mRNA abundance of selected genes regulating CHO metabolism were 
increased (GLUT4 and glycogenin) and decreased (PDK4) in response to a high-
CHO intake, whereas only FAT/CD36 mRNA increased after high-fat feeding 
(Arkinstall et al., 2004). Thus, it appears that CHO-related genes are more 
responsive to short-term dietary manipulation than those involved in the oxidation of 
FAs (Arkinstall et al., 2004). These findings support previous studies utilising high 
fat feeding (Peters et al., 2001b), fasting (Spriet et al., 2004) and lipid infusion 
(Tunstall, 2003, unpublished observations) in humans that PDK4 gene expression is 
highly sensitive to changes in plasma FA availability. The increase in PDK4 gene 
expression during prolonged fasting also reduces PDHa, thus PDK4 maybe an 
important factor mediating the starvation induced decrease in CHO oxidation (Spriet 
et al., 2004). Furthermore, elevated plasma FA levels in response to fasting, diabetes 
and high-fat feeding are associated with increased MCD mRNA in rat skeletal 
muscle, suggesting that FAs are involved in the regulation of MCD gene expression 
and possibly MCD activity, although posttranscriptional mechanisms regulating 
MCD activity appear to exist (Young et al., 2001). However, it remains unknown 
whether FA availability also influences MCD mRNA abundance and MCD activity 
during post-exercise recovery in human skeletal muscle. 
 
1.6.  FATTY ACID REGULATION OF SKELETAL MUSCLE GENE EXPRESSION 
In addition to providing an energy source and its effects on membrane lipid 
composition, FAs can regulate gene expression leading to changes in metabolism, 
growth and cell differentiation (Jump & Clarke, 1999). Once in the cell, FAs can 
undergo β-oxidation within the mitochondria or be elongated, desaturated, 
peroxidised, exchanged with membrane phospholipids and participate or interfere 
with eicosanoid synthesis (Duplus et al., 2000). Therefore, it is not only FAs per se 
but also products of FA metabolism that can act as signaling molecules in regulating 
gene expression. The majority of genes targeted by FAs encode proteins with roles in 
FA transport or metabolism. It is well known that polyunsaturated FAs (PUFAs), in 
particular n-3 unsaturated FAs, rapidly suppress hepatic de novo lipogenesis and 
triglyceride synthesis/secretion while inducing peroxisomal and microsomal FA 
oxidation (Jump & Clarke, 1999). These effects on fat metabolism are mediated by 
changes in gene expression leading to induction or suppression of mRNAs encoding 
for key metabolic enzymes (Jump & Clarke, 1999).  
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A number of postulated mechanisms can account for the FA regulation of gene 
transcription, as summarised in Figure 1.4. FAs, FA-CoAs or FA metabolites can 
initiate a signal transduction cascade to induce covalent modification of a 
transcription factor, thereby modifying its transcriptional activity. Alternatively, FAs 
or their derivatives may act as ligands for a transcription factor, which can then bind 
directly to DNA at a FA response element and activate or repress transcription. FAs 
can also act indirectly by modifying transcription factor mRNA stability or gene  
transcription, resulting in variations of de novo transcription factor synthesis that 
impacts on the transcription rate of proteins involved in FA transport or metabolism. 
Furthermore, transcription factors can bind to the cognate response element in 
isolation as a monomer or together with the same (homodimer) or different 
(heterodimer) transcription factor (Duplus et al., 2000). 
 
 1.6.1. Fatty Acid–Responsive Transcription Factors 
Specific FA-regulated transcription factors that have been identified in mammalian 
cells include peroxisome-proliferator-activated receptor (PPAR) family, nuclear 
factor κB (NFκB), sterol regulatory element-binding protein-1c (SCREBP1-c), 
retinoid X receptors (RXRα, β and γ), liver X receptors (LXRα and β) (Duplus et al., 
2000) and more recently in skeletal muscle forkhead homolog in rhabdomyosarcoma 
(FKHR) (Kamei et al., 2003). Since the initial identification of PPARα (Issemann & 
Green, 1990), several PPAR family members have been cloned. These include PPAR 
gamma (PPARγ1 and γ2) and PPAR delta (PPARδ)  (Clarke et al., 1999). Each 
isoform is encoded by a separate gene and display unique tissue distribution patterns. 
PPARα is expressed most abundantly in highly oxidative tissues where it plays a key 
role in activating pathways of β-oxidation (Braissant et al., 1996). Conversely, 
PPARγ is expressed primarily in adipose tissue and thus promotes adipocyte 
differentiation and activates transcription of genes involved in lipid storage 
(Braissant et al., 1996). PPARδ is ubiquitiously expressed and its function is unclear, 
however it appears to have a role in regulating cholesterol metabolism (Chawla et al., 
2003). 
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Figure 1.4. Postulated mechanisms for fatty acid control of gene 
transcription. TF, transcription factor; FARE, fatty acid response element; 
TF*, different transcription factor. Modified from Duplus et al. (2000). 
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PPARα is considered the major subtype that mediates FA-induced activation of fat 
oxidative genes, since PPARα knockout mice exhibit decreased fat oxidative gene 
expression together with low rates of β-oxidation and FA accumulation in both 
cardiac and hepatic tissues during fasting (Leone et al., 1999). In primary cultured 
human skeletal muscle cells, specific activation of PPARα increases the gene 
expression of CPT I, MCD and PDK4 along with enhancing FA oxidation (Muoio et 
al., 2002b). PDK4 mRNA abundance, PDK4 protein and PDK4 activity are also 
increased with PPARα activation in rodent skeletal muscle (Wu et al., 1999). 
Furthermore, treatment with a PPARα agonist increases skeletal and cardiac muscle 
MCD mRNA and activity, while specific PPAR gamma (PPARγ) activation 
decreases muscle MCD gene expression (Young et al., 2001). The same study 
demonstrated that FAs increased the expression of MCD mRNA, suggesting that FA-
induced MCD expression is mediated through PPARα in rodent skeletal and cardiac 
muscle (Young et al., 2001; Campbell et al., 2002). Whether the same FA-induced 
regulation of MCD gene expression exists in human skeletal muscle is unknown. 
However, other studies demonstrate that the role of PPARs in regulating FA-induced 
gene expression is more complex as there may be no obligatory participation of 
PPARα in the upregulation of PDK4 gene expression during fasting (Holness et al., 
2002; Muoio et al., 2002a; Spriet et al., 2004) and a PPARδ compensatory 
mechanism may exist in PPARα knockout mice (Muoio et al., 2002a).  
 
1.7.  SUMMARY 
Skeletal muscle is the predominant tissue regulating whole body fat oxidation at rest 
and in the post-exercise recovery period. After prolonged or glycogen-lowering 
exercise plasma FAs increase in response to the substantial FFA mobilisation from 
adipose tissue to support the elevated rate of fat oxidation. Some evidence also 
suggests that IMTGs are an important fuel source during post-exercise recovery in 
the presence of elevated glucose and insulin, however the use of IMTG as an energy 
substrate after exercise requires further investigation. Many studies also suggest that 
glucose uptake after strenuous exercise is partitioned away from oxidation and 
towards storage in skeletal muscle, reflecting the high metabolic priority of glycogen 
resynthesis during post-exercise recovery. However, the underlying mechanisms 
accounting for the interaction between fat and CHO oxidation after exercise remain 
poorly defined. An increasing body of evidence suggests that AMPK activation 
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increases post-exercise skeletal muscle FA oxidation by lowering the concentration 
of malonyl-CoA and thus allowing for enhanced CPT I mediated LCFA transport 
into the mitochondria. AMPK is postulated to decrease malonyl-CoA levels through 
inactivating ACC and increasing MCD activity in rodent skeletal muscle, although it 
is unknown whether this mechanism is also operative in human skeletal muscle after 
exercise. Exercise increases transient changes in metabolic gene expression during 
the post-exercise recovery period which may be important in the cellular adaptation 
to repeated bouts of exercise. Numerous studies in rodent skeletal muscle as well as 
investigations conducted in human adipose and hepatic tissue indicate substrate 
availability may also be an important mediator of oxidative gene expression at rest. 
However it remains to be determined if altering FFA and glucose availability during 
post-exercise recovery can induce the same effect. 
 
The broad aim of this thesis was to examine the regulation of fat and CHO 
metabolism during recovery from glycogen-lowering exercise in the presence of 
altered fat and glucose availability. This series of studies examine alterations in 
metabolic protein activity, content and gene expression in human skeletal muscle in 
response to a strenuous exercise stimulus followed by manipulation of substrate 
availability.  
 
1.8.  AIMS 
Specifically the purpose of this thesis was to: 
 
1. Examine the utilisation of IMTG as an energy substrate and provide a more 
in-depth understanding of the metabolic changes which occur in skeletal 
muscle after exhaustive exercise when combined with high-CHO feeding to 
replenish muscle glycogen.  
 
2. Determine the effect of acute alterations in circulating plasma FFA 
availability on malonyl-CoA concentration and whole-body fat and CHO 
oxidation during post-exercise recovery.  
 
3. Determine whether changes in whole body fat and CHO oxidation are related 
to post-translational modifications in AMPKα and ACCβ phosphorylation 
during post-exercise recovery.  
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4. Determine the effect of acute alterations in circulating plasma FFA and 
glucose availability on IMTG concentration during post-exercise recovery.  
 
5. Determine whether acute changes in circulating plasma FFA and glucose 
availability alters the mRNA expression of key proteins involved in the 
regulation of fat and CHO oxidation during post-exercise recovery.  
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CHAPTER TWO 
GENERAL METHODS 
 
 
This chapter provides a detailed description of the methods and procedures that were 
used in the studies presented in this thesis. Experimental protocols specific to a study 
are described in the methods section of the relevant chapter. Throughout this thesis, 
each study is referred to numerically as outlined below: 
 
 Study I Skeletal muscle fat and carbohydrate metabolism during  
  recovery from glycogen-depleting exercise in humans 
 
 Study II Regulation of skeletal muscle fat metabolism after exercise in  
  humans: influence of fat availability 
 
 Study III Effect of glucose availability on the regulation of fat 
metabolism in human skeletal muscle during post-exercise 
recovery 
 
Study I was conducted in the Department of Human Biology and Nutritional 
Sciences, University of Guelph, Guelph, Ontario, Canada under the guidance of Dr. 
David Dyck, Professor Lawrence Spriet and Professor George Heigenhauser. Studies 
II and III were conducted at the School of Exercise and Nutrition Sciences, Deakin 
University, Burwood, Australia. Malonyl-CoA analysis for Study II was completed 
by Dr. Asish Saha and Professor Neil Ruderman at the Diabetes & Metabolism 
Research Unit, Boston Medical Centre, USA.  
 
2.1.  SUBJECTS 
Individuals who volunteered as subjects for the above studies were endurance trained 
males aged between 18 and 36 years. Volunteers were eligible to participate if they 
achieved a 2OV& max greater than 55 ml⋅kg-1⋅min-1 and had a history of endurance 
training and/or racing for at least the previous 3 months. A total of twenty subjects 
were recruited for all studies from a variety of competitive backgrounds including 
road cycling (4), mountain biking (4), swimming (3), triathlon (2), running (2) 
canoeing (1), rowing (1), whilst three were recreationally active. All subjects were 
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considered to be healthy, did not smoke or take any medications, and had no 
evidence of cardiovascular or metabolic diseases. The experimental procedures, 
possible risks and benefits were fully explained to each subject before their written, 
informed consent was obtained. All experiments were approved by the ethics 
committees of each institution (Study I: University of Guelph; Studies II and III: 
Deakin University), and were performed according to the Declaration of Helsinki. 
 
2.2.  PROCEDURES 
 2.2.1. Dietary Analysis   
Daily energy intake and composition of each subject’s habital food and fluid intake 
was assessed using a 4-day food record (3 weekdays and 1 weekend day). Dietary 
data were analysed for energy intake and macronutrient composition using dietary 
analysis software (Food Processor Nutrition Analysis Software, version 7, ESHA 
Research, Salem OH, USA). For Study I, total energy intake provided during 
recovery was matched closely to the average energy intake reported from individual 
4-day food records.  
 
 2.2.2. Maximal Oxygen Uptake ( 2OV& max) and Familiarization 
Prior to each experimental trial the maximal oxygen uptake of all participants was 
assessed using an incremental cycle ergometer test on an electronically-braked cycle 
ergometer (Study I: Lode Excalibur, Quinton Instruments, Seattle, WA, USA; 
Studies II and III: Excalibur II, Lode Groningen, The Netherlands). The protocol 
started at a workload of 150 W and increased by either 30, 40 or 50 W every 2 min 
for 5 work intervals, after which the workload increased either 15, 20 or 25 W⋅min-1 
until volitional exhaustion. Expired air from subjects was collected through a 
mouthpiece and plastic hosing and was analysed by an on-line metabolic cart (Study 
I: Quinton Q-plex 1, Quinton Instruments; Studies II and III: Applied 
Electrochemical Instrument, Pittsburgh). The analysers were calibrated prior to each 
test using commercial gases of known composition. The duration of each test was 
~15 min and 2OV& max was determined from a plateau in 2OV& max (increase <2 ml⋅kg-
1⋅min-1) with a further increase in power output. Heart rate was measured 
continuously via a heart rate monitor (Polar Sports Tester, Polar Electro, Finland). 
From the 2OV& max test, power outputs corresponding to submaximal  values to be 
used during the experimental trial were determined using linear regression analysis 
2OV&
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for each subject. A familiarization trial was conducted approximately one week 
before the first trial to verify the experimental power outputs determined from the 
2OV& max test. In addition, all subjects were familiarized with the intensity of the 
glycogen-lowering protocol and the approximate number of intervals to be 
completed during each high-intensity phase. 
 
 2.2.3. Muscle Biopsies 
In all studies muscle samples were obtained from the vastus lateralis muscle using 
the percutaneous needle biopsy technique (Bergstrom & Hultman, 1967). For studies 
II and III, the biopsy technique was modified to include suction (Evans et al., 1982).  
Incisions were made after a local anaesthetic (Study I: 2% lidocaine; Studies II and 
III: 1% xylocaine) injection in the mid-thigh region and spaced approximately 2-3cm 
apart. Muscle biopsies were always performed through a new incision on a 
previously intact part of the thigh. Duplicate muscle biopsies at each time point were 
performed in study I for the measurement of muscle triacylglyercol. Excised muscle 
tissue from the biopsy was immediately frozen in liquid nitrogen (N2), removed from 
the needle while frozen and stored in liquid N2 until subsequent analysis.  
 
 2.2.4. Venous Catheterisation 
Venous catheters were inserted into an antecubital vein for blood sampling and 
infusion of Intralipid, glucose or saline solutions. Approximately 1 ml of blood waste 
was drawn and discarded prior to each 5 ml blood draw for sampling. The catheter 
was flushed with 0.5 ml of saline immediately after each blood sample to prevent 
blood coagulation within the sampling site.  
 
 2.2.5. Respiratory Exchange Ratio (RER) and Substrate Oxidation 
2OV& , , and RER were determined at rest and during recovery using a Medical 
Graphics Corporation metabolic cart (Cardio2 and CPX/D system, St Paul, MN). 
Expired air samples were analysed breath by breath (reported as 30 sec average) and 
RER calculated by averaging for the final 5 min of a 10-min collection period. The 
metabolic cart was manually calibrated prior to each test using 0.01% alpha rated 
gases. Assuming a non-protein RER value, whole body CHO and fat oxidation (g) 
were calculated from  and  measurements during the last 5 min of each 
collection period according to the following equations (Peronnet & Massicotte, 1991
2COV&
2OV& 2COV&) :
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CHO oxidation = 4.585 2COV&  – 3.226 2OV&
Fat oxidation = 1.695 2OV&  – 1.701  2COV&
  
2.3.  ANALYTICAL TECHNIQUES 
 2.3.1. Blood Analysis 
 Plasma Free Fatty Acids   
For Study I, a portion of whole blood (1.5 ml) from a heparinised collection tube was 
centrifuged and 800 µl of plasma added to 200 µl of 5 M NaCl at 56°C for 30 min to 
inactivate lipoprotein lipase. The treated plasma was stored at –20°C for subsequent 
analysis. For Studies II and III, a portion of whole blood (1 ml) from a non-
heparinised syringe was added to 20 µl of EGTA and reduced glutathione. In 
addition, 10 µl of tetrahydrolipstatin (120 mg⋅l-1) from Xenical (Orlistat) capsules 
(Roche, Nutley, NJ) was added to prevent in vitro lipolysis (Krebs et al., 2000). The 
samples were centrifuged at 13000 r.p.m. for 2 min and the treated plasma stored at –
20°C prior to analysis for free fatty acids (FFAs). All plasma samples were analysed 
for FFAs using a Wako NEFA C test kit (Wako Chemicals, Richmond, VA, USA) 
and the concentration of FFAs determined in 10 µl of sample (Study I) and 5 µl of 
sample (Studies II and III) by extrapolation from a standard curve. The mean intra-
assay coefficient of variation (CV) from two samples with low and high FFA 
concentrations was 4.8%, obtained from a total of sixteen FFA assays performed in 
studies II and III. 
 
 Glycerol   
A 200 µl aliquot of whole blood was deproteinised in 1 ml of 0.6 M HClO4 
(perchloric acid, PCA) and spun at 13000 r.p.m. for 2 min. The supernatant was 
stored at –80°C for subsequent fluorometric determination of whole blood glycerol 
(Bergmeyer, 1974). The mean intra-assay CV from two samples with low and high 
glycerol concentrations was 2.9%, obtained from a total of four assays performed in 
studies II and III. 
 
 Glucose and Lactate   
In Study I, PCA treated whole blood (as described for glycerol) was used for the 
fluorometric determination of whole blood glucose and lactate (Bergmeyer, 1974). 
For studies II and III, blood was placed into heparinised vials, mixed, and 
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centrifuged at 13000 r.p.m. at 4°C for 2 min. The plasma was subsequently decanted 
and stored at –20°C until time of analysis. Plasma glucose and lactate were measured 
using an automated glucose/lactate analyser (EML 105, Radiometer, Copenhagen, 
Denmark). The mean intra-assay CV for the glucose and lactate assays were 1.0% 
and 4.8%, respectively. 
 
 Plasma Insulin 
Blood for insulin analysis was placed in a heparinised tube, mixed, and centrifuged at 
13000 r.p.m. at 4°C for 2 min. The plasma was subsequently decanted and stored at –
20°C until time of analysis. Plasma insulin was assayed in duplicate using an insulin 
radioimmunoassay kit (Study I: LINCO Research, St Charles, MO, USA; Studies II 
and III: Phadeseph, Pharmacia & Upjohn, Sweden), which utilises 125I-labelled 
insulin and insulin antiserum in a double antibody technique. The mean intra-assay 
CV from three samples was 8.6% for studies II and III. 
 
 2.3.2. Muscle Glycogen 
Briefly, freeze-dried muscle was dissected free of blood, connective tissue and 
visible fat and powdered. In studies II and III, a small aliquot of the powdered 
muscle (2-3 mg) was suspended in 1 M HCl and incubated for 2 h at 95-100°C. After 
incubation, the extract was neutralised with 750 µl of 0.667 M NaOH and stored at –
80°C until analysis. Muscle glycogen was measured using an enzymatic flurometric 
technique as previously described (Harris et al., 1974) and expressed in mmol⋅kg-1 
dry weight. The mean intra-assay CV from three samples was 6.4% for studies II and 
III. 
 
 2.3.3. Muscle Triacylglycerol 
Total muscle triacylglycerol (IMTG) was determined by extracting a 4-8 mg sample 
of powdered muscle in chloroform-methanol (2:1) (Frayn & Maycock, 1980). After 
phospholipid removal using silicic acid (study I only), the reconstituted extracts were 
saponified with ethanolic KOH at 60°C for 1 h, and neutralised with MgSO4. 
Extracts were stored at –80°C until IMTG concentration was determined by assaying 
the liberated glycerol fluorometrically (Froberg & Mossfeldt, 1971). For study I, 
IMTG content was calculated from the mean of the paired biopsies at each time 
point. For studies II and III, a CV of 7.1% for IMTG concentration was obtained 
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when two aliquots from the same muscle were analysed separately using four muscle 
samples. The mean intra-assay CV was 2.8% for glycerol from five samples. 
 
 2.3.4. Muscle Pyruvate Dehydrogenase Activity 
PDH activation (PDHa) was determined from a small (10-20 mg) sample of wet 
muscle in Study I using a previously described radioisotopic method (Constantin-
Teodosiu et al., 1991) with some modifications. Briefly, the assay buffer for PDHa 
was slightly modified as previously reported (Putman et al., 1993). During the assay, 
200 µl aliquots were sampled at 1, 2 and 3 min intervals. The reaction was stopped 
by addition of each aliquot to 40 µl of 0.5 M PCA. After 5 min each aliquot was 
neutralised with 1.0 M K2CO3, centrifuged for 3 min at 13000 r.p.m. and the 
resulting supernatant stored at –80°C until analysed for acetyl-CoA by the method of 
Cederblad et al. (1990). Plots of acetyl-CoA as a function of time were used to 
determine the reaction rates. 
 
 2.3.5. Malonyl-CoA 
Malonyl-CoA concentration was determined from a small sample of wet muscle 
tissue (~10 mg) using the previously described radioisotopic method (McGarry et al., 
1978) with modifications (Saha et al., 1995; Chien et al., 2000). Briefly, this method 
is based on the malonyl-CoA-dependent incorporation of labelled acetyl-CoA into 
palmitic acid catalyzed by fatty acid synthetase in the presence of NADPH. An 
internal malonyl-CoA standard was utilised with each sample to correct for differing 
levels of acetyl-CoA. 
 
 2.3.6. Muscle Metabolites 
An aliquot of powdered muscle was extracted in a solution of 0.5 M PCA and 1 M 
Ethylenediaminetetraacetric acid (EDTA) and was neutralised with 2.2 M KHCO3.  
For study I, the neutralised PCA extracts were assayed for ATP, phosphocreatine 
(PCr) and creatine by spectrophotometry as previously described (Bergmeyer, 1974; 
Harris et al., 1974). Pyruvate was determined flurometrically (Passoneau & Lowry, 
1993) and acetyl-CoA and acetylcarnitine were determined by radiometric assays 
(Cederblad et al., 1990). In studies II and III, extracts were assayed for ATP, PCr and 
creatine using an enzymatic, fluorometric technique (Bergmeyer, 1974).  
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  2.3.7. RNA Isolation 
 RNA Extraction 
Total RNA was isolated from 5–10 mg skeletal muscle using a modification of the 
acid guanidium thiocyanate-phenol-chloroform extraction technique (FastRNA™ 
Kit-Green; Bio101, Carlsbad). Muscle tissue was added to 550 µl of RNA-bee 
solution (BioTex Laboratories, USA) and processed using the FastPrep™ Instrument 
(BIO 101, Vista CA; Savant Farmingdale, NY), twice for 20 sec at a rate of 5.5, 
separated by 5 min on ice. Following a series of centrifugation and separation steps, 
a pellet of RNA was obtained and suspended in 5 µl of EDTA-treated water.   
 
To determine the RNA concentration, 1 µl of the suspension was diluted with 400 µl 
of sterile water to measure the OD 260 and OD280 using UV spectrometry (Heλios, 
Unicam, Cambridge, United Kingdom). Total RNA concentration was determined 
using the equation OD260/0.0625 µg⋅µl-1 (Sambrook et al., 1989). RNA purity was 
determined by the equation OD260/OD280, with values between 1.7-2.0 indicative 
of the sample being free of genomic and protein contaminants.  RNA was stored at –
80oC until subsequent reverse transcription (RT).  
 
 cDNA Synthesis 
RNA was diluted to 0.1 µg⋅µl-1 in a total volume of 5 µl and heated to 65oC for 10 
min immediately prior to first-strand cDNA being generated using AMV reverse 
transcriptase (Promega, Madison, WI). RNA was combined with oligo (dT)15 primers 
(1 µg⋅µl-1 of RNA), in the presence of 5 mM MgCl, 10 mM Tris-HCl (pH 8.8), 50 
mM KCl, 1% Triton® X-100, 1 mM of each dNTP and 20 U of recombinant RNasin 
ribonuclease inhibitor (40 U⋅µl-1). A RT negative was obtained by not adding any 
RNA to an aliquot of the RT mix. After the addition of 15 U AMV Reverse 
Transcriptase (20 U⋅µl-1), the mixture was incubated at 42oC for 60 min, before the 
reaction was terminated by incubation at 99oC for 5 min followed by 5 min at 4oC 
using the PCRexpress Thermal Cycler (Hybaid, Middlesex, United Kingdom). All 
samples being compared underwent RT together and cDNA was stored at –20oC 
until subsequent analysis.  
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 2.3.8. Real Time RT-PCR 
Real time reverse transcriptase polymerase chain reaction (RT-PCR) was performed 
using the GeneAmp 5700 sequence detection system (Applied Biosystems, Foster 
City, CA). A real time RT-PCR mix of 0.5 X SYBR Green 1 PCR Master Mix, 
forward and reverse primers (3 µM) and 12ng cDNA was run for 40 cycles of PCR 
in a volume of 20 µl. Samples for each gene were run on two plates for study II (with 
a control sample) and a single plate for study III using a no template control and in 
duplicate to control for amplification efficiency. To compensate for variations in 
input RNA amounts and efficiency of RT, the mRNA expression of the 
housekeeping gene cyclophilin (CYC) was quantitated, and results normalised to 
these values. Recent work in this laboratory has identified CYC as an appropriate 
housekeeping gene for quantification of skeletal muscle mRNA abundance during 
both dietary and exercise interventions (Murphy et al., 2003). Fluorescent emission 
data were captured, and mRNA levels were quantified for each gene by use of the 
critical threshold (CT) value (Schmittgen et al., 2000). The ∆CT was calculated by 
subtracting the CT for CYC from the CT for the gene of interest. The relative 
expression of the gene of interest is calculated using the expression 2-∆CT and 
reported as arbitrary units. 
 
 2.3.8.1. Primer Design and Optimisation 
Forward and reverse primers (Table 2.1) were designed using Primer Express 
software package version 1.0 (Applied  Biosystems, Foster City, CA) from gene 
sequences obtained from GenBank. A BLAST search for each primer and probe 
confirmed homologous binding to the desired mRNA of human skeletal muscle 
(Altschul et al., 1990). Primers were purchased from Geneworks (Adelaide, SA, 
Australia).  
 
Primers were optimised for real time RT-PCR to determine the minimum primer 
concentrations giving the highest fluorescence at the lowest CT value. A PCR mix 
was prepared to run triplicates of each of the four conditions as shown in Table 2.2. 
The results demonstrated that optimal CT values were obtained using 3 µM of both 
forward and reverse primer for each gene except for GLUT4 where 9 µM was 
optimal (Table 2.2).  
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 Table 2.1.  
Gene primer sequences  
Gene 
 
Primer Sequence (5' → 3') 
GenBank 
Accession 
(Amplicon Size, 
bp) 
Conc, 
µM 
Cyclophilin 
Forward: 
Reverse: 
CCC ACC CTC TTC TTC GAC AT 
CCA GTG CTC AGA GCA CGA AA 
NM_021130.1 
(80) 
3 
3 
GLUT4 
Forward: 
Reverse: 
CCA ACA GAT AGG CTC CGA AGA 
CGC AGA GAA CAC AGC AAG GA 
NM_001042 
(2128) 
3 
9 
LPL 
Forward: 
Reverse: 
TTG TGA AAT GCC ATG ACA AGT CT 
CAT GCC GTT CTT TGT TCT CTA GA 
NM_000237 
(3549) 
3 
3 
MCD 
Forward: 
Reverse: 
TCA TAA AGC GAG TCG TCA AGG A 
CAG GTA TAG GTG ACA GAC TG AAA ACA 
NM_012213 
(2136) 
3 
3 
PDK4 
Forward: 
Reverse: 
CCC GAG AGG TGG AGC ATT T 
GCA TTT TCT GAA CCA AAG TC AGT A 
NM_002612    
(82) 
3 
3 
See text for definitions. 
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Table 2.2.  
Concentration combinations for forward and reverse primers for primer  
optimisation. 
 
 Forward Primer Conc. (µM) 
Reverse Primer Conc. (µM) 3 9 
3 3 / 3 3 / 9 
9 9 / 3 9 / 9 
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2.3.9. Protein Analysis 
For detection of ACCβ and total AMPKα (α1 and α2) phosphorylation (ACCβ-P and 
AMPK-P), approximately 10–15 mg of muscle were homogenised in 20 volumes of 
homogenisation buffer (50 mM Tris pH 7.5, 1% Triton X-100, 1mM EDTA, 1mM 
EGTA, 1mM DTT, 50mM NaF, 5 mM Na pyrophosphate, 10% glycerol) for 
approximately 30 sec on ice. The homogenate was then centrifuged (5 min, 1000 g at 
4°C) and stored at –80°C for subsequent analysis. Protein concentration was 
determined using the BCA method. 
 
Proteins were separated and identified using SDS-PAGE. 35µg of protein from each 
sample were loaded onto 1.5mm 7% acrylamide gels before undergoing 
electrophoresis for 75 min at 150V. Proteins were wet transferred to a nitrocellulose 
membrane for 120 min at 100V. Membranes were then cut at ~100 kDa and the top 
portion (ACCβ-P) blocked for 1 h in blocking buffer (7% skim milk powder in Tris 
buffered saline and 0.25% Tween (TBST)) and exposed overnight at 4°C to the anti-
phospho-ACCβ-221 polyclonal antibody (1:500) (Chen et al., 2000). The lower 
membrane (AMPKα-P) was blocked overnight at 4°C in 7% blocking buffer and 
exposed for 60 min at room temperature to the phospho-specific AMPKα thr172 
antibody (1:1000). Membranes were exposed to anti-rabbit horseradish peroxidase 
(HRP) conjugated secondary antibodies (diluted 1:10,000) in blocking buffer for 45 
min at room temperature. Antibody binding was viewed by incubating in enhanced 
chemiluminescence substrate (Pierce SuperSignal Chemiluminescent, Rockford) and 
exposing to a Kodak Image Station 440CF (NEN Life Science Products, Boston). 
Bands were identified and quantified using Kodak 1D Image Analysis Software 
(Eastman Kodak, Rochester).  
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CHAPTER THREE 
SKELETAL MUSCLE FAT AND CARBOHYDRATE METABOLISM 
DURING RECOVERY FROM GLYCOGEN-DEPLETING 
EXERCISE IN HUMANS  
 
 
3.1.  INTRODUCTION 
Fat is an important source of energy for resting and contracting muscle, and is 
available exogenously (FAs, chylomicrons, very low density lipoproteins (VLDL)), 
as well as within the muscle fibre. Intramuscular triacylglycerol (IMTG) is found in 
the form of lipid droplets adjacent to mitochondria (Hoppeler et al., 1999) and are 
believed to be an energy substrate during long-term endurance activities (Havel et 
al., 1967; Essen, 1977; Staron et al., 1989; Romijn et al., 1993; Klein et al., 1994; 
Romijn et al., 1995; Watt et al., 2002a). However, the specific contribution of the 
IMTG pool as a metabolic substrate during prolonged submaximal exercise is 
debatable. The majority of evidence from isotopic tracer and 1H-magnetic resonance 
spectroscopy (MRS) studies demonstrate a net utilization of IMTG during 90-120 
min of exercise, while the findings of studies measuring IMTG content directly from 
skeletal muscle biopsies have been controversial (for review, see (Watt et al., 
2002b)).  
 
Relatively little attention has been given to lipid utilisation during the recovery 
period following exhaustive, glycogen-depleting exercise in human beings. The data 
from several studies indicate an increase in whole body fat oxidation after exercise, 
as demonstrated by a decrease in the respiratory exchange ratio (RER) (Krzentowski 
et al., 1982; Bielinski et al., 1985; Kiens & Richter, 1998). Recently, it was also 
demonstrated that IMTG content decreased significantly during the initial 18 h of 
recovery in well-trained individuals (Kiens & Richter, 1998). These authors 
suggested that following glycogen-depleting exercise, muscle glycogen resynthesis is 
of high metabolic priority, resulting in the preferential utilization of IMTG and 
exogenous fat by the recovering skeletal muscle. Paradoxically, the reduction in 
IMTG content occurred during a period of high-CHO feeding when circulating 
insulin, an antilipolytic hormone, was elevated. However, more recent 1H-MRS 
studies in endurance-trained subjects have failed to demonstrate a reduction in IMTG 
content during recovery, with reports of either unchanged (Decombaz et al., 2000; 
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Decombaz et al., 2001) or increased (Larson-Meyer et al., 2002) IMTG content.  It 
should be noted that there are several differences between the biopsy and MRS 
studies which may result in different findings. First, IMTG is measured in soleus or 
tibialis anterior muscles (primarily Type I fibres) in the MRS studies, as opposed to 
the vastus lateralis (50% Type I / 50% Type II) in the biopsy studies. Second, the 
recruitment pattern is likely to be different in these muscles given the different 
modes of exercise (running, MRS; cycling, biopsy). Third, differences in the timing 
of post-exercise sampling may be an issue i.e. post-exercise IMTG content was not 
determined until 22 hr of recovery in the study by Larson-Meyer (Larson-Meyer et 
al., 2002) as opposed to a more detail time course in the first 6 hr of recovery in the 
study by Kiens and Richter (Kiens & Richter, 1998).  
 
Since the existing MRS data suggests that IMTG are not utilised as an energy source 
in the post-exercise recovery period, verifying these findings with direct 
measurements in human biopsy samples is important.  Furthermore, potential 
mechanisms underlying altered substrate utilisation following glycogen-depleting 
exercise, when combined with the standard practice of high-CHO feedings to 
replenish muscle glycogen stores, remain unknown. Accordingly, the objectives of 
this study were to: 1) examine the role of IMTG as an energy substrate after 
exhaustive exercise, and 2) provide a more thorough examination of the metabolic 
changes which occur in skeletal muscle during the recovery period following 
exhaustive, glycogen-depleting exercise. In order to facilitate comparison to the only 
previous study to measure IMTG content in muscle biopsies during recovery, the 
experimental protocol of Kiens & Richter (1998) was essentially replicated. There 
were two major differences in design between this study and the previous one (Kiens 
& Richter, 1998). First, the sampling of muscle biopsies was in duplicate at each 
time point, which should permit a more accurate determination of IMTG content (our 
coefficient of variation between duplicate biopsies in trained individuals is 12% 
(Watt et al., 2002a) compared to 24% in untrained individuals (Wendling et al., 
1996). Second, additional metabolic measurements were included, namely pyruvate 
dehydrogenase activation (PDHa), and changes in muscle pyruvate, acetyl CoA and 
acetylcarnitine contents during recovery. Based on 1) the premise that circulating 
lipids could likely support the increased FA oxidation in resting muscle during the 
recovery period, 2) that elevated insulin levels would be expected to inhibit IMTG 
lipolysis, and 3) recent MRS data which does not support the use of IMTG following 
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exercise, it was hypothesised that IMTG content would remain unchanged during the 
recovery phase. Furthermore, despite the elevation of insulin subsequent to the 
feeding of high-CHO meals, it was hypothesised that PDHa would decrease during 
recovery to facilitate the partitioning of glucose towards glycogen resynthesis. 
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3.2.  METHODS 
Subjects 
Eight endurance-trained males, age, 25 ± 3 years; body mass, 72.7 ± 2.1 kg; and 
2OV& max, 63.1 ± 2.6 ml⋅kg-1⋅min-1 (mean ± SEM) volunteered to participate in this 
study. Six of the subjects were competitive athletes (3 swimmers, 2 runners, 1 
canoeist) and two were highly active. All subjects were considered to be healthy, did 
not smoke or take any medications, and had no evidence of cardiovascular or 
metabolic diseases. The experimental procedures and possible risks of the study were 
explained verbally and in writing to all participants before obtaining their informed, 
written consent to participate. The study protocol (Figure 3.1) was approved by the 
ethics committees of both institutions, and was performed according to the 
Declaration of Helsinki.  
 
Pre-Experimental Protocol 
Daily energy intake and composition of each subject’s habitual diet was assessed 
using a 4-day food record (3 weekdays and 1 weekend day). Dietary data (Table 3.1) 
was analysed for energy intake and macronutrient composition (FoodPro Version 
7.11). Subjects’ maximal oxygen uptake ( 2OV& max) was determined on an 
electromagnetically braked cycle ergometer (Lode Excalibur, Quinton Instruments, 
Seattle, WA, USA). 2OV& max was determined from a plateau in  (increase <2 ml⋅ 
kg
2OV&
-1⋅min-1) with a further increase in power output. From the 2OV& max test, power 
outputs corresponding to submaximal  values to be used during the experimental 
trial (see below) were determined using linear regression analysis for each subject. 
All subjects were familiarised with the intensity of the glycogen-depleting protocol 
and the experimental power outputs verified ~1 week before the experiments. For 
two days prior to the experimental trials, all subjects consumed a high-CHO diet to 
maximise glycogen stores (Table 3.1) and abstained from exercise, and consumption 
of caffeine and alcohol. 
2OV&
 
Experimental Protocol 
Subjects reported to the laboratory at 1000 on the experiment day after a 10-12 hr 
overnight fast. After voiding, body mass was recorded and a teflon catheter inserted 
into an antecubital vein for blood sampling. Following 30 min of rest in a supine 
position, resting  and  were measured (for determination of the respiratory 2OV& 2COV&
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exchange ratio (RER)), and a 5 mL venous blood sample was drawn prior to 
exercise. Subjects then consumed a light breakfast consisting of CHO-rich, high 
glycemic index (GI) foods (Table 3.1). During a subsequent 2 h rest period, two 
incisions were made over the vastus lateralis muscle under local anesthesia (2% 
licodaine without adrenaline (epinephrine)). Respiratory and blood samples were 
then obtained and exercise initiated on a Lode Excalibur cycle ergometer. The 
glycogen-depleting protocol was performed as previously described (Kuipers et al., 
1987; Kiens & Richter, 1998). This consisted of cycling at 75% 2OV& max for 20 min, 
followed by alternating 2-min bouts of 90% and 50% of VO2max for 4-5 intervals, 
then decreasing intensity to 80% and 50% 2-min bouts for another 4-5 intervals, and 
finishing with 2-min 70% and 50% bouts until exhaustion. The mean exercise 
duration was 85.8 ± 3.2 min. During exercise, subjects ingested water ad libitum and 
a blood sample was taken just prior to exhaustion. After cessation of exercise 
(exhaustion), subjects were moved from the cycle ergometer to an examination table, 
at which point two percutaneous needle muscle biopsies were obtained from the 
same thigh. Approximately 3-4 minutes lapsed between the termination of the 
exercise, and the procurement of the muscle samples. During the recovery period, 
duplicate muscle biopsies were obtained at 3, 6 and 18 h by alternating between left 
and right thighs through different incisions spaced 2-3 cm apart. Blood and breath 
samples were obtained after 30 min, and every hour during the initial 6 h of recovery, 
and again after 18 h the following morning. , , and RER were determined 
at rest and during exercise using a metabolic cart (Quinton Q-plex 1, Quinton). RER 
was calculated by averaging expired air samples for the final 5 min of a 10-min 
collection period. 
2OV& 2COV&
  
Recovery Diet 
Energy and macronutrient intake for the 3 meals consumed during the recovery 
period (Table 3.1) were calculated for each subject, and were similar to that used 
previously (Kiens & Richter, 1998). All subjects ate the same type of common food 
items and each meal was carefully prepared and weighed to the nearest gram prior to 
each trial. The first meal was ingested after 1 h of recovery and provided sufficient 
energy to replace that used during the exercise bout (~1450 kcal). A much lighter 
second meal was eaten after 4 h of recovery, followed by a third meal 7 h into the 
recovery period. After the final meal, subjects were only permitted to drink water 
until their final two muscle biopsies the next morning at 18 h of recovery. Total 
 48 
energy intake during recovery was matched closely to the average energy intake 
reported from individual 4-day food records (Table 3.1). The composition of the 
post-exercise recovery diet was calculated to provide 65-70% of energy from CHO, 
20 % from fat, and 10-15 % from protein, with an average GI of 60-65 using glucose 
as a reference (Table 3.1). 
 
Analyses 
Blood samples were analysed for whole blood glycerol and plasma FFA, insulin, 
glucose and lactate according to procedures outlined in chapter 2. Muscle PDHa, 
glycogen, IMTG, ATP, PCr, creatine, acetyl-CoA and acetylcarnitine were analysed 
as previously described in chapter 2. 
 
Statistics 
Results were analysed using a one-way ANOVA with repeated measures for the time 
factor to test for changes in each variable measured during the recovery period. A 
Newman–Keuls post hoc test was used if differences between time points were 
detected. Significance was accepted at P ≤ 0.05. Values are presented as mean ± 
SEM. 
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3.3.  RESULTS 
Diet Analysis 
Total energy intake (Table 3.1) during trial day (breakfast + recovery meals) 
averaged 13212 ± 687 kJ and was closely matched to daily habitual energy intake 
(12505 ± 961 kJ). Dietary composition during recovery consisted of an average of 67 
± 0.9 % of energy from CHO, 21 ± 0.8 % from fat and 13 ± 0.3 % from protein, and 
an average GI of 64.5 ± 0.6. Total CHO intake during the recovery period was 491 ± 
28 g or 6.8 ± 0.3 g⋅kg-1. Total fat intake was 73 + 3 g during the recovery period. The 
first meal consumed during recovery provided an average of 46 ± 0.9% and 52 ± 
0.5%, respectively, of the total energy and CHO intake for trial day. 
 
Respiratory and Blood Responses 
Resting RER was 0.77 ± 0.02 at 2 h prior to exercise, and 0.80 ± 0.02 immediately 
prior to exercise. These were not statistically significant (Table 3.2). During the hour 
following exhaustive exercise, RER was significantly lower than baseline (P < 
0.001), and remained unchanged for the remaining 17 h of recovery. 
Resting whole blood glucose was 4.1 ± 0.10 mmol.l-1 (Table 3.2) prior to the 
commencement of exercise. After 2 h of recovery (1 h after the first high-CHO 
meal), blood glucose concentrations rose significantly above baseline and remained 
elevated for another 3 h (P < 0.001). Plasma insulin concentrations increased 
markedly above baseline after meal 1 to reach a peak of 68.3 ± 2.0 µU/mL (P < 
0.001) at 2 h of recovery (Table 3.2). For the following 4 h, plasma insulin 
concentration remained significantly elevated and returned to baseline levels by the 
following morning at 18 h after exercise. Plasma FFA levels were 0.22 ± 0.03 
mmol.l-1  prior to exercise and increased significantly (P < 0.001) during the first 
hour of recovery to 1.54 ± 0.17 mM (Table 3.2). After ingestion of the first meal, 
FFA concentration rapidly declined at 2 h (0.40 ± 0.07 mM) and remained near 
baseline throughout the recovery period. Plasma glycerol concentrations were 
highest near exhaustion (0.23 ± 0.02 mmol.l-1), and similar to FFA responses, 
showed a marked reduction at 2h and throughout recovery (Table 3.2). The exercise 
protocol produced a significant elevation in plasma lactate concentration (5.2 ± 0.6 
mM, P < 0.001), although levels quickly returned to baseline after 1 h and remained 
unchanged during the recovery (Table 3.2).  
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IMTG 
At the termination of exercise, IMTG content was 23.5 ± 3.5 mmol⋅kg-1 dry wt 
(Figure 3.2), and remained constant at 24.6 ± 2.6, 25.7 ± 2.8 and 28.4 ± 3.0 mmol⋅ 
kg-1 dry wt after 3, 6 and 18 h of recovery, respectively.  
 
Muscle Glycogen and Metabolites 
Muscle glycogen content was 37 ± 11 mmol⋅kg-1 dry wt upon completion of the 
exercise bout and increased significantly throughout the recovery period to reach a 
maximal content of 424 ± 22 mmol⋅kg-1 dry wt (P < 0.001) after 18 h of recovery 
(Figure 3.3).  Muscle ATP, PCr and creatine were generally unchanged throughout 
the recovery period (Table 3.3). Acetyl CoA and acetylcarnitine content decreased 
significantly during the first 3 h of recovery (P < 0.001) and remained significantly 
below post-exercise concentrations throughout the recovery period (Table 3.3). 
Pyruvate (P < 0.01) was also significantly reduced compared to levels at exhaustion 
and remained low throughout the post-exercise period (Table 3.3). 
 
PDHa 
PDHa was 1.37 ± 0.17 mmol⋅min-1⋅kg-1 w.w. after exhaustive exercise, and decreased 
during recovery, being significantly different from exhaustion at 6 (0.66 ± 0.10 
mmol⋅min-1⋅kg-1 w.w., P < 0.01) and 18 h (0.71 ± 0.15 mmol.min-1⋅kg-1 w.w., P < 
0.05) of recovery (Figure 3.4). 
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Figure 3.1. Schematic representation of protocol. 
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Table 3.1. Daily energy intake, dietary composition and glycemic index before and during post-exercise recovery. 
   Pre-exercise Recovery
 Habitual 2 Days   Before Breakfast 
Meal 1        
1 h 
Meal 2        
4 h 
Meal 3        
7 h Average 
Energy, kJ   12505 ± 961 12578 ± 1254     858 ± 0  6051 ± 393 2890 ± 139 3413 ± 239  13212 ± 687 
CHO, %    54 ± 1.6      60 ± 1.8*       84 ± 0     70 ± 0.5    64 ± 0.8   65 ± 1.7   66 ± 0.9 
Fat, %    32 ± 1.2      26 ± 1.6*       12 ± 0     19 ± 0.3    22 ± 0.4   22 ± 1.9   21 ± 0.8 
Protein, %    14 ± 0.7    14 ± 0.9 4 ± 0     11 ± 0.2    14 ± 0.4   13 ± 0.3   13 ± 0.3 
CHO, g·kg-1 ND  ND 0.63 ± 0.02    3.5 ± 0.2   1.5 ± 0.1  1.8 ± 0.1  2.3 ± 0.2 
Glycemic Index (GI) ND ND    68.7 ± 0.0  64.1 ± 0.3 62.3 ± 0.3     55.8 ± 0.5     64.5 ± 0.6 
Values are means ± S.E.M., n = 8. CHO, carbohydrate; ND, not determined. *Significantly different (P < 0.05) from habitual.  
 
 
  
 
Table 3.2. Blood glucose, glycerol and lactate, plasma insulin an
exercise, near exhaustion and during an 18 hour post-exercise rec
Time 
(h) RER 
Glucose 
(mmol l-1) 
Insulin 
(µU ml-1) 
FFA 
(mmol l
Rest  0.77 ± 0.02 4.2 ± 0.12 8.9 ± 0.9 0.26 ± 0.
Pre-exercise  0.80 ± 0.02 4.1 ± 0.10   14.3 ± 2.0 0.22 ± 0.
End-exercise ND 3.6 ± 0.15  4.5 ± 0.6 0.40 ± 0.
 0.5 0.62 ± 0.03‡ 3.6 ± 0.10     5.5 ± 0.4   1.27 ± 0.
  1 0.66 ± 0.03‡ 3.7 ± 0.18     5.5 ± 1.3   1.54 ± 0.
  2  0.77 ± 0.02   6.3 ± 0.30‡  68.3 ±13.3‡ 0.40 ± 0.
  3  0.77 ± 0.02   5.7 ± 0.31‡ 65.7 ± 1.6‡ 0.19 ± 0.
  4  0.80 ± 0.02   5.3 ± 0.30‡ 61.9 ± 9.4‡ 0.18 ± 0.
  5  0.84 ± 0.02 4.8 ± 0.25‡ 66.6 ± 8.3‡ 0.18 ± 0.
  6  0.79 ± 0.02 4.2 ± 0.21  41.7 ± 3.1* 0.22 ± 0.
  18  0.76 ± 0.02 4.3 ± 0.11   10.2 ± 1.0    0.44 ± 0
Values are means ± S.E.M., n = 8. FFA, free fatty acids; RER, respiratory exc
Significantly different from before exercise, * P < 0.05, † P < 0.01, ‡ P < 0.0d FFA, and RER before 
overy period. 
-1) 
Glycerol 
(mmol l-1) 
Lactate 
(mmol l-1) 
04 0.08 ± 0.01 0.3 ± 0.05 
03 0.09 ± 0.003 0.5 ± 0.04 
06  0.23 ± 0.02‡ 5.2 ± 0.6‡ 
16‡ 0.20 ± 0.02‡ 1.7 ± 0.3† 
17‡ 0.19 ± 0.02‡ 0.8 ± 0.15 
07  0.11 ± 0.01   1.2 ± 0.2 
03 0.09 ± 0.01   1.2 ± 0.1 
03 0.09 ± 0.01 0.9 ± 0.08 
02 0.09 ± 0.01 0.9 ± 0.10 
07  0.08 ± 0.01 0.8 ± 0.09 
.06 0.10 ± 0.04 0.4 ± 0.05 
hange ratio; ND, not determined. 
01.
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Table 3.3. Muscle metabolite concentrations immediately after exercise and 
during an 18 hour post-exercise recovery period. 
Metabolite 0 h 3 h 6 h 18 h 
ATP 23.5 ± 0.9 25.0 ± 1.0 26.2 ± 1.1  27.0 ± 1.6† 
PCr 64.4 ± 3.0 68.0 ± 3.0 69.2 ± 3.1      69.1 ± 4.8 
Creatine 48.4 ± 3.1 44.8 ± 2.5 43.7 ± 2.0 43.8 ± 2.6 
Acetyl CoA 22.0 ± 1.8     3.7 ± 1.0‡     9.5 ± 2.0†     7.3 ± 0.8‡ 
Acetyl carnitine 17.5 ± 2.7     1.9 ± 0.4‡     2.3 ± 0.6‡     3.0 ± 0.5‡ 
Pyruvate   0.34 ± 0.07     0.15 ± 0.03†     0.14 ± 0.05†     0.10 ± 0.01† 
Values are means ± S.E.M., n = 8. Significantly different from 0 hours, † P < 0.01, ‡ P < 
0.001 
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Figure 3.2. Muscle triacylglycerol (IMTG) contents in the vastus 
lateralis muscle immediately after exercise and during an 18 hour 
recovery period. Values are means ± SEM for 8 subjects. 
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Figure 3.3. Muscle glycogen contents in the vastus lateralis muscle 
immediately after exercise and during an 18 hour recovery period. 
Values are means ± SEM for 8 subjects. *Significantly different (P < 
0.001) from each previous time point. 
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Figure 3.4. Muscle pyruvate dehydrogenase activation (PDHa) in the 
vastus lateralis muscle immediately after exercise and during an 18 
hour recovery period. Values are means ± SEM for 8 subjects. 
#Significantly different (P < 0.01) from 0 hours; *significantly 
different (P < 0.05) from 0 hours. 
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3.4.  DISCUSSION 
Consistent with previous studies (Krzentowski et al., 1982; Bielinski et al., 1985; 
Kiens & Richter, 1998), these results indicate a greater contribution from fat 
oxidation during recovery in the presence of reduced muscle glycogen. This is in 
support of the hypothesis that a metabolic priority of recovering muscle is to 
resynthesise glycogen stores, resulting in a relative shift from CHO to fat oxidation. 
Indeed, activation of glycogen synthase in exercised human muscle has been recently 
demonstrated (Wojtazsewski et al., 2001), supporting the contention that glycogen 
resynthesis is of high priority early in recovery. However, the present study does not 
support the previous findings of (Kiens & Richter, 1998) that IMTG are a significant 
source of lipid to be utilised during recovery. Rather, this study supports the more 
recent findings of 1H-MRS studies that IMTG content does not decrease during 
recovery from exhaustive exercise in well-trained individuals even when low fat 
meals were ingested after exercise (Decombaz et al., 2000; Decombaz et al., 2001; 
Larson-Meyer et al., 2002). This suggests that the primary lipid source during 
recovery may be exogenously derived (i.e. plasma FAs and TG), which is in 
agreement with the observation of a rapid reduction of plasma FAs during the first 2 
hours of recovery. However, this reduction may also be due in part to reduced 
lipolysis, as indicated by the low glycerol. Furthermore, the large reduction in muscle 
acetylcarnitine stores early in recovery may have provided additional acetyl units for 
oxidation, and therefore have contributed to energy provision during this period. 
Despite the significant increase of insulin in response to the high-CHO feedings 
during recovery, muscle PDHa decreased. This reduction in activity is likely due, at 
least in part, to reduced substrate (pyruvate) availability as a result of the preferential 
partitioning of glucose towards glycogen resynthesis.  
 
Responses During the First Hour of Recovery 
During the first hour of recovery, we observed very low RER values (i.e. below 
0.70). The explanation for this is uncertain, but is likely due to a shift towards 
predominantly fat oxidation, as well as the replenishment of the body’s CO2 stores 
within the bicarbonate pool (Jones & Heigenhauser, 1996). This would lead to a 
reduction in CO2 production and consequently, an underestimation of the RER. The 
rapid increase in plasma FAs post-exercise, subsequent to the release of fatty acid 
trapped within adipose tissue (Hodgetts et al., 1991; Romijn et al., 1993) would have 
provided a large source of energy for the recovering muscle. In addition, the reduced 
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insulin and glucose levels, i.e. factors that are anti-lipolytic and inhibit fat oxidation, 
are likely to contribute to the increase in fat utilisation during the immediate recovery 
period. Muscle acetyl-CoA and acetylcarnitine accumulation was also evident post-
exercise as previously reported (Howlett et al., 1998; Watt et al., 2002a).  
 
Responses During 1 – 6 Hours of Recovery 
After ingestion of the first high carbohydrate meal at 1 h, insulin and glucose levels 
were increased markedly while FAs and glycerol concentrations were rapidly 
reduced. Despite these responses, RER values remained low (0.77 to 0.80) until the 
following meal at 4 h, indicating predominantly fat oxidation, as previously observed 
during the early phase of recovery from prolonged (Krzentowski et al., 1982; 
Bielinski et al., 1985; Horton et al., 1998) or exhaustive exercise (Kiens & Richter, 
1998). The source of increased fat oxidation after glycogen depleting exercise has 
previously been attributed to the utilisation of IMTG (Kiens & Richter, 1998). 
However, in this study, IMTG content remained unchanged during the first 6 hours 
of recovery, suggesting that exogenous sources such as plasma FAs, and possibly 
plasma TG, are major sources of fat oxidation during recovery. Indeed, previous 
studies have found an increase in the activity of the muscle lipoprotein lipase (LPL) 
activity after exhaustive exercise (Lithell et al., 1981; Kiens & Richter, 1998); (Kiens 
et al., 1989), as well as increased muscle LPL mRNA at 4 h and protein content at 8 
h post-exercise (Seip et al., 1997). Glycogen content increased rapidly after 3 and 6 h 
of recovery (4.5 and ~7 fold respectively) in the presence of high circulating insulin 
and glucose. However, in spite of the elevated insulin, PDHa declined after 3 h and 
showed a further downward trend at 6 h to a value significantly (P < 0.01) below that 
observed immediately post-exercise (Figure 3.4). Coincident with this reduction in 
PDHa was a reduction in muscle acetylcarnitine stores, indicating that this pool may 
have been a significant source of acetyl units for oxidation early in recovery. Taken 
together, these data indicate a relative partitioning of glucose uptake during recovery 
towards muscle glycogen resynthesis and an increased reliance on FAs as an 
oxidative fuel.  Approximately 365 g of glucose were consumed during the first 6 
hours of recovery. During this period, muscle glycogen content increased by ~200 
mmol⋅kg-1 d.w., which corresponds to a total of ~100 g of glucosyl units, assuming 
that ~12 kg of muscle mass were utilised during the exhausting exercise and actively 
resynthesising glycogen during recovery. Thus, assuming complete absorption, 
~40% of the ingested glucose was directed towards muscle glycogen resynthesis 
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during the first 6 hours of recovery. Of the remaining glucose absorbed (365 – 100 = 
265 g), ~210 g can be accounted for by 1) whole-body glucose oxidation (~30 g) 
based on an average RER and VO2 of 0.78 and 0.3 L⋅min-1, respectively, and 2) liver 
glycogen resynthesis (~180 g), assuming a liver mass of ~2 kg, and near repletion of 
its glycogen stores. The remaining unaccounted glucose (55 g) may be due to either 
incomplete glucose absorption, or an underestimation of the working muscle mass.  
 
Responses During 6 – 18 Hours of Recovery 
The main finding during this period of recovery was that there was no change in 
IMTG content. Glycogen content continued to significantly increase during this 
period, increasing from 250.2 ± 17.7 to 423.8 ± 22.2 mmol⋅kg-1 d.w. The RER 
remained low, as expected, following the overnight fast (0.76 ± 0.02), indicating a 
continued reliance on fat. In addition, plasma FA levels were slightly elevated in 
response to low concentrations` of circulating insulin. In further support of a shift in 
metabolic priority towards glycogen resynthesis and away from CHO oxidation 
during recovery, PDHa activity, muscle pyruvate and acetyl-CoA concentrations 
were similar to levels found at 6 h of recovery. 
 
Mechanisms for Increased Lipid Metabolism During Recovery 
The mechanism for increased fat oxidation during recovery, in the presence of 
elevated insulin and glucose, is not readily apparent. IMTG contentration was 
unchanged during recovery, suggesting muscle lipid stores are not an appreciable 
source of FAs for increasing fat oxidation. Therefore, it is likely that elevated plasma 
FAs during the first hour of recovery resulted in an increased uptake and oxidation of 
FAs within glycogen depleted muscle. The rapid decline in plasma FA levels after 1 
hour recovery can be attributed to both the rapid clearance by peripheral tissues, 
including skeletal muscle, as well as an insulin-mediated reduction in peripheral 
lipolysis (Horowitz et al., 1997; Mittendorfer et al., 2002) following the first high-
CHO meal during recovery. It is paradoxical, though, that fat oxidation remained 
elevated in the presence of elevated insulin levels. It should be noted, however, that 
resistance to insulin’s inhibition of FA oxidation during recovery from a marathon 
has previously been reported (Tuominen et al., 1996).  
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Regulation of IMTG Content During Post-exercise Recovery 
Enzymatic regulation of muscle TG esterification and hydrolysis during resting and 
contracting conditions is poorly understood. Recently, a neutral hormone-sensitive 
lipase (HSL) was identified in skeletal muscle (Langfort et al., 1998) and appears to 
be under dual control by adrenaline (Langfort et al., 1999) and contraction-related 
mechanisms (Langfort et al., 2000). Plasma adrenaline concentrations were not 
determined in the present study, but would be expected to decrease rapidly (i.e. 
within 30 min) during recovery. Regulation of HSL activity may also result from 
allosteric feedback inhibition by long chain fatty acyl CoA (Jepson & Yeaman, 
1992). Thus, the large increase in plasma FAs observed early in recovery may have 
elevated cytosolic LCFA-CoA concentrations and reduced IMTG hydrolysis by 
inhibiting HSL. For example, during a resting hyperinsulinemic glucose clamp with 
elevated FA levels, a rapid increase in the IMTG pool was found during a 5 h time 
period (Brechtel et al., 2001). It is therefore probably not surprising that IMTG 
content did not decrease during the early stages of recovery given the marked 
elevation of insulin, and the possible accumulation of cytosolic LCFA-CoA in the 
recovering muscle. However, in fairness, it should be pointed out that during the first 
hour of recovery in the study by Kiens & Richter (1998), plasma FAs were also 
significantly elevated (~ 2 mM), at a time when IMTG stores were being utilised.  
 
In spite of conclusions regarding IMTG use, the possibility of simply being unable to 
detect a small, but physiologically meaningful contribution from IMTG 
hydrolysis/oxidation must be acknowledged. Estimation of IMTG utilization using 
biochemical analysis or other established techniques such as isotope tracer kinetics 
and 1H-MRS is limited by the inability to account for TG/FFA cycling. Using the 
dual label pulse-chase technique in isolated rat soleus muscle, it has been 
demonstrated that the IMTG pool undergoes simultaneous esterification and 
hydrolysis during both rest and contraction (Dyck & Bonen, 1998). This raises the 
possibility that TG resynthesis during recovery may have masked the utilisation of 
IMTG as an oxidative fuel during recovery from exhaustive exercise. A recent pulse-
chase study in exercising humans (Guo et al., 2000) indicated that FA incorporation 
into IMTG was relatively small compared to the rates of IMTG oxidation i.e. ~8%, 
making this possibility unlikely. However, it is possible that the incorporation of FAs 
into TG might be greater during recovery. Furthermore, determining the specific 
contribution of IMTG as an oxidative fuel during post-exercise recovery is 
 62 
complicated by the methodological limitations associated with the muscle biopsy 
technique. While the use of trained subjects reduces the coefficient of variation 
between biopsies to 12.3 + 9.4% (Watt et al., 2002a), compared to 23.5 + 14.6% in 
untrained subjects (Wendling et al., 1996), this does not explain the discrepancy 
between the present findings, and those of Kiens and Richter (Kiens & Richter, 
1998), who used equally well-trained subjects in their study.  
 
Regulation of PDHa During Post-exercise Recovery 
While the regulation of PDH activity during acute and prolonged exercise has been 
widely examined, to our knowledge this study is the first to report PDH activation in 
human skeletal muscle during CHO feeding after exhaustive exercise. PDH activity 
is controlled by the relative activities of PDH kinase (PDK), which phosphorylates 
and deactivates PDH, and PDH phosphatase (PDP), which dephosphorylates and 
activates PDH. PDK is stimulated by a high ATP/ADP, acetyl-CoA/CoA-SH and 
NADH/NAD+ ratios and is inhibited by elevated pyruvate concentrations, whereas 
PDP is stimulated by Ca2+ and increased pyruvate. Muscle ATP, acetyl-CoA and 
pyruvate concentrations were unchanged during recovery, while Ca2+ and the 
NADH/NAD+ ratio were not measured in this study. However, since pyruvate is a 
substrate for PDH and an inhibitor of PDK, the possibility exists that a decline in 
pyruvate availability contributed to the trend in PDHa reduction between 3 and 6 h of 
recovery. In addition, it is well documented that PDK4 gene expression is increased 
during recovery from prolonged, exhaustive exercise (Pilegaard et al., 2000; 
Pilegaard et al., 2002), which may also account for the observed decrease in PDHa. 
 
Conclusions 
In summary, we report that IMTG content remains unchanged during recovery from 
glycogen-depleting exercise in the presence of elevated glucose and insulin levels. It 
appears that the partitioning of exogenous glucose towards glycogen resynthesis is of 
high metabolic priority during immediate post-exercise recovery, and is supported by 
the trend towards reduced PDH activity and increased fat oxidation. Plasma FAs (and 
possibly plasma TG), as well as intramuscular acetylcarnitine stores are likely to be 
important fuels for muscle metabolism in the immediate recovery period. However, 
IMTG appears to have a negligible role in contributing to the enhanced fat oxidation 
during recovery from exhaustive exercise.  
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CHAPTER FOUR 
REGULATION OF SKELETAL MUSCLE FAT METABOLISM 
AFTER EXERCISE IN HUMANS: INFLUENCE OF FAT 
AVAILABILITY 
 
 
4.1.  INTRODUCTION 
After a bout of endurance exercise the recovering skeletal muscle relies primarily on 
plasma-derived fatty acids (FAs) as an oxidative energy source. In the fasted state, 
post-exercise lipolysis in peripheral adipose tissue is substantial (Mulla et al., 2000), 
resulting in elevated rates of plasma-derived fat oxidation (Bielinski et al., 1985; 
Devlin et al., 1989; Wolfe et al., 1990; Schrauwen et al., 1997; Tuominen et al., 
1997; Mulla et al., 2000). A major factor regulating skeletal muscle FA oxidation is 
malonyl-CoA, an allosteric inhibitor of carnitine palmitoyltransferase I (CPT I), the 
enzyme that regulates the transfer of long-chain fatty acids (LCFAs) into the 
mitochondria for β-oxidation (McGarry & Brown, 1997). Malonyl-CoA 
concentration in the cytoplasm is under the dual control of synthesis by acetyl-CoA 
carboxylase (ACC) and degradation by the enzyme malonyl-CoA decarboxylase 
(MCD) (Alam & Saggerson, 1998).  
 
Regulation of malonyl-CoA concentration and potentially skeletal muscle fat 
metabolism during post-exercise recovery is likely to be mediated by the metabolic 
fuel sensor 5’AMP-activated protein kinase (AMPK) (Ruderman et al., 2003). 
Exercise-induced activation of AMPK appears to co-ordinately regulate a decrease in 
ACC and increase in MCD activity during post-exercise recovery (Park et al., 
2002a). Such coordinated changes in MCD and ACC attributable to AMPK are 
suggested to lower malonyl-CoA concentration and result in an increased oxidation 
and decreased synthesis of FAs (Park et al., 2002a; Ruderman et al., 2003). While an 
increasing body of evidence suggests that AMPK, ACCβ and MCD have key roles in 
regulating malonyl-CoA and LCFA oxidation following exercise in rodent muscle 
(Ruderman et al., 2003), it is unknown whether these mechanisms exist in human 
skeletal muscle. Furthermore, it also remains to be determined whether altering 
circulating free fatty acid (FFA) levels can induce changes in skeletal muscle fat 
oxidation during post-exercise recovery through modification of AMPK, ACCβ, and 
malonyl-CoA.  
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In addition to plasma FAs, intramuscular triglyceride (IMTG) may also be an 
important source of FAs for skeletal muscle oxidation after glycogen-depleting 
exercise (Kiens & Richter, 1998). Paradoxically, the reduction in IMTG 
concentration occurred during conditions of elevated glucose and insulin which are 
known to reduce hormone-sensitive lipase activity (Watt et al., 2004a) and calculated 
IMTG oxidation during low intensity exercise (Coyle et al., 1997). However, 
Chapter 3 which essentially replicated the experimental protocol of Kiens & Richter 
(1998), demonstrated that IMTG has a negligible role in contributing to the enhanced 
fat oxidation during recovery from exhaustive exercise. Thus, the available evidence 
is equivocal regarding the importance of IMTG is an energy substrate for post-
exercise skeletal muscle metabolism.   
 
Recovery from prolonged, endurance exercise is characterised by a transient increase 
in metabolic gene transcription (Baar et al., 1999; Pilegaard et al., 2000; Pilegaard et 
al., 2002). For many genes, transcriptional activation and increases in mRNA 
abundance peak after 1-4 of recovery and return to basal levels within a ~24 h period 
(Pilegaard et al., 2000). Reduced muscle glycogen after prolonged exercise also 
appears to enhance the transcriptional activation and mRNA of pyruvate 
dehydrogenase kinase 4 (PDK4), raising the possibility that signalling mechanisms 
sensitive to muscle glycogen content may be linked to the transcriptional control of 
exercise-responsive genes (Pilegaard et al., 2002). Fatty acids can also act as signals 
involved in regulating gene expression. Elevated plasma FA levels in response to 
fasting, diabetes and high-fat feeding are associated with increased MCD mRNA in 
rat skeletal muscle (Young et al., 2001). This suggests that FAs are involved in the 
regulation of MCD gene expression and possibly MCD activity, although 
posttranscriptional mechanisms regulating MCD activity appear to exist (Young et 
al., 2001). However, it remains unknown whether FA availability also influences 
MCD mRNA abundance and MCD activity during post-exercise recovery in human 
skeletal muscle. Furthermore, human skeletal muscle PDK4 gene expression is 
highly sensitive to changes in plasma FA availability during high fat feeding (Peters 
et al., 2001), fasting (Spriet et al., 2004) and lipid infusion (Tunstall, 2003, 
unpublished observations). 
 
The objectives of this study were to examine the effect of plasma FFA availability 
during recovery from glycogen lowering exercise on: (1) malonyl-CoA 
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concentration, (2) ACCβ and AMPKα phosphorylation, (3) the importance of IMTG 
as an energy substrate, and (4) the mRNA abundance of proteins regulating fat 
(MCD, LPL) and carbohydrate (PDK4) oxidation. In the first of three trials, FFA 
levels were elevated by a combined infusion of Intralipid and heparin, a 
physiological intervention that is known to decrease malonyl-CoA concentrations at 
rest (Odland et al., 2000) and increase fat oxidation (Nisoli et al., 2000). During a 
second trial plasma FFA availability was lowered with oral administration of the 
lipolytic inhibitor nicotinic acid (NA), a drug previously described to increase CHO 
oxidation (Howlett et al., 2001; Stellingwerff et al., 2003) and PDH activity 
(Stellingwerff et al., 2003) during exercise. The third trial involved saline infusion 
during recovery to serve as a control.  
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4.2.  METHODS 
Subjects 
Eight endurance-trained males, age, 32 ± 1 years; body mass, 79.8 ± 5.5 kg; peak 
power output,  5.0 ± 0.04 watts⋅kg-1 and 2OV& max, 61.1 ± 3.0 ml⋅kg-1⋅min-1 (mean ± 
SEM) volunteered to participate in this study. All subjects were considered to be 
healthy, did not smoke or take any medications, and had no evidence of 
cardiovascular or metabolic diseases. The experimental procedures and possible risks 
of the study were explained verbally and in writing to all participants before 
obtaining their informed and written consent to participate. The study protocol was 
approved by the Deakin University Human Research Ethics Committee and was 
performed according to the Declaration of Helsinki.  
 
Pre-experimental protocol 
Daily energy intake and composition of each subject’s habitual diet was assessed 
using a 4-day food record (3 weekdays and 1 weekend day). Dietary data (Table 4.1) 
was analysed for energy intake and macronutrient composition (Food Processor 
Nutrition Analysis Software, version 7, ESHA Research, Salem OH, USA). One to 
two weeks prior to testing, maximal oxygen uptake ( 2OV& max) was determined on an 
electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, The 
Netherlands). Expired air was analysed by O2 and CO2 analysers (AEI Technologies, 
Pittsburgh, PA, USA) and 2OV& max determined from a plateau in  (increase <2 
ml⋅kg
2OV&
-1⋅min-1) with a further increase in power output. From the 2OV& max test, power 
outputs corresponding to submaximal  values to be used during the experimental 
trial were determined using linear regression analysis for each subject. All subjects 
were familiarised with the intensity of the glycogen-lowering protocol and the 
experimental power outputs verified ~1 week before the experiments. For 2 days 
prior to experimental trials, subjects abstained from exercise and the consumption of 
caffeine and alcohol. In addition, on the day before each experimental trial subjects 
were provided with a high-CHO diet to maximise glycogen stores (Table 4.1). 
2OV&
 
Experimental protocol 
Subjects participated in three randomised, counterbalanced experimental trials, each 
separated by at least a 1 week period. On each occasion, subjects reported to the 
laboratory at 0715 after a 10-12 hr overnight fast. After voiding, body mass was 
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recorded and a teflon catheter inserted into an antecubital vein for blood sampling. 
Following 30 min of rest in a supine position, resting and  were measured 
(for determination of the respiratory exchange ratio – RER), and a 5 ml venous blood 
sample was drawn. Subjects then consumed a light, high-CHO breakfast (Table 4.1). 
During a subsequent 90 min rest period, three incisions were made over the vastus 
lateralis muscle under local anesthesia (1% xylocaine solution). Expired gas and 
blood samples were then obtained and exercise initiated on a Lode Excalibur cycle 
ergometer. The glycogen-lowering protocol was performed as previously described 
(Kuipers et al., 1987). This consisted of cycling at 75% 
2OV& 2COV&
2OV& max for 20 min, followed 
by alternating 2 min bouts of 90% and 50% of 2OV& max for 5-10 intervals, then 
decreasing intensity to 80% and 50% 2-min bouts for another 4-5 intervals, and 
finishing with 2 min 70% and 50% bouts until 90-min of exercise had been 
completed. During exercise, subjects ingested water ad libitum and after 60 min were 
administered either a capsule of nicotinic acid (8 mg⋅kg-1) or placebo. A blood 
sample was also taken ~5 min prior to exhaustion. After cessation of exercise, 
subjects moved from the cycle ergometer to a bench where a percutaneous needle 
muscle biopsy was obtained from the thigh. Approximately 30 sec lapsed between 
the termination of the exercise, and the procurement of the muscle sample using the 
percutaneous needle biopsy technique with suction. Additional muscle biopsies were 
taken from separate incisions on the same thigh at 3 h and at completion of the 6 h 
recovery period. 
 
Immediately after the initial muscle sample, a second teflon catheter was inserted 
into the opposite antecubital vein. Infusion of either an Intralipid 20% solution at 1.5 
ml⋅min-1 (Baxter Healthcare, Deerfield, IL) and a 200 U bolus of heparin followed by 
0.2 U⋅kg-1⋅min-1 (Faulding, Parkville, Australia) (HFA) or 0.9% saline (Viaflex 
Baxter Healthcare, NSW, Australia) at 1.5 ml⋅min-1 (CON) was then commenced for 
6 h via an IMED Gemini PC-1 volumetric infusion pump (Alaris Medical Systems, 
San Diego, CA). During recovery, NA (LFA) or placebo capsules were administered 
at 30 min and 1 h (3.7 mg⋅kg-1), 2 and 3 (5 mg⋅kg-1), and 4 and 5 h (3.7 mg⋅kg-1). 
Blood samples were also obtained at 30 min intervals and breath samples collected 
every hour according to procedures outlined in Chapter 2.  
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Due to difficulties in collecting respiratory measurements for two subjects, RER and 
substrate oxidation data are presented for six subjects. Water ingestion was allowed 
ad libitum during the post-exercise recovery. An overview of the experimental 
protocol is provided in Figure 4.1. 
 
Analyses 
Blood samples were analysed for whole blood glycerol and plasma FFA, insulin, 
glucose and lactate according to procedures outlined in Chapter 2. Muscle glycogen, 
IMTG, malonyl-CoA, ATP, PCr, creatine, gene expression and AMPKα and ACCβ 
phosphorylation were analysed as previously described in Chapter 2. 
 
Statistics 
Results were analysed using a two-way ANOVA with repeated measures (time x 
trial) and specific differences were located using a Tukey post hoc test (SigmaStat, 
version 3). Statistical significance was accepted at P ≤ 0.05. Values are presented as 
the mean ± SEM. 
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4.3.  RESULTS 
Diet Analysis 
Total energy intake in the 2 days immediately prior to each trial was not different 
from habitual (Table 4.1). During the day prior to each trial, CHO intake was higher 
(P < 0.001) and fat intake lower (P < 0.001) to elevate levels of muscle glycogen.  
 
RER and substrate oxidation 
Resting and pre-exercise RER were not different between trials (Table 4.2). During 
the initial hour of recovery, RER was significantly lower (P < 0.01) than rest for 
CON and HFA trials only. Between 4 and 6 h of recovery during the LFA trial, RER 
was significantly higher than the CON (P < 0.01, 4 & 5 h) and HFA (P < 0.01, 5 & 6 
h). Consistent with the RER data, CHO oxidation during the entire recovery period 
was significantly higher than fat oxidation for the LFA trial (P < 0.001) and greater 
for LFA (P < 0.01) compared with the HFA and CON trials (Figure 4.2). Fat 
oxidation increased ~2-fold compared with CHO oxidation during HFA (P < 0.001), 
and was significantly greater (P < 0.05) during HFA compared with LFA.  
 
Blood responses 
Plasma FFA levels were similar at rest, prior to and after exercise for all three trials 
(Figure 4.3B). During recovery, fat infusion significantly elevated FFA 
concentrations above rest (P < 0.001) and above the CON trial after 1.5 h (P < 0.01). 
NA ingestion lowered FFA levels to baseline values that were significantly below 
CON (P < 0.01) throughout recovery except at 4h. Plasma glycerol responses at the 
end of exercise were significantly higher than rest for CON (P < 0.001) and LFA (P 
< 0.05) trials only (Figure 4.3A). NA during recovery reduced plasma glycerol 
compared to HFA (P < 0.01) and CON (P < 0.01) except at 1 and 4 h. Plasma 
glucose did not change during all three trials, except for a lower (P < 0.05) post-
exercise value during CON and higher (P < 0.05) 1 h value during LFA (Table 4.3). 
Pre-exercise plasma insulin was significantly higher (P < 0.01) than rest for CON 
and HFA trials as a result of the high-CHO breakfast (Table 4.3). During recovery, 
elevated FAs increased plasma insulin above levels observed during CON (P < 0.05, 
2-6 h) and LFA (P < 0.001, 1-5 h). Plasma lactate increased significantly (P < 0.01) 
above rest in response to the high intensity exercise and returned to baseline levels 
throughout recovery for all trials (Table 4.3).  
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Muscle metabolites 
No difference in muscle glycogen content between all three trials was observed upon 
completion of the exercise bout (Table 4.4). During the LFA trial, muscle glycogen 
increased significantly (P < 0.001) after 3 h with no further change at 6 h. A 
significant increase (P < 0.01) in glycogen was observed after 6 h for the HFA trial. 
No change in IMTG concentration was detected during recovery for all three trials 
(Table 4.4). Muscle ATP, PCr and creatine also remained unchanged throughout the 
recovery period (Table 4.4). 
 
Malonyl-CoA 
After glycogen depleting exercise (0 h), no difference in malonyl-CoA concentration 
was observed between trials (Figure 4.4). During recovery, a significant increase in 
malonyl-CoA occurred at 3 and 6 h for the CON trial only (P < 0.001). In 
comparison with CON, malonyl-CoA was significantly lower at 6 h during LFA (P < 
0.01) and at 3 h (P < 0.05) and 6 h (P < 0.01) during the HFA trial. 
 
ACCβ and AMPK phosphorylation 
Immediately after exercise (0 h), ACCβ-P was ~4-fold higher than 3 or 6 h during 
CON (P < 0.01) and LFA and HFA (P < 0.001) (Figure 4.5A). No treatment effect 
for ACCβ-P was observed during recovery. An exercise or treatment effect was not 
observed for AMPK-P throughout the recovery period (Figure 4.5B).  
 
Gene expression 
Gene expression of the three genes measured during post-exercise recovery relative 
to the housekeeping gene CYC are presented in Figure 4.6. mRNA abundance of 
MCD increased by ~3-fold during CON and ~4-fold during HFA (P < 0.001), 
however this response was blunted during LFA resulting in a significantly lower 
expression (P < 0.05) after 6 h compared with the HFA trial (Figure 4.6A). A strong 
trend towards a reduction in MCD mRNA during LFA compared with CON (P = 
0.055) was also observed. Intralipid infusion induced a ~2.5-fold increase (P < 0.01) 
in LPL mRNA after 6 h and a similar trend occurred during CON (P = 0.074) 
(Figure 4.6B). NA ingestion prevented an increase in LPL mRNA during the 
recovery period, although mRNA abundance was similar to the other trials. In 
response to the exercise bout and elevated FA levels during CON and HFA trials, 
PDK4 gene expression was markedly increased after 3 and 6 h of recovery during 
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CON (~19-fold, P < 0.001) and HFA (~15-fold, P < 0.05) (Figure 4.6C). Lowering 
FAs transiently abolished the substantial increase in PDK4 mRNA, resulting in 
significantly lower levels (P < 0.05) during LFA after 3 h compared to CON or HFA. 
However, no further suppression of PDK4 mRNA was evident as levels were 
significantly (P < 0.05) higher after 6 h than immediately post-exercise. 
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Figure 4.1. Schematic representation of protocol. 
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Table 4.1. Daily energy and macronutrient intake before post-exercise recovery.  
 Habitual 2 days before 1 day before Trial breakfast 
Energy, kJ 14486 ± 1411     12814 ± 865     13768 ± 588        1281 ± 0 
CHO, %    57 ± 2.9    59 ± 1.6      76 ± 1.3*   82 ± 0 
Fat, %    25 ± 2.1    25 ± 2.2      11 ± 0.5*   13 ± 0 
Protein, %    16 ± 1.9    16 ± 1.4    13 ± 0.9     5 ± 0 
Values are means ± S.E.M., n = 8. CHO, carbohydrate. * Significantly different from 2 days 
before and habitual, P < 0.001.  
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Table 4.2. Respiratory exchange ratio values before exercise and during a 6 hour post-exercise recovery period. 
Trial Rest Pre-exercise 1 h 2 h 3 h 4 h 5 h 6 h 
CON    0.81 ± 0.02    0.84 ± 0.02     0.69 ± 0.04†    0.79 ± 0.02    0.81 ± 0.02    0.77 ± 0.01    0.75 ± 0.01    0.78 ± 0.02 
LFA    0.79 ± 0.02 0.82 ± 0.03     0.77 ± 0.03    0.85 ± 0.02   0.82 ± 0.02    0.80 ± 0.02*    0.85 ± 0.02*‡    0.79 ± 0.01‡
HFA    0.79 ± 0.01 0.80 ± 0.03   0.69 ± 0.02†    0.78 ± 0.03    0.79 ± 0.02    0.73 ± 0.01    0.73 ± 0.01    0.74 ± 0.01 
Values are means ± S.E.M., n = 6. † Significantly different from the resting value of the same trial, P < 0.01; * significantly different  
from CON trial, P < 0.01; ‡ significantly different from HFA trial, P < 0.05. 
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Table 4.3. Plasma glucose, insulin and lactate at rest, before exercise, end 
exercise recovery period. 
  CON   LFA
Time (h) Glucose (mmol l-1) 
Insulin      
(µU ml -1) 
Lactate 
(mmol l-1) 
Glucose 
(mmol l-1) 
Insulin     
(µU ml -1) 
Lacta
(mmol 
Rest 4.9 ± 0.2 5.8 ± 0.8 1.4 ± 0.1 4.9 ± 0.2 5.3 ± 1.2 1.4 ± 0
Pre-exercise 4.4 ± 0.3   8.8 ± 1.1† 1.7 ± 0.2 4.4 ± 0.3   10.1 ± 3.2 1.8 ± 0
End-exercise   4.3 ± 0.1# 4.3 ± 0.3   5.9 ± 0.9† 4.5 ± 0.4 3.8 ± 0.8   5.2 ± 0
1 4.5 ± 0.1 3.8 ± 0.3 1.9 ± 0.1   5.0 ± 0.1*   2.8 ± 0.3‡ 1.6 ± 0
2 4.6 ± 0.1 3.7 ± 0.4 1.3 ± 0.1 4.7 ± 0.1   3.0 ± 0.5‡ 1.4 ± 0
3 4.6 ± 0.2 4.0 ± 0.5 1.2 ± 0.1 4.8 ± 0.1   2.9 ± 0.5‡ 1.3 ± 0
4 4.8 ± 0.1 3.8 ± 0.6 1.2 ± 0.1 4.9 ± 0.1   2.9 ± 0.5‡ 1.3 ± 0
5 4.8 ± 0.1 3.9 ± 0.3 1.2 ± 0.2 4.8 ± 0.1   2.8 ± 0.6‡ 1.3 ± 0
6 4.7 ± 0.1 3.7 ± 0.4 1.2 ± 0.1 4.8 ± 0.2 3.8 ± 0.9 1.4 ± 0
Values are means ± S.E.M., n = 8. Significantly different from the resting value of the sam
significantly different from CON trial, P < 0.05; ‡ significantly different from HFA trial, 
 of exercise and during a 6 hour post-
   HFA
te 
l-1) 
Glucose 
(mmol l-1) 
Insulin     
(µU ml -1) 
Lactate 
(mmol l-1) 
.1 4.9 ± 0.1 5.8 ± 0.6 1.4 ± 0.1 
.2 4.6 ± 0.3 10.4 ± 1.4† 1.7 ± 0.1 
.6† 4.6 ± 0.4 4.6 ± 0.5   5.6 ± 0.6† 
.1 4.7 ± 0.1 5.0 ± 0.4 2.1 ± 0.3 
.1 4.8 ± 0.1   5.4 ± 0.4* 1.6 ± 0.2 
.2 4.8 ± 0.1   6.3 ± 0.5* 1.6 ± 0.1 
.2 4.8 ± 0.1   6.4 ± 0.4* 1.4 ± 0.1 
.2 4.8 ± 0.1   7.5 ± 1.0* 1.3 ± 0.1 
.2 4.7 ± 0.1   6.1 ± 0.5* 1.4 ± 0.1 
e trial, # P < 0.05, † P < 0.01; * 
P < 0.001. 
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Table 4.4. Muscle metabolite concentrations immediately after exercise and during a 6 hour post-exercise 
recovery period. 
  CON     LFA
 HFA
Metabolite 0 h 3 h 6 h 0 h 3 h 6 h 0 h 3 h 6 h 
ATP 23.1 ± 0.8 22.9 ± 0.8 23.3 ± 1.1 22.8 ± 0.7 22.2 ± 0.6 22.7 ± 0.6 23.3 ± 0.8 22.8 ± 0.7 23.2 ± 0.8 
PCr 86.6 ± 3.2 86 ± 3.2 83.8 ± 2.7 86.1 ± 1.4 78.6 ± 3.2 81.0 ± 3.0 88.0 ± 2.6 83.8 ± 2.9 83.2 ± 2.2 
Creatine 47.0 ± 4.9 47.6 ± 3.0 49.8 ± 3.1 47.5 ± 4.8 55.0 ± 3.2 52.6 ± 3.9 47.2 ± 4.7 49.8 ± 3.2 50.3 ± 3.7 
Glycogen 138 ± 24 159 ± 19 163 ± 19 101 ± 24   155 ± 30†   153 ± 24† 127 ± 27 146 ± 24   170 ± 34* 
IMTG 42.2 ± 5.8 35.3 ± 5.4 39.7 ± 4.6 30.7 ± 1.8 36.1 ± 6.8 38.0 ± 6.8 33.8 ± 5.4 36.0 ± 7.5   45.6 ± 10 
Values are means ± S.E.M., n = 8. All values are expressed as mmol kg-1 d.m. PCr, phosphocreatine; IMTG, intramuscular 
triglyceride. Significantly different from 0 h, * P < 0.01, † P < 0.001. 
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Figure 4.2. Total carbohydrate (CHO) and fat oxidation during a 6 h 
recovery period with either saline (CON) and Intralipid infusion 
(HFA) or nicotinic acid ingestion (LFA). Values are means ± S.E.M. 
for 6 subjects. * Significantly different from CON and HFA trials, P < 
0.01; # significantly different from LFA trial, P < 0.05; † significantly 
different from fat oxidation, P < 0.001. 
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Figure 4.3. Plasma glycerol (A) and free fatty acid (FFA) (B) 
concentrations at rest, before and after exercise and during a 6 h recovery 
period with either saline (CON) and Intralipid infusion (HFA) or nicotinic 
acid ingestion (LFA). Values are means ± S.E.M. for 8 subjects. 
Significantly different from the resting value of the same trial, # P < 0.05, † 
P < 0.001; * significantly different from CON trial, P < 0.01; ‡ significantly 
different from HFA trial, P < 0.01. 
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Figure 4.4. Malonyl-CoA concentration immediately after exercise (0 h) 
and during a 6 h recovery period with either saline (CON) and Intralipid 
infusion (HFA) or nicotinic acid ingestion (LFA). Values are means ± 
S.E.M. for 8 subjects. † Significantly different from 0 h, P < 0.001; * 
significantly different from 3 h, P < 0.001; significantly different from 
CON, ‡ P < 0.05, # P < 0.01. 
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Figure 4.5. Acetyl-CoA carboxylase-β (ACCβ) (A) and AMP-
activated protein kinaseα threonine 172 phosphorlyation (AMPK) 
using a phospho-specific antibody that recognises both the α1 and α2 
AMPK subunits (B) immediately after exercise (0 h) and during a 6 h 
recovery period with either saline (CON) and Intralipid infusion 
(HFA) or nicotinic acid ingestion (LFA). Values are means ± S.E.M. 
for 8 subjects. Significantly different from 3 and 6 h, * P < 0.01, † P < 
0.001; # significantly different from LFA trial, P < 0.05. 
 
 81
 
0.00
0.02
0.04
0.06
0.08
0.10
0.12 0 h
3 h
6 h* †
†*
#
M
C
D
 / 
C
yc
lo
ph
ili
n
(A
rb
itr
ar
y 
U
ni
ts
)
A
0.00
0.02
0.04
0.06
0.08
0.10
‡
‡
LP
L 
/ C
yc
lo
ph
ili
n
(A
rb
itr
ar
y 
U
ni
ts
)
B
CON LFA HFA
0.0
0.8
1.6
2.4
3.2
4.0
†
†
# §
‡ ‡
C
PD
K
4 
/ C
yc
lo
ph
ili
n
(A
rb
itr
ar
y 
U
ni
ts
)
‡
 
 
Figure 4.6. mRNA abundance of MCD (A), LPL (B) and PDK4 (C) 
immediately after exercise (0 h) and during a 6 h recovery period with 
either saline (CON) and Intralipid infusion (HFA) or nicotinic acid 
ingestion (LFA). Values are means ± S.E.M. for 8 subjects. Significantly 
different from 0 h, ‡ P < 0.05, † P < 0.001; * significantly different from 
3 h, P < 0.01; § significantly different from CON trial, P < 0.05; # 
significantly different from HFA trial, P < 0.05.  
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4.4.  DISCUSSION 
This study examined the effect of fat availability on whole body substrate utilisation, 
factors regulating skeletal muscle fat oxidation (malonyl-CoA content, ACCβ and 
AMPKα phosphorylation), IMTG concentration and gene expression during post-
exercise recovery. Contrary to results obtained from rodent skeletal muscle, changes 
in whole body fat metabolism after exercise are unrelated to levels of malonyl-CoA 
in human skeletal muscle. In particular, the significant increase in fat oxidation 
observed during 6 h of Intralipid infusion compared with NA ingestion was not 
associated with a difference in malonyl-CoA concentration. The following novel 
observations have also been made, (1) the significant increase in fat oxidation with 
elevated FAs were independent of an increase in ACCβ phosphorylation, (2) IMTG 
remained unchanged during recovery despite the dramatic changes in FFA levels, (3) 
administering NA attenuated the post-exercise increase in skeletal muscle MCD after 
6 h and PDK4 gene expression after 3 h of recovery. 
 
The CPT complex plays a pivotal role in the regulation of LCFA entry into the 
mitochondria for subsequent β-oxidation. Malonyl-CoA is a well known inhibitor of 
CPT I activity in a variety of tissues (McGarry & Brown, 1997) and it is believed 
that malonyl-CoA could be the key regulator of fat oxidation in rodent skeletal 
muscle during muscle contraction (Winder, 1998). However, malonyl-CoA is 
unchanged in human skeletal muscle during moderate-intensity exercise when there 
are large increases in the rate of fat oxidation (Odland et al., 1996; Odland et al., 
1998; Dean et al., 2000), suggesting that the regulation of CPT I activity is more 
complex than simple changes in malonyl-CoA levels and/or that malonyl-CoA 
inhibition is overridden during exercise (Bezaire et al., 2004). Malonyl-CoA is 
decreased in response to Intralipid infusion at rest (Odland et al., 2000) and remains 
depressed for up to 90 min after a single bout of exercise in rats which has been 
postulated to allow for increased fat utilisation and a partitioning of glucose towards 
muscle glycogen resynthesis (Rasmussen et al., 1998). However, this study suggests 
that in the immediate post-exercise recovery period, human skeletal muscle malonyl-
CoA is not a primary regulator of fat metabolism, since malonyl-CoA content was 
not correlated with changes in whole-body fat oxidation. Indeed, these data appear to 
be the first to indicate an increase in skeletal muscle malonyl-CoA during post-
exercise recovery. It should also be noted that immediately after glycogen-lowering 
exercise, malonyl-CoA concentration was low in comparison with values reported 
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after high-intensity knee-extensor exercise to exhaustion (Dean et al., 2000), 
suggesting a decline in malonyl-CoA content occurred during the exercise bout. 
Therefore, the observed increase in malonyl-CoA during CON may reflect a shift 
towards resting values that was blunted during the LFA and HFA trials. The reason 
for an increase in malonyl-CoA during recovery with saline infusion only remains 
unknown. 
 
During post-exercise recovery, decreased malonyl-CoA content in rodent skeletal 
muscle is associated with a coordinate reduction in ACC and increase in MCD 
activity, mediated by the activation of AMPK (Park et al., 2002a). In this study, 
ACCβ-P, which is inversely related to ACC activity in rat muscle (Park et al., 
2002b), rapidly declined after 3 h and remained unchanged after 6 h of recovery 
despite significant change in fat oxidation between the HFA and LFA trials. A 
substantial increase in ACCβ-P followed by a rapid decline after 1 h of moderate 
intensity exercise in well-trained individuals has also been reported, indicating that 
ACCβ-P is particularly sensitive to exercise when muscle glycogen is reduced 
(Wojtaszewski et al., 2002b). Furthermore, AMPKα-P, which is correlated with total 
AMPK activity in rodent (Park et al., 2002b) and human (Wojtaszewski et al., 
2002a; Clark et al., 2004) skeletal muscle, did not decline throughout the 6 h 
recovery period in any trial. It should be noted however that AMPKα-P data in this 
study represent phosphorylation of both α1 and α2 subunits, raising the possibility 
that isoform-specific changes at the end of exercise and during recovery were not 
detected. Indeed, a higher degree of AMPKα2 compared with AMPKα1 activation in 
endurance-trained human skeletal muscle is reported in some (Wojtaszewski et al., 
2000b; Wojtaszewski et al., 2003; Yu et al., 2003) but not all (Clark et al., 2004) 
studies in response to prolonged or high-intensity exercise. During immediate (1-3 
hours) post-exercise recovery, isoform-specific changes are also observed. These 
include a rapid decrease in AMPKα2 activity to near resting levels together with 
unchanged AMPKα1 activation (Wojtaszewski et al., 2000b; Wojtaszewski et al., 
2002a; Wojtaszewski et al., 2003), whilst total AMPKα phosphorylation also 
decreases (Wojtaszewski et al., 2002a). Although a pre-exercise biopsy was not 
obtained in this study, it can be inferred from previous studies that AMPKα-P was 
elevated immediately after exercise (Wojtaszewski et al., 2000b; Wojtaszewski et 
al., 2003; Yu et al., 2003; Clark et al., 2004). Therefore, despite the absence of a 
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significant decrease in AMPKα-P throughout recovery in all trials, AMPK activation 
is unlikely to have remained above resting levels during recovery. On the basis of 
this postulate, increased FA availability was unable induce AMPKα activity after 
exercise and thus may account for the lack of increase in ACCβ-P during the CON 
and HFA trials. In support of this hypothesis, 5 h of Intralipid infusion has no effect 
on AMPKα1 or α2 activity at rest (Tunstall et al., unpublished observations). 
Furthermore, the low AMP/ATP ratio and stable ATP demand under resting 
conditions during recovery would be expected to keep AMPK in its inactive 
(dephosphorylated) form. 
 
Fat oxidation was significantly higher during fat infusion compared with NA 
ingestion during recovery, however no difference in ACCβ-P was observed. These 
data suggest there is dissociation between skeletal muscle ACCβ-P and fat oxidation 
in humans during post-exercise recovery. A similar dissociation between ACCβ-P 
and fat oxidation has been reported in human skeletal muscle during exercise 
(Wojtaszewski et al., 2002a; Clark et al., 2004). Furthermore, the lack of association 
between ACCβ-P and malonyl-CoA in all trials suggests that factors other than the 
phosphorylation state of ACCβ are regulating ACC activity and thus malonyl-CoA in 
human skeletal muscle. Although not determined in this study, these factors could 
include the cytosolic concentration of citrate, an allosteric activator of ACC (Saha et 
al., 1997; Saha et al., 1999; Bavenholm et al., 2000) or LCFA-CoA, an allosteric 
inhibitor of ACC (Saha et al., 1999). Alternatively, differences in MCD activity 
could account for the differing malonyl-CoA values in the three trials.  
 
Activation of AMPK during post-exercise recovery is also postulated to mediate an 
increase in MCD activity and further reduce cytosolic malonyl-CoA in rodent 
skeletal muscle (Park et al., 2002a). In addition to phosphorylation control by 
AMPK, activation of MCD may also be regulated by increased protein content (Dyck 
et al., 2000; Sakamoto et al., 2000), or by the existence of a separate protein or 
allosteric regulator (Dyck et al., 2000; Young et al., 2001), although the exact nature 
of these regulatory mechanisms remain unknown. Gene expression may also be an 
important determinant of MCD activity, since MCD mRNA is most abundant in 
human cardiac and skeletal muscles, tissues in which cytoplasmic malonyl-CoA is a 
potent inhibitor of CPT I and, thus, of mitochondrial LCFA oxidation (Sacksteder et 
al., 1999). Indeed, elevated plasma FA levels in response to fasting, diabetes and 
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high-fat feeding are associated with increased skeletal muscle MCD mRNA (Young 
et al., 2001). Consistent with these results, this study demonstrated that high FFA 
levels increased MCD gene expression after 6 h of post-exercise recovery by 3–4-
fold, although the exercise-independent effect of elevated FAs on MCD mRNA in 
human skeletal muscle is unknown. In comparison with the HFA trial, this effect was 
abolished when FFA levels were lowered using NA and tended to be reduced when 
compared with CON (P = 0.055). These results support the hypothesis that FAs are 
involved in the regulation of rodent skeletal muscle MCD gene expression (Young et 
al., 2001) and extend these data to suggest that FAs are also involved in the 
regulation of MCD mRNA in human skeletal muscle. However, the effect of altered 
MCD mRNA during recovery on MCD activation is uncertain, since MCD activity 
was not determined in this study or in previous studies investigating post-exercise 
metabolism in humans. The mechanisms by which FAs potentially regulate MCD 
expression remain undefined. Specific activation of peroxisome proliferator-
activated receptor-alpha (PPARα) in primary cultured human skeletal muscle cells 
increases MCD mRNA and FA oxidation (Muoio et al., 2002). Furthermore, PPARα 
activation increases skeletal and cardiac muscle MCD gene expression, while 
specific PPAR gamma (PPARγ) activation decreases muscle MCD mRNA, 
suggesting that FA-induced MCD expression is mediated through PPARα (Young et 
al., 2001).  
 
The substantial increase (15–19-fold) in PDK4 gene expression after 6 h of recovery 
during CON and HFA trials confirms previous findings that PDK4 is a highly 
exercise-responsive gene (Pilegaard et al., 2000; Pilegaard et al., 2002). 
Furthermore, reducing post-exercise plasma FFA concentration transiently blunted 
the increase in PDK4 mRNA, suggesting that FAs are involved in the regulation of 
PDK4 as well as MCD gene expression in human skeletal muscle. PDK4 is one of 
four isoenzymes present in mammalian tissues that phosphorylates and inactivates 
the PDH complex. Expression of PDK4 is induced in skeletal muscle by sustained 
increases in fat availability that occur during fasting (Wu et al., 1999; Holness et al., 
2002; Spriet et al., 2004), high fat feeding (Holness et al., 2000; Peters et al., 2001) 
and streptozotocin-induced diabetes in rats (Wu et al., 1999). Similar to MCD 
expression, specific activation of PPARα increases the mRNA abundance of PDK4 
(Muoio et al., 2002) in primary cultured human skeletal muscle cells. Furthermore, 
PDK4 gene expression, PDK4 protein and PDK4 activity are also increased with 
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PPARα activation in rodent skeletal muscle (Wu et al., 1999). Recently, the 
progressive increase in PDK4 mRNA during prolonged fasting in humans has been 
associated with a decline in PDHa (Spriet et al., 2004). Therefore in the present 
study, reduced PDK4 gene expression after 3 h of recovery during LFA may have 
maintained PDHa, and thus in part provides a mechanism for the higher rate of CHO 
oxidation observed during the LFA trial. It should also be noted that in addition to 
lowered plasma FAs, elevated insulin decreases the abundance of PDK4 mRNA 
(Huang et al., 2002). Since NA suppressed plasma insulin in comparison with fat 
infusion, a reduction in insulin concentration may account for the transient 
suppression PDK4 observed at 3 h during recovery. Indeed, increased plasma 
glucose and insulin induces a prolonged suppression of PDK4 mRNA together with 
increased CHO oxidation in comparison with saline infusion after a 6 h post-exercise 
recovery period (Chapter 5).  
 
Although the mechanism of action of NA is not well understood, the possibility 
exists that an NA-induced increase in plasma epinephrine may also effect metabolic 
gene expression during post-exercise recovery. Suppression of plasma FFA with NA 
during exercise is associated with increases in plasma epinephrine (Hawley et al., 
2000; Howlett et al., 2001; Watt et al., 2004b) which coincides with a blunting of the 
exercise-induced increase in PPARα and PPARδ mRNA after prolonged exercise 
(Watt et al., 2004b). Therefore, in response to NA ingestion in the final 30 min of 
exercise and throughout recovery, an epinephrine-mediated decline in PPARα and 
PPARδ activation may have indirectly contributed to the reduction of MCD and 
PDK4 expression in addition to the direct effect of lowered plasma FFAs during 
recovery. However, this hypothesis needs to be directly tested in human skeletal 
muscle.  
 
In addition to plasma-derived FFAs, hydrolysis of IMTG may also be an important 
source of LCFA supporting the increase in post-exercise fat metabolism (Kiens & 
Richter, 1998). Using chemical extraction of muscle samples, no change IMTG 
concentration was observed during recovery despite the marked reduction in 
circulating FFAs with NA ingestion, supporting the previous hypothesis that plasma-
derived FAs are the preferential fuel source for skeletal muscle fat metabolism 
during recovery from glycogen-lowering exercise (Chapter 3). Although NA 
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ingestion increased RER and CHO oxidation during recovery as reported previously 
(Walker et al., 1991; Trost et al., 1997), fat oxidation remained at a similar rate to 
that observed during CON and IMTG concentration tended to increase with NA. 
These results indicate that the significant blunting of post-exercise lipolysis did not 
limit fat oxidation, consistent with the observation that only a small fraction of the 
substantial adipose tissue lipolysis during post-exercise recovery is taken up by 
exercised muscle in the lower extremities (Mulla et al., 2000). Indeed, up to 90% of 
the FAs released during recovery are reesterified in the liver (Wolfe et al., 1990). 
Furthermore, the absence of a significant decrease in fat oxidation during NA 
compared with CON highlights the substantial reduction in FA derived energy 
expenditure during post-exercise recovery. For example, it is plausible that total fat 
oxidation was reduced by at least 75% after exercise, since maximal rates of fat 
oxidation measured using indirect calorimetry during exercise are 0.60 g⋅min-1 
(Achten et al., 2002) compared with a maximum of only 0.16 g⋅min-1 during the fat 
infusion trial. Therefore, the large decrease in FA requirement after exercise appears 
to account for the negligible effect of FA availability on fat oxidation and IMTG 
concentration during LFA and HFA compared with CON. Surprisingly, IMTG 
content was not significantly increased in response to high FFA concentrations 
during Intralipid and heparin infusion. In resting skeletal muscle, increased IMTG 
concentration has been observed with elevated plasma FAs (Boden et al., 2001), 
however this difference is most likely attributable to the reduced sensitivity of the 
muscle biopsy technique in comparison with the non-invasive method of 1H-NMR 
(Boden et al., 2001).  
 
In conclusion, altering the availability of plasma FFA during recovery induces 
changes in whole-body substrate oxidation that are unrelated to differences in 
skeletal muscle malonyl-CoA. Furthermore, fat oxidation and ACCβ phosphorylation 
appear to be dissociated after exercise, suggesting mechanisms other than 
phosphorylation-mediated changes in ACC activity have an important role in 
regulating malonyl-CoA and fat metabolism in human skeletal muscle during post-
exercise recovery. Alternative mechanisms regulating post-exercise fat metabolism 
include citrate and LCFA-CoA mediated changes in ACC activity, or differences in 
MCD activity. Reducing plasma FFA concentrations with NA attenuated the post-
exercise increase in MCD and PDK4 gene expression, suggesting that FAs and/or 
other factors induced by NA are involved in the regulation of these genes. Despite 
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marked changes in plasma FFA availability, no significant change in IMTG 
concentration was detected, providing further evidence that plasma-derived FAs are 
the preferential fuel source contributing to the enhanced fat oxidation during 
recovery from glycogen-lowering exercise.   
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CHAPTER FIVE 
EFFECT OF GLUCOSE AVAILABILITY ON THE REGULATION 
OF FAT METABOLISM IN HUMAN SKELETAL MUSCLE 
DURING POST-EXERCISE RECOVERY 
 
 
5.1.  INTRODUCTION 
Recovery from exercise is characterised by numerous changes in skeletal muscle 
metabolism that persist for several hours after exercise. In the fasted state, there is 
substantial free fatty acid (FFA) mobilisation from adipose tissue following exercise 
(Mulla et al., 2000), resulting in elevated rates of plasma-derived fat oxidation 
(Devlin et al., 1989; Wolfe et al., 1990; Tuominen et al., 1997; Mulla et al., 2000). 
Insulin stimulated glucose uptake and glycogen synthase activity are also increased 
during post-exercise recovery in human skeletal muscle (Mikines et al., 1988; 
Wojtaszewski et al., 2000a) and this appears to be influenced by the extent of muscle 
glycogen depletion (Nielsen et al., 2001). Furthermore, skeletal muscle insulin 
sensitivity is increased at least 48 h after a bout of exercise (Mikines et al., 1988), 
leading to a rapid rate of glycogen resynthesis when high-carbohydrate foods are 
consumed following glycogen-depleting exercise (Chapter 3). Collectively, these 
findings clearly indicate that recovery from prolonged exercise induces a number of 
changes in skeletal muscle that favour fat oxidation and allow for a high metabolic 
priority towards glycogen resynthesis. 
 
Potential mechanisms that facilitate an increase in fat metabolism whilst allowing the 
partitioning of glucose towards glycogen resynthesis in human skeletal muscle 
remain poorly understood. In the presence of elevated glucose and insulin, a decline 
in PDHa during post-exercise recovery coincides with a rapid increase in glycogen 
synthesis and lowered RER values (Chapter 3). In rodent skeletal muscle, an 
increasing body of evidence suggests that AMPK activation increases post-exercise 
skeletal muscle fat oxidation by lowering the concentration of malonyl-CoA and thus 
allowing for enhanced CPT I mediated long-chain FA (LCFA) transport into the 
mitochondria (Ruderman et al., 2003). AMPK is postulated to decrease malonyl-
CoA levels in rodent skeletal muscle through two mechanisms: 1) inactivating 
acetyl-CoA carboxylase (ACC), the enzyme facilitating an increase in malonyl-CoA 
synthesis, and 2) increasing malonyl-CoA decarboxylase (MCD) activity, the 
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enzyme involved in the degradation of malonyl-CoA (Park et al., 2002a). However, 
in response to altered fat availability in human skeletal muscle, ACCβ and AMPKα 
phosphorylation appear to be dissociated after exercise, whilst changes in whole-
body substrate oxidation are unrelated to differences in malonyl-CoA during the 
immediate post-exercise recovery period (Chapter 4). To further examine the 
hypothesis that AMPK regulates post-exercise skeletal muscle fat oxidation, this 
study examined whether glucose availability induced changes in substrate oxidation 
during post-exercise recovery that can be explained by an AMPK-mediated change 
in ACC. 
 
During recovery from glycogen-depleting exercise, intramuscular triglyceride 
(IMTG) has been identified as an important source of FAs to support the enhanced 
rate of skeletal muscle fat oxidation (Kiens & Richter, 1998). However, during 
similar conditions of elevated plasma glucose and insulin (Chapter 3), IMTG appears 
to have a negligible role in contributing to the enhanced fat oxidation during 
recovery from exhaustive exercise. Furthermore, post-exercise IMTG concentration 
does not decline in the presence of reduced FA availability (Chapter 4), supporting 
the previous hypothesis that plasma-derived FAs are the preferential fuel source for 
skeletal muscle fat metabolism after glycogen-lowering exercise (Chapter 3). Despite 
these findings, it is unknown whether IMTG is an important energy substrate for 
post-exercise skeletal muscle metabolism in the presence of elevated glucose without 
an associated hyperinsulinemic response. 
 
Increases in metabolic gene transcription relevant to fat and CHO oxidation are well 
documented during exercise and appear to increase further during the post-exercise 
recovery period (Kraniou et al., 2000; Pilegaard et al., 2000; Pilegaard et al., 2002). 
For many genes, transcriptional activity peaks during the initial recovery phase after 
endurance exercise and returns to basal levels within a ~24 h period (Pilegaard et al., 
2000). Transcriptional activation is followed by increases in mRNA that are 
observed  to peak after 1–4 h of recovery (Kraniou et al., 2000; Pilegaard et al., 
2000; Pilegaard et al., 2002). Substrate availability during post-exercise recovery 
may also be linked with the transcriptional activation of metabolic genes in response 
to exercise. Reduced muscle glycogen after prolonged exercise is associated with 
enhanced transcriptional activation and mRNA of PDK4, raising the possibility that 
signalling mechanisms sensitive to muscle glycogen content may be linked to the 
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transcriptional control of exercise-responsive genes (Pilegaard et al., 2002). 
Furthermore, increased PDK4 gene expression is associated with reduced pyruvate 
dehydrogenase activity (PDHa) during prolonged fasting (Spriet et al., 2004) and 
may be an important long-term regulator of the PDH complex when there is 
sustained changes in tissue fat delivery and/or handling (Peters et al., 1998; Sugden 
& Holness, 2003).   
 
The objectives of this study were to examine the effect of plasma glucose availability 
during recovery from glycogen-lowering exercise on: (1) the phosphorylation state of 
ACC and its key regulator AMPK and, (2) the importance of IMTG as an energy 
substrate, (3) the mRNA abundance of proteins regulating fat (MCD, LPL) and 
carbohydrate (PDK4, GLUT4) oxidation. In the first of two trials, plasma glucose 
was elevated using glucose infusion, a physiological intervention that facilitates a 
large increase in glycemia without an associated hyperinsulinemic response (Perley 
& Kipnis, 1967). During a second trial, saline was infused as a control over a 6 h 
recovery period after a strenuous bout of exercise. On the basis that elevated plasma 
glucose is associated with decreased AMPK activity (Itani et al., 2003), it was 
hypothesised that post-exercise glucose infusion would reduce both total AMPKα 
and ACCβ phosphorylation leading to a decrease in fat oxidation compared with the 
control trial.   
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5.2.  METHODS 
Subjects 
Seven endurance-trained males, age, 29.4 ± 1.5 years; body mass, 78.1 ± 3.6 kg; 
peak power output, 5.1 ± 0.2 watts⋅kg-1 and 2OV& max, 61.6 ± 2.0 ml⋅kg-1⋅min-1 (mean ± 
SEM) volunteered to participate in this study. All subjects were considered to be 
healthy, did not smoke or take any medications, and had no evidence of 
cardiovascular or metabolic diseases. The experimental procedures and possible risks 
of the study were explained verbally and in writing to all participants before 
obtaining their informed and written consent to participate. The study protocol was 
approved by the Deakin University Human Research Ethics Committee and was 
performed according to the Declaration of Helsinki.  
 
Pre-experimental protocol 
Daily energy intake and composition of each subject’s habitual diet was assessed 
using a 4-day food record (3 weekdays and 1 weekend day). Dietary data (Table 5.1) 
was analysed for energy intake and macronutrient composition (Food Processor 
Nutrition Analysis Software, version 7, ESHA Research, Salem OH, USA). One to 
two weeks prior to testing, maximal oxygen uptake ( 2OV& max) was determined on an 
electromagnetically braked cycle ergometer (Lode Excalibur, Groningen, The 
Netherlands). Expired air was analysed by O2 and CO2 analysers (AEI Technologies, 
Pittsburgh, PA, USA) and 2OV& max determined from a plateau in  (increase <2 
ml⋅kg
2OV&
-1⋅min-1) with a further increase in power output. From the 2OV& max test, power 
outputs corresponding to submaximal  values to be used during the experimental 
trial were determined using linear regression analysis for each subject. All subjects 
were familiarised with the intensity of the glycogen-lowering protocol and the 
experimental power outputs verified ~1 week before the experiments. For 2 days 
prior to experimental trials, subjects abstained from exercise and the consumption of 
caffeine and alcohol. In addition, on the day before each experimental trial subjects 
were provided with a high-CHO diet to maximise glycogen stores (Table 5.1). 
2OV&
 
Experimental protocol 
Subjects participated in two randomised, counterbalanced experimental trials [saline 
infusion (CON) vs. glucose infusion (GLU)], each separated by at least a 1 week 
period. On each occasion, subjects reported to the laboratory at 0715 after a 10-12 hr 
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overnight fast. After voiding, body mass was recorded and a teflon catheter inserted 
into an antecubital vein for blood sampling. Following 30 min of rest in a supine 
position, resting and  were measured (for determination of the respiratory 
exchange ratio – RER), and a 5 ml venous blood sample was drawn. Subjects then 
consumed a light, high-CHO breakfast (Table 5.1). During a subsequent 90 min rest 
period, three incisions were made over the vastus lateralis muscle under local 
anesthesia (1% xylocaine solution). Expired gas and blood samples were then 
obtained and exercise initiated on a Lode Excalibur cycle ergometer. The glycogen-
lowering protocol was performed as previously described (Kuipers et al., 1987). This 
consisted of cycling at 75% 
2OV& 2COV&
2OV& max for 20 min, followed by alternating 2 min bouts 
of 90% and 50% of 2OV& max for 5-10 intervals, then decreasing intensity to 80% and 
50% 2-min bouts for another 4-5 intervals, and finishing with 2 min 70% and 50% 
bouts until 90-min of exercise had been completed. During exercise subjects ingested 
water ad libitum. A blood sample was also taken ~5 min prior to exhaustion. After 
cessation of exercise, subjects moved from the cycle ergometer to a bench where a 
percutaneous needle muscle biopsy with suction was obtained from the thigh. 
Approximately 30 sec lapsed between the termination of the exercise, and the 
procurement of the muscle sample. Additional muscle biopsies were taken from 
separate incisions on the same thigh at 3 h and at completion of the 6 h recovery 
period. 
 
Immediately after the initial muscle sample, a second teflon catheter was inserted 
into the opposite antecubital vein. Infusion of either a 25% glucose solution at 4 
mg⋅kg-1⋅min-1 (Viaflex Baxter Healthcare, NSW, Australia) (GLU) or 0.9% saline at 
1.5 ml⋅min-1 (CON) was then commenced for 6 hours. Blood samples were also 
obtained at 30 min intervals and breath samples collected every hour according to 
procedures outlined in Chapter 2. Due to difficulties in collecting respiratory 
measurements for one subject, RER and substrate oxidation data are presented for six 
subjects. Water ingestion was allowed ad libitum during the recovery period.  
 
Analyses 
Blood samples were analysed for whole blood glycerol and plasma FFA, insulin, 
glucose and lactate according to procedures outlined in Chapter 2. Muscle glycogen, 
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IMTG, ATP, PCr, creatine, gene expression and AMPKα and ACCβ 
phosphorylation were analysed as previously described in Chapter 2. 
 
Statistics 
Results were analysed using a two-way ANOVA with repeated measures (time x 
trial) and specific differences were located using a Tukey post hoc test (SigmaStat, 
version 3). Statistical significance was accepted at P ≤ 0.05. Values are presented as 
the mean ± SEM. 
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5.3.  RESULTS 
Diet Analysis 
Total energy intake in the 2 days immediately prior to each trial was not different 
from habitual energy intake (Table 5.1). During the day prior to each trial, CHO 
intake was higher (P < 0.001) and fat intake lower (P < 0.001) to elevate levels of 
muscle glycogen.  
 
RER and substrate oxidation 
Resting and pre-exercise RER were not different between trials (Table 5.2). During 
the initial hour of recovery, RER was significantly lower (P < 0.01) than rest for the 
GLU trial only. During recovery, RER was significantly higher at 3 and 6 h (P < 
0.05) and 5 h (P < 0.01) in the GLU trial compared with CON. Fat oxidation during 
the entire recovery period was significantly higher than CHO oxidation for the CON 
trial (P < 0.01) (Figure 5.1). When compared with CON, CHO oxidation during 
GLU was significantly greater (P < 0.01) and fat oxidation significantly lower (P < 
0.05) throughout recovery. 
 
Blood responses 
Plasma glucose levels were similar at rest, prior to and after exercise for both trials 
(Figure 5.2B). During recovery, glucose concentrations were significantly greater 
during GLU compared with CON (P < 0.01) and significantly above rest after 2 h (P 
< 0.01) in the GLU trial. Pre-exercise plasma insulin was significantly higher (P < 
0.01) than rest for both trials as a result of the high-CHO breakfast (Figure 5.2A). 
Glucose infusion increased plasma insulin throughout recovery in comparison with 
CON (P < 0.05), although the magnitude of this response was small compared with 
the rapid increase in insulin after oral ingestion of glucose at breakfast. Plasma FFA 
levels were similar at rest, prior to and immediately after exercise for both trials 
(Table 5.3). During CON, plasma FFAs increased significantly above rest after 1 h of 
recovery (P < 0.001), whilst elevated glucose levels during GLU significantly 
reduced plasma FFAs compared with CON (P < 0.01).  Plasma glycerol responses at 
the end of exercise were significantly higher than rest for both trials (P < 0.001) 
(Table 5.3). Consistent with FFA responses, glycerol remained elevated above rest 
throughout recovery in the CON trial (P < 0.001, 1, 3 and 6 h; P < 0.05, 2 and 5 h) 
except at 4 h. No change in plasma glycerol was detected during recovery in the 
GLU trial as a result of glucose infusion.  Plasma lactate increased significantly (P < 
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0.01) above rest in response to the high intensity exercise and returned to baseline 
levels throughout recovery in both trials (Table 5.3).  
 
Muscle metabolites 
No difference in muscle glycogen content between trials was observed upon 
completion of the exercise bout (Table 5.4). During the GLU trial, muscle glycogen 
increased significantly after 3 h (P < 0.05) and 6 h (P < 0.01) compared with 0 h. No 
change in IMTG concentration was detected during recovery for both trials (Table 
5.4). Muscle ATP, PCr and creatine also remained unchanged throughout the 
recovery period (Table 5.4). 
 
ACCβ and AMPK phosphorylation 
Immediately after exercise (0 h), ACCβ-P was ~5-fold higher than 3 or 6 h during 
CON (P < 0.01) (Figure 5.3A). An exercise-induced increase in ACCβ-P was also 
observed for the GLU trial (~3-fold) compared with 3 h (P < 0.001) and 6 h (P < 
0.01), although no treatment effect for ACCβ-P was detected during recovery. No 
exercise or treatment effect was observed for AMPK-P throughout the recovery 
period (Figure 5.3B).   
 
Gene expression 
Gene expression of the four genes measured during post-exercise recovery relative to 
the housekeeping gene CYC are presented in Figure 5.4. mRNA abundance of MCD 
increased by ~3-fold during CON and ~5-fold during GLU (P < 0.001) (Figure 
5.4A). A ~4.5-fold increase (P < 0.05) in LPL mRNA was observed after 6 h of 
glucose infusion, however this effect was not observed during CON (Figure 5.4B). 
Glucose infusion induced a ~3-fold increase (P < 0.05) in GLUT4 gene expression 
after 6 h of recovery (Figure 5.4C).  No change in GLUT4 mRNA was observed 
during CON. In response to the exercise bout and elevated FA levels during CON, 
PDK4 gene expression was markedly increased after 3 and 6 h of recovery (~11-fold, 
P < 0.001) (Figure 5.4D). During glucose infusion, a significant increase in PDK4 
mRNA after 3 h was also observed (~8-fold, P < 0.01), however PDK4 expression 
was significantly reduced compared with mRNA levels at 3 h during CON (P < 
0.05). Furthermore, the exercise induced increase in PDK4 mRNA was abolished 
during GLU, resulting in significantly higher PDK4 mRNA abundance in CON 
compared to GLU after 6 h (P < 0.05).  
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Table 5.1. Daily energy and macronutrient intake before post-exercise recovery.  
 Habitual 2 days before 1 day before Trial breakfast 
Energy, kJ 14536 ± 1109 13868 ± 1331     14150 ± 571        1281 ± 0 
CHO, %    59 ± 0.8    60 ± 1.4      75 ± 1.1*   82 ± 0 
Fat, %    25 ± 1.2    25 ± 1.8      11 ± 0.5*   13 ± 0 
Protein, %    14 ± 0.4    15 ± 1.4    14 ± 0.8     5 ± 0 
Values are means ± S.E.M., n = 7. CHO, carbohydrate. * Significantly different from 2 days 
before and habitual, P < 0.001. 
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Table 5.2. Respiratory exchange ratio values before exercise and during a 6 hour post-exercise recovery period. 
Trial Rest Pre-exercise 1 h 2 h 3 h 4 h 5 h 6 h 
CON    0.77 ± 0.01    0.84 ± 0.03    0.72 ± 0.02    0.77 ± 0.01    0.77 ± 0.02    0.76 ± 0.01    0.73 ± 0.01    0.76 ± 0.01 
GLU    0.80 ± 0.01    0.81 ± 0.02    0.71 ± 0.03*    0.80 ± 0.02   0.83 ± 0.01#    0.79 ± 0.01    0.81 ± 0.01†    0.82 ± 0.02# 
Values are means ± S.E.M., n = 6. * Significantly different from the resting value of the same trial, P < 0.05; significantly different 
from control (CON), # P < 0.05, † P < 0.01. 
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Table 5.3. Plasma fatty acids, glycerol and lactate at rest, before exercise, end of exercise and during a 6 
hour post-exercise recovery period. 
  CON   GLU
Time (h) Fatty acids      (mmol l-1) 
Glycerol       
(mmol l -1) 
Lactate     
(mmol l-1) 
Fatty acids 
(mmol l-1) 
Glycerol       
(mmol l -1) 
Lactate     
(mmol l-1) 
Rest 0.29 ± 0.07 0.06 ± 0.02 1.3 ± 0.2 0.24 ± 0.05 0.07 ± 0.02 1.1 ± 0.1 
Pre-exercise 0.16 ± 0.04 0.06 ± 0.02 1.7 ± 0.1 0.15 ± 0.03 0.06 ± 0.02 1.6 ± 0.1 
End-exercise 0.50 ± 0.15   0.21 ± 0.04‡   5.6 ± 0.9‡ 0.58 ± 0.14   0.21 ± 0.03‡   5.2 ± 0.7‡ 
1   1.11 ± 0.12‡   0.15 ± 0.04‡ 2.0 ± 0.3   0.52 ± 0.07† 0.09 ± 0.02 1.9 ± 0.1 
2   1.13 ± 0.10‡   0.12 ± 0.02* 1.3 ± 0.2   0.52 ± 0.05† 0.09 ± 0.02 1.3 ± 0.2 
3   1.24 ± 0.07‡   0.14 ± 0.03‡ 1.4 ± 0.2   0.49 ± 0.10† 0.09 ± 0.02 1.3 ± 0.1 
4   0.82 ± 0.08‡ 0.06 ± 0.02 1.2 ± 0.1   0.28 ± 0.02† 0.08 ± 0.02 1.2 ± 0.1 
5   0.85 ± 0.09‡   0.11 ± 0.03* 1.1 ± 0.2   0.37 ± 0.04† 0.09 ± 0.02 1.3 ± 0.2 
6   1.04 ± 0.11‡   0.13 ± 0.03‡ 1.2 ± 0.2   0.53 ± 0.14† 0.10 ± 0.02 1.1 ± 0.1 
Values are means ± S.E.M., n = 7. Significantly different from the resting value of the same trial, * P < 0.05, ‡ P < 0.001; † 
significantly different from CON trial, P < 0.01.
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Table 5.4. Muscle metabolite concentrations immediately after exercise and during 
a 6 hour post-exercise recovery period. 
  CON  
 GLU  
Metabolite 0 h 3 h 6 h 0 h 3 h 6 h 
ATP 24.4 ± 1.0 24.5 ± 0.9 25.8 ± 1.1  24.1 ± 0.6 24.7 ± 0.5 24.3 ± 0.7 
PCr 91.4 ± 5.6 90.6 ± 3.3 88.3 ± 3.2 82.2 ± 4.3 85.2 ± 3.3 85.7 ± 1.4 
Creatine 52.5 ± 4.9 53.3 ± 3.4 55.6 ± 2.7 61.8 ± 3.4 58.6 ± 2.8 58.1 ± 2.7 
Glycogen 153 ± 26 155 ± 34 152 ± 25 125 ± 19   171 ± 28*   185 ± 27† 
IMTG 47.9 ± 7.6 51.0 ± 7.1 51.9 ± 7.6 49.0 ± 8.1 42.5 ± 4.7 39.2 ± 6.3 
Values are means ± S.E.M., n = 7. All values are expressed as mmol kg-1 d.m. Significantly different 
from 0 h, * P < 0.05, † P < 0.01. 
 
 101
 
 
 
 
 
CON GLU
0
2 0
4 0
6 0
8 0 C H O o x
Fa t o x
*†
Su
bs
tra
te
 o
xi
da
tio
n 
(g
)
 
Figure 5.1. Carbohydrate (CHO) and fat oxidation during a 6 h 
recovery period with either saline (CON) or glucose infusion (GLU). 
Values are means ± S.E.M. for 6 subjects. * Significantly different 
from CON trial, P < 0.01; † significantly different from CHO 
oxidation, P < 0.01. 
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Figure 5.2. Plasma insulin (A) and glucose (B) concentrations at rest, before 
and after exercise and during a 6 h recovery period with either saline (CON) 
or glucose infusion (GLU). Values are means ± S.E.M. for 7 subjects. * 
Significantly different from the resting value of the same trial, P < 0.01; 
significantly different from CON trial, # P < 0.05, † P < 0.01. 
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Figure 5.3. Acetyl-CoA carboxylase-β (ACCβ) (A) and AMP-
activated protein kinaseα threonine 172 phosphorlyation (AMPK) (B) 
immediately after exercise (0 h) and during a 6 h recovery period with 
either saline (CON) or glucose infusion (GLU). Values are means ± 
S.E.M. for 7 subjects. # Significantly different from 3 and 6 h, P < 
0.001, † significantly different from 3 h, P < 0.001; * significantly 
different from 6 h, P < 0.01. 
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Figure 5.4. mRNA abundance of MCD (A), LPL (B), GLUT4 (C) and PDK4 (D) immediately after exercise (0 h) and during a 6 h 
recovery period with either saline (CON) or glucose infusion (GLU).Values are means ± S.E.M. for 7 subjects. Significantly different 
from 0 h, ‡ P < 0.05, † P < 0.001; * significantly different from 3 h, P < 0.05; # significantly different from GLU trial, P < 0.05.  
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5.4.  DISCUSSION 
After a single bout of intense, dynamic exercise in trained and untrained humans, the 
recovering skeletal muscle relies primarily on FAs as an oxidative energy source. 
However, the cellular and molecular mechanisms facilitating the increase in skeletal 
muscle fat oxidation following prolonged exercise remain poorly defined.  This study 
investigated the effect of glycogen-lowering exercise on the regulation of fat 
metabolism with or without hyperglycemia. In response to increased glucose 
availability (GLU), CHO oxidation was significantly higher during recovery 
compared with the fasted state (CON). However, in contrast with the study 
hypothesis, a decrease in fat oxidation or an associated reduction in total AMPKα or 
ACCβ phosphorylation was not observed during GLU in comparison with the CON 
trial. Despite the relatively high rates of fat oxidation and small rise in plasma insulin 
during GLU and suppression of plasma FAs in comparison with CON, a significant 
decline in IMTG concentration was not detected. In addition, novel changes in gene 
expression during post-exercise recovery were observed, of which the most notable 
was the significant reduction in PDK4 gene expression in the presence of elevated 
plasma glucose. 
 
In the immediate recovery period after prolonged exercise, skeletal muscle glycogen 
resynthesis is of high metabolic priority. In accordance with this, muscle glycogen 
content appears to be an important regulator of contraction- and insulin-induced 
muscle glucose transport in addition to its well known effect on glycogen synthase 
activity (Richter et al., 2001). Furthermore, the magnitude of muscle glycogen 
depletion during exercise influences the utilisation of long-chain FAs as an energy 
substrate (Blomstrand & Saltin, 1999). However, the mechanisms behind these 
exercise- and glycogen-induced effects are not well characterised. AMPK is 
increasingly being recognised as an important energy-sensing molecule with putative 
effects on skeletal muscle metabolism. In rodent skeletal muscle, AMPK is 
considered to play a major role in regulating fat metabolism during post-exercise 
recovery (Ruderman et al., 2003). Following high-intensity or prolonged exercise, 
isoform-specific changes in AMPK activity are observed in human skeletal muscle. 
These include a rapid decrease in AMPKα2 activity to near resting levels together 
with unchanged  AMPKα1 activation (Wojtaszewski et al., 2000b; Wojtaszewski et 
al., 2002; Wojtaszewski et al., 2003), whilst total AMPKα phosphorylation also 
decreases (Wojtaszewski et al., 2002). In this study, AMPKα-P, which is correlated 
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with total AMPKα activity in rodent (Park et al., 2002b) and human (Wojtaszewski 
et al., 2002; Clark et al., 2004) skeletal muscle, did not decline during a 6 h recovery 
period in either trial. Although a resting biopsy was not obtained in this study, it can 
be inferred from previous studies that AMPKα-P was elevated immediately after 
exercise (Wojtaszewski et al., 2000b; Wojtaszewski et al., 2003; Yu et al., 2003; 
Clark et al., 2004). Therefore, in accordance with Chapter 4, although AMPKα-P 
was similar throughout recovery in both trials, AMPKα activation is unlikely to have 
remained above resting levels during recovery. In support of this hypothesis, a 
reduced AMP/ATP ratio and stable ATP demand under resting conditions during 
recovery would be expected to keep AMPK in its inactive (dephosphorylated) form. 
ACCβ-P, which is inversely related to ACC activity in rat muscle (Park et al., 
2002b), rapidly declined after 3 h and remained unchanged after 6 h of recovery in 
both trials. These findings demonstrate that ACCβ-P is very exercise responsive 
(Chen et al., 2003; Clark et al., 2004), particularly in the presence of reduced muscle 
glycogen (Wojtaszewski et al., 2003). Furthermore, in contrast to Chapter 4, no 
dissociation between ACCβ-P and fat oxidation was observed in either trial, since no 
difference in fat oxidation between trials was apparent.  
 
After prolonged, glycogen-lowering exercise with elevated glucose and insulin to 
facilitate rapid glycogen resynthesis, the role of IMTG for energy provision during 
post-exercise recovery remains equivocal. Using glucose infusion to induce 
hyperglycemia without hyperinsulinemia during recovery, a small but non-significant 
decline in IMTG concentration was observed, whilst no change was detected in the 
CON trial. These results concur with chapters 3 and 4 and support the hypothesis that 
plasma-derived FAs are the preferential fuel source for fat oxidation during recovery 
from glycogen-lowering exercise. Evidence from isolated rodent skeletal muscle 
suggests IMTG is a dynamic substrate (Dyck & Bonen, 1998) that is regulated by the 
rate-limiting enzyme hormone-sensitive lipase (HSL) (Langfort et al., 1998). The 
regulation of skeletal muscle HSL during exercise is complex and is thought to 
involve both β-adrenergic and perhaps more importantly AMPK-mediated 
mechanisms (Watt et al., 2004c). Indeed, the physiological importance of activating 
HSL for triacylglycerol hydrolysis is uncertain (Watt et al., 2004c) and requires 
further investigation during exercise and the immediate recovery period. It should 
also be noted that the muscle biopsy technique is unable to account for 
triacylglycerol (TG) and/or FA cycling. Thus, the possibility exists that TG 
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resynthesis during recovery may have masked the utilisation of TG as an oxidative 
fuel. Furthermore, variation in IMTG storage and contamination from TG between 
muscle fibres must also be considered, although the use of endurance-trained 
subjects in this study is likely to markedly reduce these measurement errors (Watt et 
al., 2002). 
 
To further understand the molecular mechanisms regulating substrate metabolism 
after glycogen-lowering exercise, genes pertinent to CHO and fat oxidation were 
measured. The major finding was the significant reduction in exercise-induced PDK4 
gene expression after 3 and 6 h of recovery during glucose infusion. PDK is a 
regulatory enzyme in skeletal muscle that phosphorylates and inactivates the E1α-
subunit of the PDH complex. During conditions of reduced glycolytic flux and 
increased FA oxidation, PDK activity and PDK4 mRNA are elevated in resting 
human skeletal muscle (Peters et al., 1998). Indeed, PDK4 is modified when there is 
a sustained change in tissue FA delivery and/or handling and is hypothesised to be a 
“lipid status”-responsive PDK isoform (Sugden et al., 2001). In support of this 
hypothesis, reducing plasma FFA levels with glucose infusion lowered the exercise-
induced increase in PDK4 mRNA observed during the CON trial. Interestingly, 
despite an enhanced suppression of plasma FAs with nicotinic acid (NA), a transient 
reduction in PDK4 expression during post-exercise recovery was observed (Chapter 
4). This discrepancy is most likely a result of the elevated insulin in the present study 
which is known to decrease the abundance of PDK4 mRNA (Huang et al., 2002). 
Although insufficient muscle tissue prevented the measurement of PDHa in this 
study, the progressive increase in PDK4 mRNA during prolonged fasting in humans 
has been associated with a decline in PDHa (Spriet et al., 2004). Therefore, the 
possibility exists that attenuated expression of PDK4 also reduced PDK activity and 
thus maintained PDHa to account for the higher rates of CHO oxidation observed 
during GLU compared with the CON trial. In support of this postulate, Chapter 3 
demonstrated that reduced FFA levels in response to high-CHO ingestion prevented 
a significant decline in PDHa after 3 h of post-exercise recovery. 
 
Elevated plasma FA levels are associated with increased skeletal muscle MCD 
mRNA and activity in oxidative (soleus) muscle (Young et al., 2001). In human 
skeletal muscle, lowering plasma FAs using NA reduces the expression of MCD 
compared with fat infusion and control trials during post-exercise recovery (Chapter 
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4). Therefore, FAs appear to be involved in the regulation of MCD as well as PDK4 
gene expression in human skeletal muscle. Consistent with these data, the present 
study indicates that high FFA levels during 6 h of post-exercise recovery in the 
fasted state increased skeletal muscle MCD gene expression by ~2.5-fold. However, 
reducing FFA availability with glucose infusion did not suppress the post-exercise 
increase in MCD mRNA abundance as observed with NA ingestion (Chapter 4). 
Since plasma FAs were significantly lower with NA compared to GLU throughout 
recovery except at 4 and 5 h (data not shown), the regulation of MCD expression 
may be sensitive to plasma FAs above resting levels or NA may suppress MCD 
mRNA through a mechanism unrelated to reduced FA availability. In support of the 
latter postulate, NA also increases plasma epinephrine which coincides with a 
blunting of the exercise-induced increase in PPARα and PPARδ mRNA after 
prolonged exercise (Watt et al., 2004a). Therefore, one inviting hypothesis is that an 
epinephrine-mediated decline in PPARα and PPARδ activation may have indirectly 
contributed to the reduction of MCD expression in Chapter 4, together with an 
additive effect of lowered plasma FFA levels during recovery. However, this 
hypothesis needs to be directly tested in human skeletal muscle.  
  
GLUT4 is a major regulatory protein involved in skeletal muscle glucose uptake and 
disposal. The increased post-exercise GLUT4 protein expression is controlled by 
both pretranslational and translational mechanisms that leads to an increase in muscle 
glucose uptake in accordance with glucose availability (Kuo et al., 1999a; Kuo et al., 
1999b). After a single bout of moderate-intensity exercise, GLUT4 mRNA is 
increased and remains elevated for up to 3 hours in recovery (Kraniou et al., 2000). 
This study has also demonstrated that GLUT4 gene expression is unchanged after 6 h 
of post-exercise recovery and extend these data to show that despite an upregulation 
of GLUT4 mRNA with increased glucose availability, no difference was observed 
between GLU or CON. In rodent skeletal muscle, CHO supplementation attenuates 
the exercise-induced GLUT4 gene expression for up to 42 h after exercise (Kuo et 
al., 1999b; Garcia-Roves et al., 2003). The discrepancy in these findings may result 
from a lowered insulin response during glucose infusion compared with oral CHO 
feeding, although this hypothesis needs verifying in human skeletal muscle. Based on 
the absence of a treatment effect, it appears unlikely that changes in GLUT4 gene 
expression contributed to the enhanced glycogen resynthesis observed during GLU. 
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Acute exercise transiently increases LPL gene expression in untrained individuals 
(Seip et al., 1997), whilst no difference in exercise-induced LPL activity was 
reported during a euglycemic hyperinsulinemic clamp after exercise compared with 
saline infusion (Kiens et al., 1989). No effect of hyperglycemia on LPL mRNA 
relative to saline infusion was demonstrated in this study, although a time effect was 
observed during GLU. Muscle LPL activity is increased in well-trained individuals 
after glycogen-depleting exercise that coincides with the use of IMTG as an energy 
source during recovery (Kiens & Richter, 1998). Although this study found no 
treatment effect of elevated plasma glucose on LPL gene expression, the possibility 
exists that LPL-mediated breakdown of very-low density lipoprotein triglyceride 
(VLDL TG) in muscle provide supplementary long-chain FAs as an oxidative fuel in 
addition to plasma-derived FAs during recovery.  
 
In summary, increased glucose availability after high-intensity exercise induces a 
significant increase in CHO oxidation compared with the fasted state, although no 
differences in whole-body fat oxidation were apparent. Although AMPKα 
phosphorylation remained elevated during recovery, it is unlikely that AMPK 
activity was sustained throughout the 6 h recovery period. No change in IMTG 
concentration was observed, supporting the hypothesis that plasma-derived FAs are 
the preferential fuel source for fat oxidation during recovery from glycogen-lowering 
exercise. The large exercise-induced PDK4 gene expression was attenuated when 
plasma FFAs were reduced during GLU, supporting the hypothesis that PDK4 is 
responsive to sustained changes in lipid availability and/or changes in plasma insulin. 
Furthermore, the possibility exists that the suppression of PDK4 mRNA also reduced 
PDK activity and thus maintained PDHa to account for the higher rates of CHO 
oxidation observed during GLU compared with the CON trial. 
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CHAPTER SIX 
DISCUSSION OF FINDINGS AND FUTURE DIRECTIONS 
 
 
6.1 DISCUSSION OF FINDINGS 
Recovery from prolonged or high-intensity exercise is characterised by an increased 
reliance on plasma-derived FAs as an oxidative fuel and a partitioning of glucose 
towards glycogen resynthesis. In response to altering fat and CHO availability after 
glycogen-lowering exercise in this thesis, RER and calculated rates of whole body 
substrate utilisation indicated FAs were a major fuel source. This finding is 
consistent with previous studies that have examined fat oxidation in the presence of 
reduced glycogen after exercise (Bielinski et al., 1985; Devlin et al., 1989; Wolfe et 
al., 1990; Schrauwen et al., 1997; Tuominen et al., 1997; Kiens & Richter, 1998). 
Furthermore, the results of this thesis support the hypothesis that recovery from 
prolonged exercise induces a number of changes in skeletal muscle that allow for a 
high metabolic priority towards glycogen resynthesis (Richter et al., 2001). Despite 
the well reported finding that skeletal muscle fat oxidation is enhanced after exercise, 
the cellular and molecular mechanisms facilitating this effect remain poorly defined. 
To further our understanding of the primary factors regulating both fat and CHO 
metabolism after exercise, this thesis examined alterations in metabolic protein 
activity, content and gene expression in human skeletal muscle. 
 
An increasing body of evidence suggests that exercise-induced activation of AMPK 
appears to co-ordinately regulate a decrease in ACC and increase in MCD activity 
during post-exercise recovery (Park et al., 2002a; Ruderman et al., 2003). Such 
coordinated changes in MCD and ACC attributable to AMPK are suggested to lower 
malonyl-CoA concentration and thus allow for enhanced CPT I mediated LCFA 
transport into the mitochondria (Park et al., 2002a; Ruderman et al., 2003). However, 
whilst this mechanism is evident in rodent muscle (Ruderman et al., 2003), it is 
unknown whether AMPK mediates an increase post-exercise fat oxidation in human 
skeletal muscle. Therefore, one aim of this thesis was to examine malonyl-CoA 
concentration together with ACCβ and AMPKα phosphorylation after exercise in 
response to altered plasma FFA availability in human muscle. 
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The first important finding of these studies is that differences in whole-body fat 
oxidation in response to acute alterations in plasma FFA availability after exercise 
are unrelated to changes in malonyl-CoA concentration. This result is in contrast to 
the important role of malonyl-CoA in regulating FA oxidation in resting human 
muscle (Bavenholm et al., 2000; Rasmussen et al., 2002) and in rodent muscle after 
exercise (Rasmussen et al., 1998; Park et al., 2002a). Thus, the data suggest that in 
human skeletal muscle, malonyl-CoA is not a primary regulator of fat metabolism 
during the immediate post-exercise recovery period. During exercise, available 
evidence also suggests that changes in malonyl-CoA concentration in human skeletal 
muscle do not play a major regulatory role in controlling LCFA oxidation (Kiens & 
Roepstorff, 2003). Furthermore, the regulation of CPT I activity appears more 
complex than simple changes in malonyl-CoA levels and/or that malonyl-CoA 
inhibition is overridden during exercise (Bezaire et al., 2004). Clearly, the role of 
malonyl-CoA as a regulator of human skeletal muscle fat metabolism after exercise 
remains uncertain and requires further study. 
 
During recovery from glycogen-lowering exercise, no change in AMPKα 
phosphorylation (AMPKα-P) was observed with altered fat or CHO availability. 
Although pre-exercise measurements were not taken, it can be inferred from previous 
studies that both AMPKα-P and ACCβ phosphorylation (ACCβ-P) were increased in 
response to glycogen-lowering exercise (Wojtaszewski et al., 2000; Wojtaszewski et 
al., 2003; Yu et al., 2003). However, previous studies suggest that AMPK activation 
is unlikely to have remained above resting levels during recovery (Wojtaszewski et 
al., 2000; Wojtaszewski et al., 2002; Wojtaszewski et al., 2003) and thus may 
account for the lack of increase in ACCβ-P (Chapters 4 and 5). Furthermore, the low 
and stable ATP demand observed during these studies would be expected to keep 
AMPK in its inactive form. Of further significance in this thesis was the absence of 
change in ACCβ-P after 3 h of recovery despite the difference in fat oxidation 
between fat infusion and NA ingestion in Chapter 4. It appears evident from this 
finding that ACCβ-P and fat oxidation are dissociated in human skeletal muscle 
during post-exercise recovery. Thus, factors other than the phosphorylation state of 
ACCβ appear to regulate ACC activity and subsequently malonyl-CoA in human 
skeletal muscle. These factors may include the cytosolic concentration of citrate and 
LCFA-CoA, or that ACCβ-P is affected by other inhibitors (e.g., by phosphatase 
activity).   
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It should also be noted that although AMPK and ACC activity was not measured in 
this thesis, AMPKα-P is correlated with total AMPK activity in rodent (Park et al., 
2002b) and human (Wojtaszewski et al., 2002; Clark et al., 2004) skeletal muscle, 
whilst ACCβ-P is inversely related to ACC activity in rat muscle (Park et al., 2002b). 
Therefore, the AMPKα and ACCβ phosphorylation data presented in this thesis 
appears to be a valid representation of AMPK and ACC activity during post-exercise 
recovery. Furthermore, AMPK and ACC total protein concentrations were not 
determined due to technical difficulties. However, total protein for AMPK and ACC 
remains stable in response to exercise and substrate availability interventions 
(McGee et al., 2003; Wojtaszewski et al., 2003; Clark et al., 2004), providing further 
support that AMPK and ACC phosphorylation measures are indicative of protein 
activity and not changes in protein content. 
 
In addition to plasma-derived FAs, IMTG hydrolysis is thought to be an important 
source of LCFAs supporting the increase in fat metabolism after exercise in the 
presence of elevated glucose and insulin (Kiens & Richter, 1998). However, using a 
protocol that essentially replicated this study, IMTG concentration was demonstrated 
to have a negligible role in contributing to the enhanced fat oxidation after 
exhaustive exercise (Chapter 3). Furthermore, despite the marked reduction in 
plasma FFA concentration with NA ingestion, fat oxidation remained similar to that 
observed during the control trial and IMTG concentration tended to increase 
(Chapter 4). These results suggest that FA requirement is substantially reduced after 
exhaustive exercise and this accounts for the negligible effect of reduced FA 
availability on lowering fat oxidation. Interestingly, elevated plasma FFAs during 
Intralipid and heparin infusion did not increase IMTG concentration as previously 
demonstrated in human skeletal muscle using the non-invasive method of 1H-NMR 
(Boden et al., 2001). No change in IMTG concentration was also observed during 
conditions of hyperglycemia without hyperinsulinemia after exercise (Chapter 5). 
Therefore, these data support the hypothesis that plasma-derived FFAs are the 
preferential fuel source contributing to the enhanced fat oxidation during recovery 
from glycogen-lowering exercise. Mechanisms regulating IMTG hydrolysis were not 
investigated in this thesis, although they are complex and involve both β-adrenergic 
and perhaps more importantly AMPK-mediated mechanisms (Watt et al., 2004b).  
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Regulation of skeletal muscle CHO metabolism following glycogen-lowering 
exercise has also been studied in this thesis. In response to increased glucose 
availability, CHO oxidation was significantly higher during recovery compared with 
the fasted state (Chapter 5). Of particular significance was the novel measurement of 
skeletal muscle PDHa during post-exercise recovery (Chapter 3). After a 3 h 
recovery period, PDHa was lower but not significantly different from immediately 
post-exercise, followed by a return to basal levels after 6 h with high-CHO ingestion. 
Although PDHa remained elevated during early post-exercise recovery, the decline 
was consistent with a rapid increase in glycogen resynthesis and high rates of fat 
oxidation, supporting the theory that muscle glycogen replenishment has high 
metabolic priority. The possibility also exists that maintenance of PDHa during the 
early phase of recovery facilitated the increase in CHO oxidation during glucose 
infusion compared with control (Chapter 5). Furthermore, the importance of PDHa as 
a regulator of skeletal muscle substrate oxidation is demonstrated by the ability of 
short-term (2-3 days) high-CHO feeding to increase PDHa and CHO oxidation at rest 
and during moderate-intensity exercise compared with a high-fat intake (Putman et 
al., 1993; Arkinstall et al., unpublished data). 
 
To further understand the molecular mechanisms regulating substrate metabolism 
after glycogen-lowering exercise, genes pertinent to CHO and fat oxidation were 
measured. Novel changes in gene expression during post-exercise recovery were 
observed, of which the most notable were a significant reduction in MCD and PDK4 
gene expression in the presence of reduced FFA availability. Indeed, it was 
demonstrated that lowering plasma FAs after exercise with NA ingestion suppresses 
MCD mRNA compared with elevated plasma FFAs during control and fat infusion 
trials (Chapter 4). These results confirm the hypothesis that FAs are involved in the 
regulation of rodent skeletal muscle MCD gene expression (Young et al., 2001) and 
extend these data to suggest that FAs are also involved in the regulation of MCD 
mRNA in human skeletal muscle. However, the effect of altered MCD mRNA 
during recovery on MCD activation is uncertain, since MCD activity was not 
determined in this thesis or in previous studies investigating post-exercise 
metabolism in humans. Interestingly, reducing FFA availability with glucose 
infusion did not suppress the post-exercise increase in MCD mRNA abundance 
(Chapter 5). This raises the possibility that NA may have suppressed MCD mRNA 
through a mechanism unrelated to reduced FA availability. In support of this 
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hypothesis, NA also increases plasma epinephrine which coincides with an 
attenuation of the exercise-induced increase in PPARα and PPARδ mRNA after 
prolonged exercise (Watt et al., 2004a). Therefore, one inviting hypothesis is that an 
epinephrine-mediated decline in PPARα and PPARδ activation may have indirectly 
contributed to the reduction of MCD expression in Chapter 4, together with an 
additive effect of lowered plasma FFA levels during recovery. Clearly, further study 
is required to directly test this hypothesis in human skeletal muscle.  
 
Expression of PDK4 is modified when there is a sustained change in tissue FA 
delivery and/or handling (Wu et al., 1999; Holness et al., 2002; Spriet et al., 2004) 
and is hypothesised to be a “lipid status”-responsive PDK isoform (Sugden et al., 
2001). Consistent with these data, lowering plasma FFA levels with glucose infusion 
induced a prolonged suppression of PDK4 mRNA during recovery (Study III), whilst 
this effect was only transient with NA ingestion (Chapter 4). Since insulin lowers 
PDK4 gene expression (Huang et al., 2002), these are the first data in human skeletal 
muscle to demonstrate that a sustained reduction in PDK4 mRNA after exercise 
results from an additive effect of decreased FA availability and increased insulin 
secretion. Furthermore, the progressive increase in PDK4 mRNA during prolonged 
fasting in humans has been associated with a decline in PDHa (Spriet et al., 2004). 
This finding raises the possibility that attenuated expression of PDK4 also reduced 
PDK activity and thus maintained PDHa to account for the higher rates of CHO 
oxidation observed during glucose infusion and NA ingestion. In support of this 
postulate, Chapter 3 demonstrated that reduced FFA levels in response to high-CHO 
ingestion prevented a significant decline in PDHa after 3 h of post-exercise recovery. 
   
Collectively, these findings demonstrate that alterations in fat and glucose 
availability after glycogen-lowering exercise induce significant changes in substrate 
oxidation and the transcription of important metabolic genes within skeletal muscle. 
However, manipulating FA and glucose availability had no additional effect on the 
exercise-induced phosphorylation state of AMPKα or ACCβ during recovery. 
Moreover, it appears that factors other than malonyl-CoA concentration have a major 
regulatory role in controlling LCFA oxidation during post-exercise recovery in 
human skeletal muscle. Large differences in FA, glucose and insulin availability had 
no impact on the degradation of IMTG after exercise. This highlights the reliance on 
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plasma-derived FAs to support the enhanced rate of fat oxidation after glycogen-
lowering exercise. 
 
6.2 FUTURE DIRECTIONS 
Although the mechanisms regulating fat metabolism during short and long-term 
exercise in humans have received considerable attention, relatively little is known 
about the regulation of FA oxidation during post-exercise recovery in human skeletal 
muscle. Clearly further studies are required to examine the transcriptional, 
translational and post-translational events involved in the metabolic adaptive process 
to acute exercise and nutritional stimuli. This series of studies has focused on the 
effect of substrate manipulation after glycogen-lowering exercise and attempted to 
integrate changes in whole body CHO and fat oxidation with changes in substrate 
concentration, protein content and activity. The abundance of selected genes was also 
determined in this thesis, although whether changes in gene expression translate to 
changes in protein content and activity remains unknown.  
 
Future studies are required to determine the extent to which the activities of key 
enzymes regulating fat metabolism such as MCD, ACC, AMPK, HSL, and CPT I are 
altered in response to substrate availability after exercise in human skeletal muscle. 
The importance of key factors regulating these enzymes such as malonyl-CoA, 
carnitine, citrate and LCFA-CoA also require further investigation. Integrating 
changes in mRNA abundance with changes in protein content and activity would 
also provide further information on the immediate and long-term regulation of these 
proteins by exercise and substrate provision. Furthermore, signalling mechanisms 
sensitive to muscle glycogen content may be linked to the transcriptional control of 
exercise-responsive genes (Pilegaard et al., 2002) and to the activity of AMPKα 
(Wojtaszewski et al., 2003). Therefore, further studies are warranted to examine the 
effect of post-exercise muscle glycogen content on metabolic gene expression and 
the activities of key enzymes regulating LCFA oxidation in humans. The effect of 
endurance exercise training on metabolic responses during recovery is another area 
of future study, since differences in gene transcription are observed in trained 
skeletal muscle after exercise (Pilegaard et al., 2003).  Examining the mechanisms 
for FA-induced changes in metabolic gene transcription during post-exercise 
recovery would also provide valuable information about the molecular regulation of 
human skeletal muscle metabolism. In particular, determining the importance of FA 
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sensitive coactivator molecules such as PPARα and δ and forkhead type 
transcription factors (FOXO), together with the PPARγ coactivator 1α (PGC1α) in 
response to exercise and substrate supply will allow a greater understanding of the 
cellular adaptation to exercise. Subsequent studies should also include a pre-exercise 
muscle biopsy to establish valid baseline measures for comparison with post-exercise 
data. 
 
This series of studies utilised the muscle biopsy technique to determine the 
degradation or esterification of IMTG in the vastus lateralis muscle after exercise. A 
more sensitive measure of FA kinetics during exercise and the subsequent recovery 
period is stable isotope infusion, which allows for the calculation of whole body fat 
oxidation, lipolysis and reesterification (Wolfe et al., 1990). Furthermore, isotope 
infusion enables the quantification of IMTG utilisation from the difference between 
total fat oxidation and the rate plasma FFA oxidation (Romijn et al., 1993; Klein et 
al., 1994; Romijn et al., 1995; van Loon et al., 2001), since the contribution from 
circulating VLDL under normal dietary conditions is typically less than 10% of total 
fat metabolism (Helge et al., 2001). Thus, stable isotope infusion during a 5-6 h post-
exercise recovery period would provide a comprehensive analysis of the relative 
contribution of plasma and intramuscular derived FAs towards oxidative energy 
production.  
 
Recently, the use of magnetic resonance spectroscopy (1H-MRS) has received 
considerable attention is an alternative technique for the non-invasive quantification 
of IMTG in human skeletal muscle in response to substrate manipulation after 
exercise (Boesch et al., 1997; Boesch et al., 1999; Decombaz et al., 2000; Krssak et 
al., 2000; Decombaz et al., 2001; Larson-Meyer et al., 2002; Van Loon et al., 2003). 
Importantly, 1H-MRS technology permits the accurate quantitative assessment of 
biologically relevant changes in IMTG for a wide spectrum of populations and also 
allows for the determination of IMTG across several muscle groups. A majority of 
1H-MRS studies have examined IMTG replenishment during a prolonged recovery 
period after exercise (1-3 days), however a more detailed time course of IMTG 
hydrolysis or resynthesis in the presence of altered CHO and fat availability requires 
further study. Using 1H-NMR to examine whether IMTG oxidation is greater in 
females compared with males after exercise is also of interest, since recent evidence 
suggests that females utilise more IMTG during exercise than males (Steffensen et 
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al., 2002). Moreover, 1H-MRS together with muscle biopsies from the vastus 
lateralis would enable simultaneous analysis of gene and enzyme activation that have 
key roles in regulating FFA and IMTG metabolism during post-exercise recovery.  
 
6.3 CONCLUSIONS 
In summary, the results of the studies presented in this thesis are as follows: 
 
1. IMTG hydrolysis appears to make a negligible contribution to the enhanced fat 
oxidation during post-exercise recovery in the presence of altered fat and CHO 
availability. 
 
2. Despite the maintenance of PDHa after 3 h of post-exercise recovery, muscle 
glycogen resynthesis is rapid and fat oxidation is increased, indicating that 
glycogen replenishment has high metabolic priority in human skeletal muscle.  
 
3. Changes in whole body fat oxidation after exercise are unrelated to levels of 
malonyl-CoA in human skeletal muscle, suggesting that malonyl-CoA is not a 
primary regulator of fat metabolism. 
 
4. ACCβ-P remained unchanged despite significant differences in fat oxidation 
with altered fat availability, suggesting there is dissociation between ACCβ-P 
and fat oxidation in humans during post-exercise recovery.  
 
5. The lack of association between ACCβ-P and malonyl-CoA with altered fat 
availability suggests that factors other than the phosphorylation state of ACCβ 
are regulating ACC activity and thus malonyl-CoA in human skeletal muscle. 
These factors could include the cytosolic concentration of citrate, LCFA-CoA 
or differences in MCD activity. 
 
6. Reducing plasma FFA levels with NA suppressed the post-exercise increase in 
MCD mRNA, suggesting that FAs and/or other factors induced by NA are 
involved in the regulation of MCD gene expression in human skeletal muscle.  
 
7. Glycogen-lowering exercise induces a large increase in PDK4 gene expression 
that is attenuated in response to a reduction in post-exercise plasma FFA 
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concentration and/or elevated plasma insulin. Reduced expression of PDK4 
may have also reduced PDK activity and thus maintained PDHa to account for 
the higher rates of CHO oxidation observed during glucose infusion and NA 
ingestion. 
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